Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples

Exposure to a variety of toxins and/or infectious agents leads to disease, degeneration and death, often characterised by circumstances in which cells or tissues do not merely die and cease to function but may be more or less entirely obliterated. It is then legitimate to ask the question as to whether, despite the many kinds of agent involved, there may be at least some unifying mechanisms of such cell death and destruction. I summarise the evidence that in a great many cases, one underlying mechanism, providing major stresses of this type, entails continuing and autocatalytic production (based on positive feedback mechanisms) of hydroxyl radicals via Fenton chemistry involving poorly liganded iron, leading to cell death via apoptosis (probably including via pathways induced by changes in the NF-κB system). While every pathway is in some sense connected to every other one, I highlight the literature evidence suggesting that the degenerative effects of many diseases and toxicological insults converge on iron dysregulation. This highlights specifically the role of iron metabolism, and the detailed speciation of iron, in chemical and other toxicology, and has significant implications for the use of iron chelating substances (probably in partnership with appropriate anti-oxidants) as nutritional or therapeutic agents in inhibiting both the progression of these mainly degenerative diseases and the sequelae of both chronic and acute toxin exposure. The complexity of biochemical networks, especially those involving autocatalytic behaviour and positive feedbacks, means that multiple interventions (e.g. of iron chelators plus antioxidants) are likely to prove most effective. A variety of systems biology approaches, that I summarise, can predict both the mechanisms involved in these cell death pathways and the optimal sites of action for nutritional or pharmacological interventions.

[1]  Diego di Bernardo,et al.  Computational Biology and Drug Discovery: From Single-Target to Network Drugs , 2006 .

[2]  R. Bucala,et al.  Therapeutic approaches to innate immunity: severe sepsis and septic shock , 2003, Nature Reviews Drug Discovery.

[3]  M. Ziol,et al.  Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis. , 2008, Gastroenterology.

[4]  T. Rönnemaa,et al.  Dietary and serum vitamins and minerals as predictors of myocardial infarction and stroke in elderly subjects. , 2005, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[5]  L. Weinehall,et al.  Iron Stores and HFE Genotypes Are Not Related to Increased Risk of Ischemic Stroke , 2007, Cerebrovascular Diseases.

[6]  G. Challis,et al.  Recent advances in siderophore biosynthesis. , 2009, Current opinion in chemical biology.

[7]  Martin Brown,et al.  Information-theoretic sensitivity analysis: a general method for credit assignment in complex networks , 2007, Journal of The Royal Society Interface.

[8]  D. Dickson,et al.  Iron and reactive oxygen species activity in parkinsonian substantia nigra. , 2010, Parkinsonism & related disorders.

[9]  E. Hirsch,et al.  Iron metabolism and Parkinson's disease. , 1998, Movement disorders : official journal of the Movement Disorder Society.

[10]  J. Forrester Prevention of Plaque Rupture: A New Paradigm of Therapy , 2002, Annals of Internal Medicine.

[11]  V. De Sanctis,et al.  Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre. , 2008, Pediatric endocrinology reviews : PER.

[12]  Young Woo Kim,et al.  Efficacy of sauchinone as a novel AMPK-activating lignan for preventing iron-induced oxidative stress and liver injury. , 2009, Free radical biology & medicine.

[13]  A. Young,et al.  A small-molecule therapeutic lead for Huntington's disease: Preclinical pharmacology and efficacy of C2-8 in the R6/2 transgenic mouse , 2007, Proceedings of the National Academy of Sciences.

[14]  V Hachinski,et al.  Diffuse vacuolization (spongiosis) and arteriolosclerosis in the frontal white matter occurs in vascular dementia. , 1996, Archives of neurology.

[15]  B. Corominas-Murtra,et al.  On the basic computational structure of gene regulatory networks. , 2009, Molecular bioSystems.

[16]  Yong Tong,et al.  Iron Chelators as Potential Therapeutic Agents for Parkinson's Disease. , 2008, Current bioactive compounds.

[17]  K. Kowdley,et al.  Curcumin reduces the toxic effects of iron loading in rat liver epithelial cells , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[18]  G. Perry,et al.  Metal ions and oxidative protein modification in neurological disease. , 2005, Annali dell'Istituto superiore di sanita.

[19]  E. Taylor,et al.  Molecular modeling of the oxidized form of nuclear factor-kappa B suggests a mechanism for redox regulation of DNA binding and transcriptional activation. , 2008, Journal of molecular graphics & modelling.

[20]  I. Boldogh,et al.  Iron-mediated dismutation of superoxide anion augments antigen-induced allergic inflammation: effect of lactoferrin. , 2007, Postepy higieny i medycyny doswiadczalnej.

[21]  J. Ziegler,et al.  Kaposi's sarcoma, oncogenic viruses, and iron. , 2001, Journal of Clinical Virology.

[22]  R. Keep,et al.  Deferoxamine Reduces Intracerebral Hematoma-Induced Iron Accumulation and Neuronal Death in Piglets , 2009, Stroke.

[23]  Declan P Naughton,et al.  Dietary chelators as antioxidant enzyme mimetics: implications for dietary intervention in neurodegenerative diseases. , 2006, Behavioural pharmacology.

[24]  F. Bronte,et al.  Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C , 2008, Haematologica.

[25]  T. Evans,et al.  Iron signalling regulated directly and through oxygen: implications for sepsis and the acute respiratory distress syndrome. , 2001, Clinical science.

[26]  J. Joseph,et al.  Transferrin Receptor-dependent Iron Uptake Is Responsible for Doxorubicin-mediated Apoptosis in Endothelial Cells , 2002, The Journal of Biological Chemistry.

[27]  A. Detsi,et al.  Multifunctional lipoic acid conjugates. , 2009, Current medicinal chemistry.

[28]  N. M. Nasab,et al.  Elevated serum ferritin concentrations in prediabetic subjects , 2008, Diabetes & vascular disease research.

[29]  Péter Csermely,et al.  The efficiency of multi-target drugs: the network approach might help drug design. , 2004, Trends in pharmacological sciences.

[30]  S. Cuzzocrea,et al.  Potential therapeutic effect of antioxidant therapy in shock and inflammation. , 2004, Current medicinal chemistry.

[31]  C. Chao,et al.  Participation of nitric oxide and iron in the oxidation of DNA in asbestos-treated human lung epithelial cells. , 1996, Archives of biochemistry and biophysics.

[32]  C. Szabó THE PATHOPHYSIOLOGICAL ROLE OF PEROXYNITRITE IN SHOCK, INFLAMMATION, AND ISCHEMIA‐REPERFUSION INJURY , 1996, Shock.

[33]  J. Błasiak,et al.  Iron and age-related macular degeneration. , 2009, Klinika oczna.

[34]  D. Schuppan,et al.  Iron, HCV, and liver cancer: hard metal setting the pace? , 2006, Gastroenterology.

[35]  N. Greig,et al.  Physiological and Pathological Role of Alpha-synuclein in Parkinson’s Disease Through Iron Mediated Oxidative Stress; The Role of a Putative Iron-responsive Element , 2009, International journal of molecular sciences.

[36]  T. Shea,et al.  Dietary supplementation with a combination of alpha-lipoic acid, acetyl-L-carnitine, glycerophosphocoline, docosahexaenoic acid, and phosphatidylserine reduces oxidative damage to murine brain and improves cognitive performance. , 2009, Nutrition research.

[37]  P. Riederer,et al.  Oxidative stress in the brain at early preclinical stages of mouse scrapie , 2006, Experimental Neurology.

[38]  A. Hilliker,et al.  RNAi-mediated suppression of the mitochondrial iron chaperone, frataxin, in Drosophila. , 2005, Human molecular genetics.

[39]  T. Montine,et al.  Association of HFE mutations with neurodegeneration and oxidative stress in Alzheimer's disease and correlation with APOE , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[40]  C. Winterbourn Toxicity of iron and hydrogen peroxide: the Fenton reaction. , 1995, Toxicology letters.

[41]  G. van Dijk,et al.  Inflammation and NF-kappaB in Alzheimer's disease and diabetes. , 2009, Journal of Alzheimer's disease : JAD.

[42]  B. Mossman,et al.  Oxygen radicals and asbestos-mediated disease. , 1994, Environmental health perspectives.

[43]  David C. Wedge,et al.  Rapid prediction of optimum population size in genetic programming using a novel genotype -: fitness correlation , 2008, GECCO '08.

[44]  T. Stein,et al.  Association of Elevated Serum Ferritin Levels and the Risk of Gestational Diabetes Mellitus in Pregnant Women , 2006, Diabetes Care.

[45]  J. Andersen,et al.  Glutathione, iron and Parkinson's disease. , 2002, Biochemical pharmacology.

[46]  A. Grafen,et al.  Pheromones, social behaviour and the functions of secondary metabolism in bacteria. , 1995, Trends in ecology & evolution.

[47]  M. A. Moro,et al.  Increased Body Iron Stores Are Associated With Poor Outcome After Thrombolytic Treatment in Acute Stroke , 2007, Stroke.

[48]  R. Mateo-Gallego,et al.  Serum ferritin is a major determinant of lipid phenotype in familial combined hyperlipidemia and familial hypertriglyceridemia. , 2010, Metabolism: clinical and experimental.

[49]  Beat Meier,et al.  Prions , 2010 .

[50]  M. Owen,et al.  Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer's disease , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[51]  P. Pietta,et al.  Flavonoids as antioxidants. , 2000, Journal of natural products.

[52]  C. Kunsch,et al.  Oxidative stress as a regulator of gene expression in the vasculature. , 1999, Circulation research.

[53]  M. Götz,et al.  The cell biology of neurogenesis , 2006, International Journal of Developmental Neuroscience.

[54]  M. Verity,et al.  Oxidative mechanisms underlying methyl mercury neurotoxicity , 1991, International Journal of Developmental Neuroscience.

[55]  S. Weitzman,et al.  Asbestos causes apoptosis in alveolar epithelial cells: role of iron-induced free radicals. , 2001, The Journal of laboratory and clinical medicine.

[56]  Robert H. Hurt,et al.  Iron Bioavailability and Redox Activity in Diverse Carbon Nanotube Samples , 2007 .

[57]  Tzong-Shyuan Lee,et al.  Colocalization of iron and ceroid in human atherosclerotic lesions. , 1998, Atherosclerosis.

[58]  D G Altman,et al.  What do we mean by validating a prognostic model? , 2000, Statistics in medicine.

[59]  P. Hawkins,et al.  Inhibition of iron-catalysed hydroxyl radical formation by inositol polyphosphates: a possible physiological function for myo-inositol hexakisphosphate. , 1993, The Biochemical journal.

[60]  C. J. Valle,et al.  NEW ANILINE DERIVATIVES IN COOKING OILS ASSOCIATED WITH THE TOXIC OIL SYNDROME , 1983, The Lancet.

[61]  A. Felsani,et al.  Mechanisms of defence from Fe(II) toxicity in human intestinal Caco-2 cells. , 2009, Toxicology in vitro : an international journal published in association with BIBRA.

[62]  A. A. Farooqui,et al.  Iron, neuroinflammation, and Alzheimer's disease. , 2005, Journal of Alzheimer's disease : JAD.

[63]  Michael P Holt,et al.  The role of damage associated molecular pattern molecules in acetaminophen-induced liver injury in mice. , 2010, Toxicology letters.

[64]  J. Dunaief,et al.  Iron homeostasis and eye disease. , 2009, Biochimica et biophysica acta.

[65]  Mark A. Smith,et al.  Iron: A Pathological Mediator of Alzheimer Disease? , 2002, Developmental Neuroscience.

[66]  B. Mossman,et al.  Implication of active oxygen species as second messengers of asbestos toxicity. , 1987, Drug and chemical toxicology.

[67]  T. Valenta,et al.  Differing sensitivity of tumor cells to apoptosis induced by iron deprivation in vitro , 2001, In Vitro Cellular & Developmental Biology - Animal.

[68]  V. Loeschcke,et al.  Evolutionary Theory and Studies of Model Organisms Predict a Cautiously Positive Perspective on the Therapeutic Use of Hormesis for Healthy Aging in Humans , 2010, Dose-response : a publication of International Hormesis Society.

[69]  S. Erzurum,et al.  Redox control of asthma: molecular mechanisms and therapeutic opportunities. , 2010, Antioxidants & redox signaling.

[70]  S. Bondy,et al.  Reactive oxygen species formation as a biomarker of methylmercury and trimethyltin neurotoxicity. , 1992, Neurotoxicology.

[71]  F. Cole,et al.  Iron deficiency prevents liver toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 1979, Science.

[72]  G. Ansari,et al.  Iron exacerbates aniline-associated splenic toxicity. , 1999, Journal of toxicology and environmental health. Part A.

[73]  J A Helpern,et al.  Quantitative Assessment of Iron Accumulation in the Deep Gray Matter of Multiple Sclerosis by Magnetic Field Correlation Imaging , 2007, American Journal of Neuroradiology.

[74]  Anupom Borah,et al.  Melatonin inhibits 6‐hydroxydopamine production in the brain to protect against experimental parkinsonism in rodents , 2009, Journal of pineal research.

[75]  D. Kell Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases , 2008, BMC Medical Genomics.

[76]  G. Lenaz,et al.  Generation of Reactive Oxygen Species by Mitochondrial Complex I: Implications in Neurodegeneration , 2008, Neurochemical Research.

[77]  W. Bal,et al.  Induction of oxidative DNA damage by carcinogenic metals. , 2002, Toxicology letters.

[78]  G. Cairo,et al.  Role of HIF-1 and NF-κB Transcription Factors in the Modulation of Transferrin Receptor by Inflammatory and Anti-inflammatory Signals* , 2008, Journal of Biological Chemistry.

[79]  N. Webster,et al.  Elevated serum bleomycin-detectable iron concentrations in patients with sepsis syndrome , 1996, Intensive Care Medicine.

[80]  S. Sigurdarson,et al.  Iron and iron/manganese ratio in forage from Icelandic sheep farms: relation to scrapie , 2006, Acta veterinaria Scandinavica.

[81]  K. Becker,et al.  Dietary roles of phytate and phytase in human nutrition: A review , 2010 .

[82]  P. Bork,et al.  A side effect resource to capture phenotypic effects of drugs , 2010, Molecular systems biology.

[83]  Louise K. Charkoudian,et al.  Iron prochelator BSIH protects retinal pigment epithelial cells against cell death induced by hydrogen peroxide. , 2008, Journal of inorganic biochemistry.

[84]  N. Trinajstic,et al.  SAR and QSAR of the antioxidant activity of flavonoids. , 2007, Current medicinal chemistry.

[85]  B. Nemery,et al.  Metal toxicity and the respiratory tract. , 1990, The European respiratory journal.

[86]  J. Beckman Oxidative damage and tyrosine nitration from peroxynitrite. , 1996, Chemical research in toxicology.

[87]  M. Ristow,et al.  How increased oxidative stress promotes longevity and metabolic health: The concept of mitochondrial hormesis (mitohormesis) , 2010, Experimental Gerontology.

[88]  D. Bagchi,et al.  Oxidative mechanisms in the toxicity of metal ions. , 1995, Free radical biology & medicine.

[89]  G. Perry,et al.  Oxidative Stress and Redox‐Active Iron in Alzheimer's Disease , 2004, Annals of the New York Academy of Sciences.

[90]  A. Prentice,et al.  Iron and infection: effects of host iron status and the iron-regulatory genes haptoglobin and NRAMP1 (SLC11A1) on host-pathogen interactions in tuberculosis and HIV. , 2006, Clinical science.

[91]  G. Weiss Genetic mechanisms and modifying factors in hereditary hemochromatosis , 2010, Nature Reviews Gastroenterology &Hepatology.

[92]  J. Andersen,et al.  Iron and Paraquat as Synergistic Environmental Risk Factors in Sporadic Parkinson's Disease Accelerate Age-Related Neurodegeneration , 2007, The Journal of Neuroscience.

[93]  R. Hotchkiss,et al.  Endothelial cell apoptosis is accelerated by inorganic iron and heat via an oxygen radical dependent mechanism. , 1997, Surgery.

[94]  F. Muller,et al.  Trends in oxidative aging theories. , 2007, Free radical biology & medicine.

[95]  B. Halliwell,et al.  The iron chelator desferrioxamine inhibits atherosclerotic lesion development and decreases lesion iron concentrations in the cholesterol-fed rabbit. , 2005, Free radical biology & medicine.

[96]  Rohit Bakshi,et al.  Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity. , 2005, Archives of neurology.

[97]  E. Hassoun,et al.  Time‐ and concentration‐dependent production of superoxide anion, nitric oxide, DNA damage and cellular death by ricin in the J774A.1 macrophage cells , 1999, Journal of biochemical and molecular toxicology.

[98]  R. Bone,et al.  Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. , 1996, Critical care medicine.

[99]  A. Pastore,et al.  Understanding the binding properties of an unusual metal‐binding protein − a study of bacterial frataxin , 2007, The FEBS journal.

[100]  E. Mazzon,et al.  GREEN TEA POLYPHENOL EXTRACT ATTENUATES ZYMOSAN-INDUCED NON-SEPTIC SHOCK IN MICE , 2006, Shock.

[101]  K. Hasegawa,et al.  Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients. , 2007, Free radical biology & medicine.

[102]  M. Netea,et al.  The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. , 2007, Journal of lipid research.

[103]  D. Kusewitt,et al.  Deferoxamine delays the development of the hepatotoxicity of acetaminophen in mice. , 1999, Toxicology letters.

[104]  A. Hofman,et al.  Mutations in the hemochromatosis gene (HFE), Parkinson's disease and parkinsonism , 2003, Neuroscience Letters.

[105]  G. Ansari,et al.  Erythrocyte-aniline interaction leads to their accumulation and iron deposition in rat spleen. , 1995, Journal of toxicology and environmental health.

[106]  Mark A. Smith,et al.  Nanoparticle and iron chelators as a potential novel Alzheimer therapy. , 2010, Methods in molecular biology.

[107]  A. Satoskar,et al.  Role of STAT1, NF‐κB, and C/EBPβ in the macrophage transcriptional regulation of hepcidin by mycobacterial infection and IFN‐γ , 2009, Journal of leukocyte biology.

[108]  V. Gordeuk,et al.  Hereditary hemochromatosis: insights from the Hemochromatosis and Iron Overload Screening (HEIRS) Study. , 2009, Hematology. American Society of Hematology. Education Program.

[109]  E. Gould,et al.  Mini-review: in vivo neurogenesis in the adult brain: regulation and functional implications. , 2000, The European journal of neuroscience.

[110]  P. Lansbury,et al.  Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. , 2003, Annual review of neuroscience.

[111]  Paolo Maria Rossini,et al.  Neuronal functionality assessed by magnetoencephalography is related to oxidative stress system in acute ischemic stroke , 2009, NeuroImage.

[112]  T. Finkel Radical medicine: treating ageing to cure disease , 2005, Nature Reviews Molecular Cell Biology.

[113]  M. Bassett Iron and hepatitis C: Beginning to make sense , 2007, Journal of gastroenterology and hepatology.

[114]  Subramanian Rajagopalan,et al.  Chronic ferritin expression within murine dopaminergic midbrain neurons results in a progressive age-related neurodegeneration , 2007, Brain Research.

[115]  A. Attilakos,et al.  Homozygous MTHFR C677T gene mutation and recurrent stroke in an infant. , 2006, Pediatric neurology.

[116]  E. Filippi-Chiela,et al.  Resveratrol and quercetin cooperate to induce senescence‐like growth arrest in C6 rat glioma cells , 2009, Cancer science.

[117]  M. De la Fuente,et al.  Role of free radicals in sepsis: antioxidant therapy. , 2005, Current pharmaceutical design.

[118]  I. Marzi,et al.  Involvement of oxygen radicals in shock related cell injury. , 1993, British medical bulletin.

[119]  P Mendes,et al.  On the analysis of the inverse problem of metabolic pathways using artificial neural networks. , 1996, Bio Systems.

[120]  J. Hare,et al.  Nitroso–Redox Interactions in the Cardiovascular System , 2006, Circulation.

[121]  E. Mazzon,et al.  Treatment with green tea extract attenuates secondary inflammatory response in an experimental model of spinal cord trauma , 2009, Naunyn-Schmiedeberg's Archives of Pharmacology.

[122]  M. Bulgin,et al.  What veterinary practitioners should know about scrapie. , 2007, Journal of the American Veterinary Medical Association.

[123]  K. Pantopoulos Function of the hemochromatosis protein HFE: Lessons from animal models. , 2008, World journal of gastroenterology.

[124]  J. Haddad,et al.  Antioxidant/pro-oxidant equilibrium regulates HIF-1alpha and NF-kappa B redox sensitivity. Evidence for inhibition by glutathione oxidation in alveolar epithelial cells. , 2000, The Journal of biological chemistry.

[125]  G. Perry,et al.  The role of metals in neurodegenerative diseases. , 2000, Cellular and molecular biology.

[126]  Gary Williamson,et al.  Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. , 2005, The American journal of clinical nutrition.

[127]  E. Schwedhelm,et al.  Increased urinary excretion of 8-iso-prostaglandin F2alpha in patients with HFE-related hemochromatosis: a case-control study. , 2006, Free radical biology & medicine.

[128]  M. Elstner,et al.  Individual dopaminergic neurons show raised iron levels in Parkinson disease , 2007, Neurology.

[129]  K. Kowdley The role of iron in nonalcoholic fatty liver disease: the story continues. , 2010, Gastroenterology.

[130]  Daniela Berg,et al.  Iron metabolism in Parkinsonian syndromes , 2006, Movement disorders : official journal of the Movement Disorder Society.

[131]  C. Vulpe,et al.  Tissue-specific changes in iron metabolism genes in mice following phenylhydrazine-induced haemolysis. , 2004, Biochimica et biophysica acta.

[132]  T. Ward,et al.  Artificial metalloenzymes for asymmetric allylic alkylation on the basis of the biotin-avidin technology. , 2008, Angewandte Chemie.

[133]  Adriano Aguzzi,et al.  Molecular mechanisms of prion pathogenesis. , 2008, Annual review of pathology.

[134]  Robert H. Brown,et al.  Molecular biology of amyotrophic lateral sclerosis: insights from genetics , 2006, Nature Reviews Neuroscience.

[135]  J. Collins,et al.  Role of reactive oxygen species in antibiotic action and resistance. , 2009, Current opinion in microbiology.

[136]  Hong Wang,et al.  Insights into the behaviour of systems biology models from dynamic sensitivity and identifiability analysis: a case study of an NF-kappaB signalling pathway. , 2006, Molecular bioSystems.

[137]  C. Angelopoulos,et al.  Transferrin C2 allele, haemochromatosis gene mutations, and risk for Alzheimer's disease , 2002, Journal of neurology, neurosurgery, and psychiatry.

[138]  M. Khan,et al.  The primary role of iron-mediated lipid peroxidation in the differential cytotoxicity caused by two varieties of talc nanoparticles on A549 cells and lipid peroxidation inhibitory effect exerted by ascorbic acid. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[139]  Mardge H. Cohen,et al.  The association of serum ferritin and transferrin receptor concentrations with mortality in women with human immunodeficiency virus infection , 2006 .

[140]  A. Roussel,et al.  Acute prooxidant effects of vitamin C in EDTA chelation therapy and long-term antioxidant benefits of therapy. , 2005, Free radical biology & medicine.

[141]  Qing‐Yu He,et al.  Iron depletion decreases proliferation and induces apoptosis in a human colonic adenocarcinoma cell line, Caco2. , 2009, Journal of inorganic biochemistry.

[142]  T. Schallert,et al.  Deferoxamine Treatment for Intracerebral Hemorrhage in Aged Rats: Therapeutic Time Window and Optimal Duration , 2010, Stroke.

[143]  T. Buzan How to Mind Map , 2002 .

[144]  Barbara M. Bakker,et al.  Drug-efficacy depends on the inhibitor type and the target position in a metabolic network--a systematic study. , 2008, Journal of theoretical biology.

[145]  T. Evans,et al.  Pathogenesis of the systemic inflammatory syndrome and acute lung injury: role of iron mobilization and decompartmentalization. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[146]  G. Salvador Iron in neuronal function and dysfunction , 2010, BioFactors.

[147]  S-J. Park,et al.  Rapid in vivo screening system for anti‐oxidant activity using bacterial redox sensor strains , 2010, Journal of applied microbiology.

[148]  M. Beck,et al.  Host nutritional status: the neglected virulence factor , 2004, Trends in Microbiology.

[149]  Ya Ke,et al.  Iron misregulation in the brain: a primary cause of neurodegenerative disorders , 2003, The Lancet Neurology.

[150]  J. Ioannidis Why Most Discovered True Associations Are Inflated , 2008, Epidemiology.

[151]  K. Kataoka,et al.  Spatial redox regulation of a critical cysteine residue of NF-kappa B in vivo. , 2002, The Journal of biological chemistry.

[152]  U. Brunk,et al.  Does the calcein-AM method assay the total cellular 'labile iron pool' or only a fraction of it? , 2007, The Biochemical journal.

[153]  Mark P Mattson,et al.  Metal‐Catalyzed Disruption of Membrane Protein and Lipid Signaling in the Pathogenesis of Neurodegenerative Disorders , 2004, Annals of the New York Academy of Sciences.

[154]  G. Buonocore,et al.  Free iron, total F2‐isoprostanes and total F4‐neuroprostanes in a model of neonatal hypoxic–ischemic encephalopathy: neuroprotective effect of melatonin , 2009, Journal of pineal research.

[155]  T. Montine,et al.  Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans , 2002, Neuroscience Letters.

[156]  S. Fernaeus,et al.  Increased iron-induced oxidative stress and toxicity in scrapie-infected neuroblastoma cells , 2005, Neuroscience Letters.

[157]  Julio R. Banga,et al.  Optimization in computational systems biology , 2008, BMC Systems Biology.

[158]  E. Craig,et al.  Binding of Yeast Frataxin to the Scaffold for Fe-S Cluster Biogenesis, Isu* , 2008, Journal of Biological Chemistry.

[159]  Jeong-Chae Lee,et al.  Hydrogen peroxide induces apoptosis of BJAB cells due to formation of hydroxyl radicals via intracellular iron-mediated Fenton chemistry in glucose oxidase-mediated oxidative stress. , 2006, Molecules and cells.

[160]  Ashley I. Bush,et al.  The metallobiology of Alzheimer's disease , 2003, Trends in Neurosciences.

[161]  Y. Seol,et al.  ORIGINAL ARTICLE DOI: 10.3904/kjim.2009.24.4.368 Elevation of Serum Ferritin is Associated with the Outcome of Patients with Newly Diagnosed Multiple Myeloma , 2022 .

[162]  S. Lehmann,et al.  Oxidative stress and the prion protein in transmissible spongiform encephalopathies , 2002, Brain Research Reviews.

[163]  B. Freeman,et al.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[164]  E. Zandi,et al.  Iron activates NF-kappaB in Kupffer cells. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[165]  Sarala M. Wimalaratne,et al.  The Systems Biology Graphical Notation , 2009, Nature Biotechnology.

[166]  P. Baeuerle,et al.  [14] Assessing oxygen radicals as mediators in activation of inducible eukaryotic transcription factor NF-κB , 1994 .

[167]  K. Kowdley,et al.  Phenotypic Characteristics and Diagnoses of Patients Referred to an Iron Overload Clinic , 2010, Digestive Diseases and Sciences.

[168]  André Schrattenholz,et al.  What does systems biology mean for drug development? , 2008, Current medicinal chemistry.

[169]  M. Cronin,et al.  Metals, toxicity and oxidative stress. , 2005, Current medicinal chemistry.

[170]  L. R. Caplan,et al.  Intracerebral haemorrhage , 1992, The Lancet.

[171]  B. Rigas,et al.  NF-kappaB, inflammation and pancreatic carcinogenesis: NF-kappaB as a chemoprevention target (review). , 2006, International journal of oncology.

[172]  Leo Breiman,et al.  Statistical Modeling: The Two Cultures (with comments and a rejoinder by the author) , 2001 .

[173]  Hua-wei Ling,et al.  Correlation of iron in the hippocampus with MMSE in patients with Alzheimer's disease , 2009, Journal of magnetic resonance imaging : JMRI.

[174]  B. Antkowiak,et al.  Anaesthetic drugs: linking molecular actions to clinical effects. , 2006, Current pharmaceutical design.

[175]  Richard Morphy,et al.  Fragments, network biology and designing multiple ligands. , 2007, Drug discovery today.

[176]  Shawn D. Chase,et al.  Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease. , 2004, Kidney international.

[177]  Mudita Singhal,et al.  COPASI - a COmplex PAthway SImulator , 2006, Bioinform..

[178]  E. Faist,et al.  SYSTEMIC INFLAMMATORY RESPONSE SYNDROME (SIRS), MULTIPLE ORGAN DYSFUNCTION SYNDROME (MODS), MULTIPLE ORGAN FAILURE (MOF): ARE WE WINNING THE BATTLE? , 1998, Shock.

[179]  Role of stored iron in atherosclerosis. , 2000, Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing.

[180]  Axel Skytthe,et al.  Risk of lung cancer according to mild steel and stainless steel welding. , 2007, Scandinavian journal of work, environment & health.

[181]  Rohit Bakshi,et al.  Magnetic Resonance Imaging of Iron Deposition in Neurological Disorders , 2006, Topics in magnetic resonance imaging : TMRI.

[182]  H. Leitch Improving clinical outcome in patients with myelodysplastic syndrome and iron overload using iron chelation therapy. , 2007, Leukemia research.

[183]  P. Lavori,et al.  Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial. , 2008, Journal of the National Cancer Institute.

[184]  P. Lantos,et al.  Spatial correlations between the vacuolation, prion protein deposits, and surviving neurons in the cerebral cortex in sporadic Creutzfeldt–Jakob disease , 2001, Neuropathology : official journal of the Japanese Society of Neuropathology.

[185]  Shweta Sharma,et al.  Comparative effect of melatonin and vitamin E on phenylhydrazine‐induced toxicity in the spleen of Funambulus pennanti , 2009, Environmental toxicology.

[186]  H. Horikoshi,et al.  Combination treatment with troglitazone, an insulin action enhancer, and pravastatin, an inhibitor of HMG-CoA reductase, shows a synergistic effect on atherosclerosis of WHHL rabbits. , 1999, Atherosclerosis.

[187]  B. Palsson Systems Biology: Properties of Reconstructed Networks , 2006 .

[188]  Junxia Xie,et al.  Curcumin attenuates 6-hydroxydopamine-induced cytotoxicity by anti-oxidation and nuclear factor-kappa B modulation in MES23.5 cells. , 2009, Biochemical pharmacology.

[189]  M. Koc,et al.  Sensitivity of cells to apoptosis induced by iron deprivation can be reversibly changed by iron availability , 2006, Cell proliferation.

[190]  K. Raymond,et al.  Solution equilibria of enterobactin and metal-enterobactin complexes , 1991 .

[191]  M. Moltó,et al.  Friedreich ataxia: an update on animal models, frataxin function and therapies. , 2009, Advances in experimental medicine and biology.

[192]  U. Brunk,et al.  Autophagy, ageing and apoptosis: the role of oxidative stress and lysosomal iron. , 2007, Archives of biochemistry and biophysics.

[193]  L. Fleisher,et al.  Changes in ferritin H- and L-chains in canine lenses with age-related nuclear cataract. , 2009, Investigative ophthalmology & visual science.

[194]  S. Mandel,et al.  Simultaneous Manipulation of Multiple Brain Targets by Green Tea Catechins: A Potential Neuroprotective Strategy for Alzheimer and Parkinson Diseases , 2008, CNS neuroscience & therapeutics.

[195]  William A Weiss,et al.  A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma. , 2006, Cancer cell.

[196]  Norman W. Paton,et al.  SBRML: a markup language for associating systems biology data with models , 2010, Bioinform..

[197]  S. Heller,et al.  An Open Standard for Chemical Structure Representation: The IUPAC Chemical Identifier , 2003 .

[198]  Jeremy Nathans,et al.  Macular degeneration: recent advances and therapeutic opportunities , 2006, Nature Reviews Neuroscience.

[199]  S. Ceccatelli,et al.  Neurotoxicity and molecular effects of methylmercury , 2001, Brain Research Bulletin.

[200]  T. Carbonell,et al.  Iron, oxidative stress and early neurological deterioration in ischemic stroke. , 2007, Current medicinal chemistry.

[201]  J. Emparanza,et al.  Genes related to iron metabolism and susceptibility to Alzheimer's disease in Basque population , 2007, Neurobiology of Aging.

[202]  A. Valavanidis,et al.  Comparative study of the formation of oxidative damage marker 8-hydroxy-2′-deoxyguanosine (8-OHdG) adduct from the nucleoside 2′-deoxyguanosine by transition metals and suspensions of particulate matter in relation to metal content and redox reactivity , 2005, Free radical research.

[203]  G. J. Raymond,et al.  Hemin Interactions and Alterations of the Subcellular Localization of Prion Protein* , 2007, Journal of Biological Chemistry.

[204]  Steve Pettifer,et al.  Arcadia: a visualization tool for metabolic pathways , 2010, Bioinform..

[205]  M. Lorber The occurrence of intracellular iron in Gaucher's disease. , 1960, Annals of internal medicine.

[206]  B. Drayer,et al.  Reduced signal intensity on MR images of thalamus and putamen in multiple sclerosis: increased iron content? , 1987, AJR. American journal of roentgenology.

[207]  G. Smirnova,et al.  Influence of polyphenols on Escherichia coli resistance to oxidative stress. , 2009, Free radical biology & medicine.

[208]  V. Pachauri,et al.  Combinational chelation therapy abrogates lead-induced neurodegeneration in rats. , 2009, Toxicology and applied pharmacology.

[209]  G. Ansari,et al.  Up-regulation of heme oxygenase-1 in rat spleen after aniline exposure. , 2010, Free radical biology & medicine.

[210]  Meir Glick,et al.  Prediction of Biological Targets for Compounds Using Multiple-Category Bayesian Models Trained on Chemogenomics Databases , 2006, J. Chem. Inf. Model..

[211]  J. Mitchell,et al.  Redox imbalance in the critically ill. , 1999, British medical bulletin.

[212]  S. Rajagopalan,et al.  Chronic Iron Administration Increases Vascular Oxidative Stress and Accelerates Arterial Thrombosis , 2003, Circulation.

[213]  M. Sehested,et al.  A murine experimental anthracycline extravasation model: pathology and study of the involvement of topoisomerase II alpha and iron in the mechanism of tissue damage. , 2010, Toxicology.

[214]  A. Kallianpur Iron and oxidative injury-- a commentary on "Fatty acid-mediated iron translocation: a synergistic mechanism of oxidative injury" by D. Yao et al. , 2005, Free radical biology & medicine.

[215]  E. Calabrese,et al.  The Dose Determines the Stimulation (and Poison): Development of A Chemical Hormesis Database , 1997 .

[216]  E. Zandi,et al.  Signaling role of intracellular iron in NF-kappaB activation. , 2003, The Journal of biological chemistry.

[217]  Y. Chan,et al.  Chinese herbs and herbal extracts for neuroprotection of dopaminergic neurons and potential therapeutic treatment of Parkinson's disease. , 2007, CNS and Neurological Disorders - Drug Targets.

[218]  F. Hadacek,et al.  Hormesis and a Chemical Raison D'ětre for Secondary Plant Metabolites , 2011, Dose-response : a publication of International Hormesis Society.

[219]  R. Tsubouchi,et al.  Maltol/iron-mediated apoptosis in HL60 cells: participation of reactive oxygen species. , 2006, Toxicology letters.

[220]  C Kesavadas,et al.  Susceptibility weighted imaging: a new tool in magnetic resonance imaging of stroke. , 2009, Clinical radiology.

[221]  N. Swamy,et al.  Iron chelators deferoxamine and diethylenetriamine pentaacetic acid induce apoptosis in ovarian carcinoma. , 2006, Gynecologic oncology.

[222]  A. Romeo,et al.  Intracellular Chelation of Iron by Bipyridyl Inhibits DNA Virus Replication , 2001, The Journal of Biological Chemistry.

[223]  Masaaki Nakamura,et al.  Inhibitory effect of α-tocopherol on methylmercury-induced oxidative steress , 2004, Environmental health and preventive medicine.

[224]  Peter A. Ward,et al.  Harmful molecular mechanisms in sepsis , 2008, Nature Reviews Immunology.

[225]  P. Riederer,et al.  Neuromelanin and its interaction with iron as a potential risk factor for dopaminergic neurodegeneration underlying Parkinson's disease , 2009, Neurotoxicity Research.

[226]  C. Coopersmith,et al.  Iron dysregulation combined with aging prevents sepsis-induced apoptosis. , 2005, The Journal of surgical research.

[227]  C. Exley,et al.  Elevated urinary excretion of aluminium and iron in multiple sclerosis , 2006, Multiple sclerosis.

[228]  S. Kawanishi,et al.  Site-specific DNA damage by phenylhydrazine and phenelzine in the presence of Cu(II) ion or Fe(III) complexes: roles of active oxygen species and carbon radicals. , 1992, Chemical research in toxicology.

[229]  S. Mooney,et al.  The Ferroxidase Activity of Yeast Frataxin* , 2002, The Journal of Biological Chemistry.

[230]  M. Massari,et al.  Serum Ferritin as a Predictor of Treatment Outcome in Patients With Chronic Hepatitis C , 2009, The American Journal of Gastroenterology.

[231]  M. Cappellini,et al.  Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. , 2010, Blood.

[232]  C. Sen,et al.  Antioxidant and redox regulation of gene transcription , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[233]  D. Thickett,et al.  Statins and sepsis. , 2008, British journal of anaesthesia.

[234]  K. Okita,et al.  Protection against acetaminophen-induced liver injury in vivo by an iron chelator, deferoxamine. , 1995, Scandinavian journal of gastroenterology.

[235]  A. Shamsuddin Inositol phosphates have novel anticancer function. , 1995, The Journal of nutrition.

[236]  E. Gould,et al.  In vivo neurogenesis in the adult brain: regulation and functional implications , 2000 .

[237]  M. Marahiel,et al.  Siderophore-Based Iron Acquisition and Pathogen Control , 2007, Microbiology and Molecular Biology Reviews.

[238]  M. Sy,et al.  A Yin-Yang role for metals in prion disease. , 2001, Panminerva medica.

[239]  C. Sanfeliu,et al.  Neurotoxicity of organomercurial compounds , 2009, Neurotoxicity Research.

[240]  J. Honnorat,et al.  USPIO-Enhanced MRI of Neuroinflammation at the Sub-Acute Stage of Ischemic Stroke: Preliminary Data , 2007, Cerebrovascular Diseases.

[241]  V. Parker,et al.  Mediated, thin-layer cell, coulometric determination of redox-active iron on the surface of asbestos fibers. , 1995, Analytical chemistry.

[242]  D. Fell Understanding the Control of Metabolism , 1996 .

[243]  Hugh D. Spence,et al.  Minimum information requested in the annotation of biochemical models (MIRIAM) , 2005, Nature Biotechnology.

[244]  E. Calabrese Hormesis and medicine. , 2008, British journal of clinical pharmacology.

[245]  R. Keep,et al.  Iron-induced oxidative brain injury after experimental intracerebral hemorrhage. , 2006, Acta neurochirurgica. Supplement.

[246]  M. Karin The IκB kinase – a bridge between inflammation and cancer , 2008, Cell Research.

[247]  S. Bandinelli,et al.  Proinflammatory state, hepcidin, and anemia in older persons. , 2010, Blood.

[248]  D. Dhawan,et al.  Role of zinc in mitigating the toxic effects of chlorpyrifos on hematological alterations and electron microscopic observations in rat blood , 2006, Biometals.

[249]  J. Phillips,et al.  Attenuation of polychlorinated biphenyl induced uroporphyria by iron deprivation. , 2005, Environmental toxicology and pharmacology.

[250]  V. Skiada,et al.  Redox signaling and cancer: the role of "labile" iron. , 2008, Cancer letters.

[251]  R. Simó,et al.  Factors accounting for high ferritin levels in obesity , 2008, International Journal of Obesity.

[252]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.

[253]  R. King,et al.  On the optimization of classes for the assignment of unidentified reading frames in functional genomics programmes: the need for machine learning. , 2000, Trends in biotechnology.

[254]  J. Fernández-Real,et al.  Blood letting in high-ferritin type 2 diabetes: effects on vascular reactivity. , 2002, Diabetes care.

[255]  J. Sullivan Macrophage Iron, Hepcidin, and Atherosclerotic Plaque Stability , 2007, Experimental biology and medicine.

[256]  Mark A. Smith,et al.  In Situ Oxidative Catalysis by Neurofibrillary Tangles and Senile Plaques in Alzheimer’s Disease , 2000, Journal of neurochemistry.

[257]  T. Schiano,et al.  Blue nasal secretions: A presentation of Gaucher's disease and concurrent hemosiderosis , 1993, American journal of hematology.

[258]  M. Tyers,et al.  From large networks to small molecules. , 2004, Current opinion in chemical biology.

[259]  D. Kell Metabolomics and systems biology: making sense of the soup. , 2004, Current opinion in microbiology.

[260]  D. Ferriero,et al.  Hypoxia-inducible factor 1α and erythropoietin upregulation with deferoxamine salvage after neonatal stroke , 2005, Experimental Neurology.

[261]  J. Ruidavets,et al.  Iron status is associated with carotid atherosclerotic plaques in middle-aged adults. , 2010, The Journal of nutrition.

[262]  T. Hei,et al.  Role of oxyradicals in mutagenicity and DNA damage induced by crocidolite asbestos in mammalian cells. , 1999, Cancer research.

[263]  D. Broomhead,et al.  Something from nothing − bridging the gap between constraint‐based and kinetic modelling , 2007, The FEBS journal.

[264]  K. D. Horn Evolving strategies in the treatment of sepsis and systemic inflammatory response syndrome (SIRS). , 1998, QJM : monthly journal of the Association of Physicians.

[265]  David T. Huang,et al.  Severe sepsis and septic shock: review of the literature and emergency department management guidelines. , 2006, Annals of emergency medicine.

[266]  A. Verma,et al.  Iron overload in myelodysplastic syndromes , 2008, Leukemia & lymphoma.

[267]  D. S. Broomhead,et al.  Pulsatile Stimulation Determines Timing and Specificity of NF-κB-Dependent Transcription , 2009, Science.

[268]  Pedro Mendes,et al.  Design and Architecture of Web Services for Simulation of Biochemical Systems , 2009, DILS.

[269]  B. Ames,et al.  Detection of 8-oxo-2'-deoxyguanosine, a marker of oxidative DNA damage, in culture medium from human mesothelial cells exposed to crocidolite asbestos. , 1996, Carcinogenesis.

[270]  R. Nagai,et al.  Iron chelation and a free radical scavenger suppress angiotensin II-induced upregulation of TGF-beta1 in the heart. , 2005, American journal of physiology. Heart and circulatory physiology.

[271]  M. Kaito,et al.  Hepcidin Expression in the Liver: Relatively Low Level in Patients with Chronic Hepatitis C , 2007, Molecular medicine.

[272]  Roberto Pastor-Barriuso,et al.  Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality , 2005, Annals of Internal Medicine.

[273]  J. Dancey,et al.  Strategies for optimizing combinations of molecularly targeted anticancer agents , 2006, Nature Reviews Drug Discovery.

[274]  U. Brunk,et al.  Role of compartmentalized redox-active iron in hydrogen peroxide-induced DNA damage and apoptosis. , 2005, The Biochemical journal.

[275]  P. Vandenabeele,et al.  Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features , 2010, Cell Death and Differentiation.

[276]  S. Legrand-Poels,et al.  NF-kappaB activation by reactive oxygen species: fifteen years later. , 2006, Biochemical pharmacology.

[277]  B. Aggarwal,et al.  Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. , 2009, The international journal of biochemistry & cell biology.

[278]  K. Fukuchi,et al.  Iron deprivation‐induced apoptosis in HL‐60 cells , 1994, FEBS letters.

[279]  S. Mandel,et al.  Genes and oxidative stress in parkinsonism: cDNA microarray studies. , 2003, Advances in neurology.

[280]  C. Imrie,et al.  Spatial correlation between the prevalence of transmissible spongiform diseases and British soil geochemistry , 2009, Environmental geochemistry and health.

[281]  W. Mandemakers,et al.  A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases , 2007, Journal of Cell Science.

[282]  P. Silburn,et al.  The Cys282Tyr polymorphism in the HFE gene in Australian Parkinson's disease patients , 2002, Neuroscience Letters.

[283]  L. N. Valenti,et al.  Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis , 2001, American Journal of Gastroenterology.

[284]  R. Maccioni,et al.  Insulin resistance and Alzheimer's disease: molecular links & clinical implications. , 2008, Current Alzheimer research.

[285]  J. Doyle,et al.  Robustness as a measure of plausibility in models of biochemical networks. , 2002, Journal of theoretical biology.

[286]  M. Davies,et al.  Concentrations of iron correlate with the extent of protein, but not lipid, oxidation in advanced human atherosclerotic lesions. , 2006, Free radical biology & medicine.

[287]  C. Jones,et al.  Toxicity associated with iron overload found in hemochromatosis: possible mechanism in a rat model. , 1998, Clinical laboratory science : journal of the American Society for Medical Technology.

[288]  A. Nunomura,et al.  Oxidative Damage Is the Earliest Event in Alzheimer Disease , 2001, Journal of neuropathology and experimental neurology.

[289]  Steve Pettifer,et al.  Defrosting the Digital Library: Bibliographic Tools for the Next Generation Web , 2008, PLoS Comput. Biol..

[290]  V. Mishra Oxidative stress and role of antioxidant supplementation in critical illness. , 2007, Clinical laboratory.

[291]  R. Hall,et al.  Enrichment of tomato fruit with health-promoting anthocyanins by expression of select transcription factors , 2008, Nature Biotechnology.

[292]  V. O’Donnell,et al.  Peroxynitrite-mediated lipid oxidation and nitration: mechanisms and consequences. , 2009, Archives of biochemistry and biophysics.

[293]  M. Kruszewski,et al.  The level of 8-oxo-7,8-dihydro-2′-deoxyguanosine is positively correlated with the size of the labile iron pool in human lymphocytes , 2002, JBIC Journal of Biological Inorganic Chemistry.

[294]  D. Kell,et al.  Viability and activity in readily culturable bacteria: a review and discussion of the practical issues , 1998, Antonie van Leeuwenhoek.

[295]  E. Bertini,et al.  Friedreich's ataxia: Oxidative stress and cytoskeletal abnormalities , 2009, Journal of the Neurological Sciences.

[296]  D. Marmolino,et al.  Friedreich’s Ataxia: From the (GAA)n Repeat Mediated Silencing to New Promising Molecules for Therapy , 2009, The Cerebellum.

[297]  L. Hallberg,et al.  Inositol phosphates with different numbers of phosphate groups influence iron absorption in humans. , 1999, The American journal of clinical nutrition.

[298]  Y. Takei,et al.  Iron, hepatitis C virus, and hepatocellular carcinoma: iron reduction preaches the gospel for chronic hepatitis C , 2007, Journal of Gastroenterology.

[299]  Stephen L. Hauser,et al.  The genetics of multiple sclerosis: SNPs to pathways to pathogenesis , 2008, Nature Reviews Genetics.

[300]  J. Olynyk,et al.  Phenotypic Expression of Hereditary Hemochromatosis: What Have We Learned from the Population Studies? , 2010, Current gastroenterology reports.

[301]  F. Torti,et al.  Ferritin for the clinician. , 2009, Blood reviews.

[302]  Tilman Grune,et al.  Lipofuscin: formation, distribution, and metabolic consequences. , 2007, Annals of the New York Academy of Sciences.

[303]  A E Aust,et al.  Iron mobilization from crocidolite asbestos greatly enhances crocidolite-dependent formation of DNA single-strand breaks in phi X174 RFI DNA. , 1992, Carcinogenesis.

[304]  H. Bonkovsky,et al.  Iron as a comorbid factor in chronic viral hepatitis , 2002, American Journal of Gastroenterology.

[305]  A. Nunomura,et al.  Oxidative Stress, Antioxidants, and Alzheimer Disease , 2000, Alzheimer disease and associated disorders.

[306]  Elizabeth C. Theil,et al.  Comparison of organ dysfunction in transfused patients with SCD or beta thalassemia. , 2005, American journal of hematology.

[307]  C. Olanow,et al.  Oxidative stress and the pathogenesis of Parkinson's disease , 1996, Neurology.

[308]  V. O’Donnell,et al.  Nitric oxide, peroxynitrite and lipoxygenase in atherogenesis: mechanistic insights. , 2005, Toxicology.

[309]  R. Stoohs,et al.  Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease. , 2002, Gastroenterology.

[310]  E M Haacke,et al.  Iron stores and cerebral veins in MS studied by susceptibility weighted imaging. , 2010, International angiology : a journal of the International Union of Angiology.

[311]  W. Strittmatter,et al.  Prevention of polyglutamine oligomerization and neurodegeneration by the peptide inhibitor QBP1 in Drosophila. , 2003, Human molecular genetics.

[312]  J. Hardy,et al.  The effect of iron binding on the ability of crocidolite asbestos to catalyze DNA single-strand breaks. , 1995, Carcinogenesis.

[313]  Magnus Rattray,et al.  Bayesian inference of the sites of perturbations in metabolic pathways via Markov chain Monte Carlo , 2008, Bioinform..

[314]  G. Pescarmona,et al.  Iron metabolism and HIV infection: reciprocal interactions with potentially harmful consequences? , 1999, Cell biochemistry and function.

[315]  R. Lill Function and biogenesis of iron–sulphur proteins , 2009, Nature.

[316]  M. Cebrián,et al.  Biomarkers of oxidative stress and damage in human populations exposed to arsenic. , 2009, Mutation research.

[317]  G. Rouleau,et al.  Recent advances in the genetics of amyotrophic lateral sclerosis , 2009, Current neurology and neuroscience reports.

[318]  Oxana V. Baranova,et al.  The lipophilic metal chelators DP‐109 and DP‐460 are neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis , 2007, Journal of neurochemistry.

[319]  R. Depalma,et al.  Bloodletting: past and present. , 2007, Journal of the American College of Surgeons.

[320]  Frank J. Bruggeman,et al.  Systems Biology: Philosophical Foundations , 2007 .

[321]  A. Dancis,et al.  Oxidative stress and protease dysfunction in the yeast model of Friedreich ataxia. , 2007, Free radical biology & medicine.

[322]  R. Stoltzfus,et al.  Elevated iron stores are associated with HIV disease severity and mortality among postpartum women in Zimbabwe , 2009, Public Health Nutrition.

[323]  H. Chung,et al.  Exercise, oxidative stress and hormesis , 2008, Ageing Research Reviews.

[324]  K. Krause,et al.  The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. , 2007, Physiological reviews.

[325]  P. Doraiswamy,et al.  Metals in our minds: therapeutic implications for neurodegenerative disorders , 2004, The Lancet Neurology.

[326]  P. Riederer,et al.  Impaired iron homeostasis in Parkinson's disease. , 2000, Journal of neural transmission. Supplementum.

[327]  A. Sakudo,et al.  Prion protein functions and dysfunction in prion diseases. , 2009, Current medicinal chemistry.

[328]  J. Keaney,et al.  Hydrogen peroxide restrains endothelium-derived nitric oxide bioactivity -- role for iron-dependent oxidative stress. , 2006, Free radical biology & medicine.

[329]  A. Ghio,et al.  Deficiency in the divalent metal transporter 1 increases bleomycin-induced lung injury , 2010, BioMetals.

[330]  P. Carey,et al.  Reply from BJS Statistical Adviser , 1995, The British journal of surgery.

[331]  P. Kidd,et al.  Parkinson's disease as multifactorial oxidative neurodegeneration: implications for integrative management. , 2000, Alternative medicine review : a journal of clinical therapeutic.

[332]  J. Dunaief Iron induced oxidative damage as a potential factor in age-related macular degeneration: the Cogan Lecture. , 2006, Investigative ophthalmology & visual science.

[333]  M. Amati,et al.  Role of iron in asbestos-body-induced oxidant radical generation. , 1999, Journal of toxicology and environmental health. Part A.

[334]  J. Fernández-Real,et al.  Iron‐Related Damage in Acute Ischemic Stroke , 1994, Stroke.

[335]  M. Mattson Hormesis defined , 2008, Ageing Research Reviews.

[336]  N. Brunner,et al.  How many modes of action should an antibiotic have? , 2008, Current opinion in pharmacology.

[337]  G. Perry,et al.  Three-dimensional tomographic imaging and characterization of iron compounds within Alzheimer's plaque core material. , 2008, Journal of Alzheimer's disease : JAD.

[338]  P. Armand,et al.  Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. , 2007, Blood.

[339]  Joshua D. Knowles,et al.  Analysis of a complete DNA–protein affinity landscape , 2010, Journal of The Royal Society Interface.

[340]  S. Loft,et al.  Cancer risk and oxidative DNA damage in man , 1997, Journal of Molecular Medicine.

[341]  M. Mohan,et al.  Prion Protein Modulates Cellular Iron Uptake: A Novel Function with Implications for Prion Disease Pathogenesis , 2009, PloS one.

[342]  A. Sakudo,et al.  Fundamentals of prion diseases and their involvement in the loss of function of cellular prion protein. , 2009, Protein and peptide letters.

[343]  J. Andersen Iron dysregulation and Parkinson's disease. , 2005, Journal of Alzheimer's disease : JAD.

[344]  A. Chakravarty Friedreich's ataxia--yesterday, today and tomorrow. , 2003, Neurology India.

[345]  Csaba Szabó,et al.  Peroxynitrite: biochemistry, pathophysiology and development of therapeutics , 2007, Nature Reviews Drug Discovery.

[346]  M. Naghii Sulfur mustard intoxication, oxidative stress, and antioxidants. , 2002, Military medicine.

[347]  Gary D Bader,et al.  The Genetic Landscape of a Cell , 2010, Science.

[348]  R. Naftalin,et al.  Quercetin is a substrate for the transmembrane oxidoreductase Dcytb. , 2010, Free radical biology & medicine.

[349]  F. Torti,et al.  Serum ferritin: Past, present and future. , 2010, Biochimica et biophysica acta.

[350]  David R. Brown Brain proteins that mind metals: a neurodegenerative perspective. , 2009, Dalton transactions.

[351]  J. Kourie Prion channel proteins and their role in vacuolation and neurodegenerative diseases , 2002, European Biophysics Journal.

[352]  J. Joseph,et al.  Oxidant-induced iron signaling in Doxorubicin-mediated apoptosis. , 2004, Methods in enzymology.

[353]  H. Kitano A robustness-based approach to systems-oriented drug design , 2007, Nature Reviews Drug Discovery.

[354]  B. Zhivotovsky,et al.  Antioxidants J811 and 17β‐estradiol protect cerebellar granule cells from methylmercury‐induced apoptotic cell death , 2000, Journal of neuroscience research.

[355]  Zhiwei Wang,et al.  Cellular signaling perturbation by natural products. , 2009, Cellular signalling.

[356]  R. Hopkins,et al.  Increased GADD153 gene expression during iron chelation-induced apoptosis in Jurkat T-lymphocytes. , 2004, Biochimica et biophysica acta.

[357]  Sanjeev Banerjee,et al.  Curcumin Synergizes With Resveratrol to Inhibit Colon Cancer , 2009, Nutrition and cancer.

[358]  O. Demin,et al.  The Edinburgh human metabolic network reconstruction and its functional analysis , 2007, Molecular systems biology.

[359]  N. Schröder,et al.  Iron leads to memory impairment that is associated with a decrease in acetylcholinesterase pathways. , 2010, Current neurovascular research.

[360]  M. Sporn,et al.  Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer , 2007, Nature Reviews Cancer.

[361]  C. Masters,et al.  Pharmacotherapeutic targets in Alzheimer's disease , 2008, Journal of cellular and molecular medicine.

[362]  R. Vázquez-Manrique,et al.  Frataxin interacts functionally with mitochondrial electron transport chain proteins. , 2005, Human molecular genetics.

[363]  H. Vetter,et al.  Synergy research: vitamins and secondary plant components in the maintenance of the redox-homeostasis and in cell signaling. , 2009, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[364]  H. Faure,et al.  Increased lipid peroxidation in pregnant women after iron and vitamin C supplementation , 2001, Biological Trace Element Research.

[365]  O. Combarros,et al.  Interaction of the H63D Mutation in the Hemochromatosis Gene with the Apolipoprotein E Epsilon 4 Allele Modulates Age at Onset of Alzheimer’s Disease , 2003, Dementia and Geriatric Cognitive Disorders.

[366]  J. Morris,et al.  Codistribution of amyloid beta plaques and spongiform degeneration in familial Creutzfeldt-Jakob disease with the E200K-129M haplotype. , 2009, Archives of neurology.

[367]  J. Eaton,et al.  Suppression of colonic cancer by dietary phytic acid. , 1993, Nutrition and cancer.

[368]  D. Kell,et al.  Array-based evolution of DNA aptamers allows modelling of an explicit sequence-fitness landscape , 2008, Nucleic acids research.

[369]  L. Fésüs,et al.  Fungal siderophores function as protective agents of LDL oxidation and are promising anti-atherosclerotic metabolites in functional food. , 2008, Molecular nutrition & food research.

[370]  L. Newman,et al.  Inorganic dust pneumonias: the metal-related parenchymal disorders. , 2000, Environmental health perspectives.

[371]  U. Brunk,et al.  Lysosomes and oxidative stress in aging and apoptosis. , 2008, Biochimica et biophysica acta.

[372]  R. Heinrich,et al.  The Regulation of Cellular Systems , 1996, Springer US.

[373]  I. Verma,et al.  Inflammation-associated cancer: NF-kappaB is the lynchpin. , 2005, Trends in immunology.

[374]  Douglas B. Kell,et al.  Genetic algorithms as a method for variable selection in multiple linear regression and partial least squares regression, with applications to pyrolysis mass spectrometry , 1997 .

[375]  N. Franks General anaesthesia: from molecular targets to neuronal pathways of sleep and arousal , 2008, Nature Reviews Neuroscience.

[376]  T. Voigtländer,et al.  The pathogenic mechanisms of prion diseases. , 2007, CNS & neurological disorders drug targets.

[377]  M. Brechbiel,et al.  Role of zinc and iron chelation in apoptosis mediated by tachpyridine, an anti-cancer iron chelator. , 2004, Biochemical Pharmacology.

[378]  G. Réus,et al.  Effect of N-acetylcysteine and/or deferoxamine on oxidative stress and hyperactivity in an animal model of mania , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[379]  Moussa B. H. Youdim,et al.  Iron dysregulation in Alzheimer's disease: Multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein-processing regulatory activities as therapeutic agents , 2007, Progress in Neurobiology.

[380]  R. Goris,et al.  Mediators of multiple organ failure , 2005, Intensive Care Medicine.

[381]  B. H. Choi,et al.  Oxidative stress in neurotoxic effects of methylmercury poisoning. , 1996, Neurotoxicology.

[382]  Robert L Tanguay,et al.  Fullerene C60 exposure elicits an oxidative stress response in embryonic zebrafish. , 2008, Toxicology and applied pharmacology.

[383]  P. Jenner,et al.  Oxidative stress in Parkinson's disease , 2003, Annals of neurology.

[384]  E. Guallar,et al.  The association of biomarkers of iron status with peripheral arterial disease in US adults , 2009, BMC cardiovascular disorders.

[385]  K. Double,et al.  The comparative biology of neuromelanin and lipofuscin in the human brain , 2008, Cellular and Molecular Life Sciences.

[386]  S. Robinson,et al.  Quantitative analysis of cell death and ferritin expression in response to cortical iron: implications for hypoxia–ischemia and stroke , 2001, Brain Research.

[387]  W. Welch,et al.  Polyglutamine protein aggregation and toxicity are linked to the cellular stress response. , 2003, Human molecular genetics.

[388]  J. Keaney,et al.  Iron Chelation Improves Endothelial Function in Patients With Coronary Artery Disease , 2001, Circulation.

[389]  S. H. Park,et al.  Participation of iron and nitric oxide in the mutagenicity of asbestos in hgprt-, gpt+ Chinese hamster V79 cells. , 1998, Cancer research.

[390]  H. Mukhtar,et al.  Green tea polyphenols for prostate cancer chemoprevention: a translational perspective. , 2010, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[391]  R. Sinke,et al.  The association between H63D mutations in HFE and amyotrophic lateral sclerosis in a Dutch population. , 2007, Archives of neurology.

[392]  T. Ward,et al.  Chemogenetic protein engineering: an efficient tool for the optimization of artificial metalloenzymes. , 2008, Chemical communications.

[393]  D. Ferrara,et al.  Iron chelation and vascular function: in search of the mechanisms. , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[394]  N. Patel,et al.  ERYTHROPOIETIN ATTENUATES THE TISSUE INJURY ASSOCIATED WITH HEMORRHAGIC SHOCK AND MYOCARDIAL ISCHEMIA , 2004, Shock.

[395]  N. A. Georgiou,et al.  Can Iron Chelators Influence the Progression of Atherosclerosis? , 2008, Hemoglobin.

[396]  A. Aguzzi,et al.  The prion's elusive reason for being. , 2008, Annual review of neuroscience.

[397]  M. Youdim What have we learnt from CDNA microarray gene expression studies about the role of iron in MPTP induced neurodegeneration and Parkinson's disease? , 2003, Journal of neural transmission. Supplementum.

[398]  Jason H. Moore,et al.  BIOINFORMATICS REVIEW , 2005 .

[399]  T. Takayama,et al.  Normalization of elevated hepatic 8-hydroxy-2'-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet. , 2001, Cancer research.

[400]  C. Redman,et al.  Abnormal iron parameters in the pregnancy syndrome preeclampsia. , 2002, American journal of obstetrics and gynecology.

[401]  Suresh I. S. Rattan,et al.  Hormesis in aging , 2008, Ageing Research Reviews.

[402]  P. Galan,et al.  Iron Bioavailability Studied in Infants: The Influence of Phytic Acid and Ascorbic Acid in Infant Formulas Based on Soy Isolate , 1994, Pediatric Research.

[403]  A. Churg,et al.  Relationship of fiber surface iron and active oxygen species to expression of procollagen, PDGF-A, and TGF-beta(1) in tracheal explants exposed to amosite asbestos. , 2001, American journal of respiratory cell and molecular biology.

[404]  B. Meulemans,et al.  Increased Oxidative Stress in the Mouse Adriamycin Model of Glomerulosclerosis Is Accompanied by Deposition of Ferric Iron and Altered GGT Activity in Renal Cortex , 2004, Renal failure.

[405]  A. Mogilner,et al.  Quantitative modeling in cell biology: what is it good for? , 2006, Developmental cell.

[406]  R. Bakshi,et al.  Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients , 2001, Journal of the Neurological Sciences.

[407]  M. Štěrba,et al.  Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron , 2009, Pharmacological reports : PR.

[408]  J. Sullivan Misconceptions in the debate on the iron hypothesis. , 2001, The Journal of nutritional biochemistry.

[409]  P. Thong,et al.  The onset of atherosclerotic lesion formation in hypercholesterolemic rabbits is delayed by iron depletion , 1999, FEBS letters.

[410]  A. Prentice,et al.  Elevated Iron Status Strongly Predicts Mortality in West African Adults With HIV Infection , 2007, Journal of acquired immune deficiency syndromes.

[411]  D. Gajdusek Kuru and its contribution to medicine , 2008, Philosophical Transactions of the Royal Society B: Biological Sciences.

[412]  M. Willingham,et al.  Activation of Caspase Pathways during Iron Chelator-mediated Apoptosis* , 2002, The Journal of Biological Chemistry.

[413]  M. Runge,et al.  Oxidative stress in atherogenesis and arterial thrombosis: the disconnect between cellular studies and clinical outcomes , 2005, Journal of thrombosis and haemostasis : JTH.

[414]  R. Bakshi,et al.  T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. , 2002, Archives of neurology.

[415]  M. Cazzola,et al.  Clinical relevance of anemia and transfusion iron overload in myelodysplastic syndromes. , 2008, Hematology. American Society of Hematology. Education Program.

[416]  A. Hoffbrand,et al.  Iron chelators induce apoptosis in proliferating cells , 1995, British journal of haematology.

[417]  W. Kaelin The Concept of Synthetic Lethality in the Context of Anticancer Therapy , 2005, Nature Reviews Cancer.

[418]  Adriano Aguzzi,et al.  Pathogenesis of prion diseases: current status and future outlook , 2006, Nature Reviews Microbiology.

[419]  S. Mandel,et al.  Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[420]  M. Zurich,et al.  Contribution of in vitro neurotoxicology studies to the elucidation of neurodegenerative processes , 2009, Brain Research Bulletin.

[421]  E. Cemeli,et al.  Antioxidants and the Comet assay. , 2009, Mutation research.

[422]  Douglas B Kell,et al.  Proximate parameter tuning for biochemical networks with uncertain kinetic parameters. , 2008, Molecular bioSystems.

[423]  Daniel Hanisch,et al.  ToPNet--an application for interactive analysis of expression data and biological networks. , 2004, Bioinformatics.

[424]  W. D. Ehmann,et al.  Aluminum, calcium, and iron in the spinal cord of patients with sporadic amyotrophic lateral sclerosis using laser microprobe mass spectroscopy: a preliminary study , 1995, Journal of the Neurological Sciences.

[425]  N. Fullwood,et al.  Protein aggregation, metals and oxidative stress in neurodegenerative diseases. , 2005, Biochemical Society transactions.

[426]  E. Garman,et al.  The structures of frataxin oligomers reveal the mechanism for the delivery and detoxification of iron. , 2006, Structure.

[427]  D. Souza,et al.  Involvement of glutamate and reactive oxygen species in methylmercury neurotoxicity. , 2007, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[428]  Hubertus Haas,et al.  Siderophores in fungal physiology and virulence. , 2008, Annual review of phytopathology.

[429]  S. Przedborski,et al.  Oxidative Stress in Parkinson's Disease , 2008, Annals of the New York Academy of Sciences.

[430]  M. Reddy,et al.  Effects of soy isoflavones and phytate on homocysteine, C-reactive protein, and iron status in postmenopausal women. , 2006, The American journal of clinical nutrition.

[431]  John P. Overington,et al.  Can we rationally design promiscuous drugs? , 2006, Current opinion in structural biology.

[432]  K. Morrison,et al.  Increased serum ferritin levels in amyotrophic lateral sclerosis (ALS) patients , 2008, Journal of Neurology.

[433]  L. Landino Protein thiol modification by peroxynitrite anion and nitric oxide donors. , 2008, Methods in enzymology.

[434]  P. Moraitis,et al.  The efficacy of iron chelator regimes in reducing cardiac and hepatic iron in patients with thalassaemia major: a clinical observational study , 2009, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[435]  Heather A. O'Neill,et al.  Assembly and iron-binding properties of human frataxin, the protein deficient in Friedreich ataxia. , 2002, Human molecular genetics.

[436]  Igor Goryanin,et al.  Kinetic modelling of NSAID action on COX-1: focus on in vitro/in vivo aspects and drug combinations. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[437]  A. Astell,et al.  Molecular connexions between dementia and diabetes , 2007, Neuroscience & Biobehavioral Reviews.

[438]  S. Lehmann,et al.  Cellular pathogenesis in prion diseases. , 2008, Veterinary research.

[439]  C. Levenson Iron and Parkinson's disease: chelators to the rescue? , 2003, Nutrition reviews.

[440]  N. Gattermann Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload , 2008, International journal of hematology.

[441]  George Perry,et al.  Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. , 2010, Journal of Alzheimer's disease : JAD.

[442]  J. Sarsero,et al.  Friedreich's Ataxia, No Changes in Mitochondrial Labile Iron in Human Lymphoblasts and Fibroblasts , 2005, Journal of Biological Chemistry.

[443]  E. Guallar,et al.  Serum ferritin and risk of the metabolic syndrome in U.S. adults. , 2004, Diabetes care.

[444]  B. Halliwell Dietary polyphenols: good, bad, or indifferent for your health? , 2007, Cardiovascular research.

[445]  Edward J. Calabrese,et al.  The Importance of Hormesis to Public Health , 2006, Environmental health perspectives.

[446]  R Bakshi,et al.  MRI T2 shortening (‘black T2’) in multiple sclerosis: frequency, location, and clinical correlation , 2000, Neuroreport.

[447]  R. Keep,et al.  Effects of deferoxamine on intracerebral hemorrhage-induced brain injury in aged rats. , 2009, Stroke.

[448]  S. Richer,et al.  Serum Iron, Transferrin Saturation, Ferritin, and Dietary Data in Age-Related Macular Degeneration , 2002, American journal of therapeutics.

[449]  G. Pescarmona,et al.  Iron metabolism markers and haptoglobin phenotypes in susceptibility to HSV‐1 or/and HSV‐2 lesion relapses , 2010, Cell biochemistry and function.

[450]  N. Patel,et al.  Erythropoietin reduces the development of nonseptic shock induced by zymosan in mice* , 2006, Critical care medicine.

[451]  C. Kenyon The genetics of ageing , 2010, Nature.

[452]  K. Jellinger,et al.  Brain iron and ferritin in Parkinson's and Alzheimer's diseases , 1990, Journal of neural transmission. Parkinson's disease and dementia section.

[453]  N. Gattermann The treatment of secondary hemochromatosis. , 2009, Deutsches Arzteblatt international.

[454]  N. Kawada,et al.  Attenuation of acute and chronic liver injury in rats by iron-deficient diet. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.

[455]  Peter V Coveney,et al.  Modelling biological complexity: a physical scientist's perspective , 2005, Journal of The Royal Society Interface.

[456]  L. Horwitz,et al.  Iron-mediated cardiovascular injury , 1999, Vascular medicine.

[457]  J. Kehrer The Haber-Weiss reaction and mechanisms of toxicity. , 2000, Toxicology.

[458]  T. Kirkwood A systematic look at an old problem , 2008, Nature.

[459]  M. Shara,et al.  Dietary iron and 2,3,7,8-tetrachlorodibenzo-p-dioxin induced alterations in hepatic lipid peroxidation, glutathione content and body weight. , 1988, Drug and chemical toxicology.

[460]  D. Berg,et al.  In vivo detection of iron and neuromelanin by transcranial sonography: A new approach for early detection of substantia nigra damage , 2005, Movement disorders : official journal of the Movement Disorder Society.

[461]  W. Martin,et al.  Quantitative estimation of regional brain iron with magnetic resonance imaging. , 2009, Parkinsonism & related disorders.

[462]  B. Hasinoff,et al.  Mechanism of ochratoxin A stimulated lipid peroxidation. , 1990, Biochemical pharmacology.

[463]  B. Mossman,et al.  Prevention of asbestos-induced cell death in rat lung fibroblasts and alveolar macrophages by scavengers of active oxygen species. , 1987, Environmental research.

[464]  M. Davies,et al.  Direct Detection and Quantification of Transition Metal Ions in Human Atherosclerotic Plaques: Evidence for the Presence of Elevated Levels of Iron and Copper , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[465]  S. Kamohara,et al.  Oxidative DNA damage (8-hydroxydeoxyguanosine) and body iron status: a study on 2507 healthy people. , 2003, Free radical biology & medicine.

[466]  S. Z. Abdel‐Rahman,et al.  Oxidative DNA damage and its repair in rat spleen following subchronic exposure to aniline. , 2008, Toxicology and applied pharmacology.

[467]  T. Rabelink,et al.  Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo , 2002, European journal of clinical investigation.

[468]  D. Kell,et al.  The cellular uptake of pharmaceutical drugs is mainly carrier-mediated and is thus an issue not so much of biophysics but of systems biology , 2009 .

[469]  S. Robinson,et al.  Accumulation of Non-Transferrin-Bound Iron by Neurons, Astrocytes, and Microglia , 2011, Neurotoxicity Research.

[470]  Corey Nislow,et al.  Combination chemical genetics. , 2008, Nature chemical biology.

[471]  D. Tsikas,et al.  Oxidative stress and human diseases: Origin, link, measurement, mechanisms, and biomarkers , 2009, Critical reviews in clinical laboratory sciences.

[472]  D. Pain,et al.  The yeast connection to Friedreich ataxia. , 1999, American journal of human genetics.

[473]  R. Hotchkiss,et al.  The pathophysiology and treatment of sepsis. , 2003, The New England journal of medicine.

[474]  Dianjing Guo,et al.  Databases and Visualization for Metabolomics , 2003 .

[475]  D. Richardson,et al.  Protection against Hydrogen Peroxide-Mediated Cytotoxicity in Friedreich's Ataxia Fibroblasts Using Novel Iron Chelators of the 2-Pyridylcarboxaldehyde Isonicotinoyl Hydrazone Class , 2008, Molecular Pharmacology.

[476]  M. Kiernan,et al.  Pathophysiology of neurodegeneration in familial amyotrophic lateral sclerosis. , 2009, Current molecular medicine.

[477]  Chris Vulpe,et al.  Yeast, a model organism for iron and copper metabolism studies , 2003, Biometals.

[478]  Heather A. O'Neill,et al.  Assembly of human frataxin is a mechanism for detoxifying redox-active iron. , 2005, Biochemistry.

[479]  A. Tedgui,et al.  Cytokines in atherosclerosis: pathogenic and regulatory pathways. , 2006, Physiological reviews.

[480]  R. Bhisitkul,et al.  Iron homeostasis and toxicity in retinal degeneration , 2007, Progress in Retinal and Eye Research.

[481]  Laura P James,et al.  Acetaminophen‐Induced Hepatotoxicity: Role of Metabolic Activation, Reactive Oxygen/Nitrogen Species, and Mitochondrial Permeability Transition , 2004, Drug metabolism reviews.

[482]  G. Bartosz Free Radicals in Biology and Medicine , 2000 .

[483]  S. Ishiura,et al.  In vivo protection of a water-soluble derivative of vitamin E, Trolox, against methylmercury-intoxication in the rat , 2001, Neuroscience Letters.

[484]  J. Cowland,et al.  IL-1beta-specific up-regulation of neutrophil gelatinase-associated lipocalin is controlled by IkappaB-zeta. , 2006, Journal of immunology.

[485]  L. Horwitz,et al.  Lipophilic siderophores of Mycobacterium tuberculosis prevent cardiac reperfusion injury. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[486]  S. Fine,et al.  Age-related macular degeneration 1969-2004: a 35-year personal perspective. , 2005, American journal of ophthalmology.

[487]  R. Maccioni,et al.  Mild cognitive impairment and Alzheimer patients display different levels of redox-active CSF iron. , 2008, Journal of Alzheimer's disease : JAD.

[488]  Rohit Bakshi,et al.  3 T MRI relaxometry detects T2 prolongation in the cerebral normal-appearing white matter in multiple sclerosis , 2009, NeuroImage.

[489]  S. Cuzzocrea,et al.  Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. , 2001, Pharmacological reviews.

[490]  C. Chiueh,et al.  Neuroprotective strategies in parkinson’s disease: protection against progressive nigral damage induced by free radicals , 2009, Neurotoxicity Research.

[491]  J. Pankow,et al.  A prospective study of plasma ferritin level and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. , 2007, American journal of epidemiology.

[492]  D. Reif,et al.  Ferritin as a source of iron for oxidative damage. , 1992, Free radical biology & medicine.

[493]  M. Aschner,et al.  Glutathione modulation influences methyl mercury induced neurotoxicity in primary cell cultures of neurons and astrocytes. , 2006, Neurotoxicology.

[494]  C D Marsden,et al.  Oxidative DNA Damage in the Parkinsonian Brain: An Apparent Selective Increase in 8‐Hydroxyguanine Levels in Substantia Nigra , 1997, Journal of neurochemistry.

[495]  D. Kell,et al.  Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule? , 2008, Nature Reviews Drug Discovery.

[496]  P. Cornelis,et al.  Iron uptake and homeostasis in microorganisms , 2010 .

[497]  S. M. Sadrzadeh,et al.  Iron and brain disorders. , 2004, American journal of clinical pathology.

[498]  P. Harvey Common Eye Diseases of Elderly People: Identifying and Treating Causes of Vision Loss , 2002, Gerontology.

[499]  S. Peters,et al.  Gaucher's disease: clinical, morphologic, and pathogenetic considerations. , 1977, Pathology annual.

[500]  M. Meyerson,et al.  Bronchial and peripheral murine lung carcinomas induced by T790M-L858R mutant EGFR respond to HKI-272 and rapamycin combination therapy. , 2007, Cancer cell.

[501]  Shakir Ali,et al.  Signal transduction via the NF‐κB pathway: a targeted treatment modality for infection, inflammation and repair , 2004 .

[502]  W. Poewe,et al.  Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. , 1997, Circulation.

[503]  R. Lill,et al.  Iron–sulfur proteins in health and disease , 2010, Trends in Endocrinology & Metabolism.

[504]  J. Camadro,et al.  Friedreich ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities. , 2010, Antioxidants & redox signaling.

[505]  Jian Wang,et al.  Characterizing iron deposition in Parkinson's disease using susceptibility-weighted imaging: An in vivo MR study , 2010, Brain Research.

[506]  M. Mattson Awareness of Hormesis Will Enhance Future Research in Basic and Applied Neuroscience , 2008, Critical reviews in toxicology.

[507]  Lundin Lg,et al.  Iron-catalyzed reactions may be responsible for the biochemical and biological effects of asbestos. , 1991 .

[508]  S. Kotecha,et al.  Analytical methods for 3-nitrotyrosine as a marker of exposure to reactive nitrogen species: a review. , 1998, Nitric oxide : biology and chemistry.

[509]  Ronald C Petersen,et al.  Increased risk of type 2 diabetes in Alzheimer disease. , 2004, Diabetes.

[510]  P. Greenberg Myelodysplastic syndromes: iron overload consequences and current chelating therapies. , 2006, Journal of the National Comprehensive Cancer Network : JNCCN.

[511]  M. Jaurand,et al.  DNA breakage in asbestos-treated normal and transformed (TSV40) rat pleural mesothelial cells. , 2000, Mutagenesis.

[512]  John T. Powers,et al.  Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors , 2010, Nature.

[513]  A. Bush,et al.  Metals and neuroscience. , 2000, Current opinion in chemical biology.

[514]  P. Govitrapong,et al.  Coenzyme Q10 provides neuroprotection in iron-induced apoptosis in dopaminergic neurons , 2007, Journal of Molecular Neuroscience.

[515]  M. Daly,et al.  Genetic profile for five common variants associated with age-related macular degeneration in densely affected families: a novel analytic approach , 2009, European Journal of Human Genetics.

[516]  P. Rustin,et al.  Deferiprone targets aconitase: Implication for Friedreich's ataxia treatment , 2008, BMC Neurology.

[517]  Sten Orrenius,et al.  Mitochondrial oxidative stress: implications for cell death. , 2007, Annual review of pharmacology and toxicology.

[518]  S. Goldwurm,et al.  HFE gene mutations in a population of Italian Parkinson's disease patients. , 2008, Parkinsonism & related disorders.

[519]  J. Richardson,et al.  Brain samples from Alzheimer's patients have elevated levels of loosely bound iron. , 1996, The International journal of neuroscience.

[520]  J. Sullivan Are menstruating women protected from heart disease because of, or in spite of, estrogen? Relevance to the iron hypothesis. , 2003, American heart journal.

[521]  A. LaCroix "That which does not kill us makes us stronger". , 2009, Menopause.

[522]  S. Grambow,et al.  Potential role of increased iron stores in diabetes. , 2003, The American journal of the medical sciences.

[523]  E. Chang,et al.  Heme Regulation in Traumatic Brain Injury: Relevance to the Adult and Developing Brain , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[524]  H. Tjalsma,et al.  Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease. , 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[525]  T. Okamoto,et al.  Oxidoreductive regulation of nuclear factor kappa B. Involvement of a cellular reducing catalyst thioredoxin. , 1993, The Journal of biological chemistry.

[526]  M. Omata,et al.  Liver Involvement in Sickle Cell Disease , 1985, Medicine.

[527]  An-Ping Zeng,et al.  Decomposition of metabolic network into functional modules based on the global connectivity structure of reaction graph , 2004, Bioinform..

[528]  Michiel Kleerebezem,et al.  Metabolic engineering of lactic acid bacteria, the combined approach: kinetic modelling, metabolic control and experimental analysis. , 2002, Microbiology.

[529]  J. Epstein,et al.  Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies , 2010, British Journal of Nutrition.

[530]  T. Oury,et al.  Increased sensitivity to asbestos-induced lung injury in mice lacking extracellular superoxide dismutase. , 2006, Free radical biology & medicine.

[531]  T. Stemmler,et al.  Monomeric yeast frataxin is an iron-binding protein. , 2006, Biochemistry.

[532]  B. Baune,et al.  The role of the inflammatory markers ferritin, transferrin and fibrinogen in the relationship between major depression and cardiovascular disorders – The German Health Interview and Examination Survey , 2009, Acta psychiatrica Scandinavica.

[533]  H. Baylis,et al.  Reduction of Caenorhabditis elegans frataxin increases sensitivity to oxidative stress, reduces lifespan, and causes lethality in a mitochondrial complex II mutant , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[534]  J. Fox,et al.  Tissue pathology induced by snake venoms: how to understand a complex pattern of alterations from a systems biology perspective? , 2010, Toxicon : official journal of the International Society on Toxinology.

[535]  D. Hartl,et al.  Accelerated evolution of resistance in multidrug environments , 2008, Proceedings of the National Academy of Sciences.

[536]  B. Starnes,et al.  Atherosclerosis as Inflammation , 2005, Annals of vascular surgery.

[537]  M Worwood,et al.  Iron genes, iron load and risk of Alzheimer’s disease , 2006, Journal of Medical Genetics.

[538]  D. Kell,et al.  Sensitivity analysis of an oscillatory signal transduction pathway , 2007 .

[539]  K. Kiyosawa,et al.  Phlebotomy: a promising treatment for chronic hepatitis C , 2004, Journal of Gastroenterology.

[540]  C. Tomlin,et al.  Biology by numbers: mathematical modelling in developmental biology , 2007, Nature Reviews Genetics.

[541]  G. Wondrak Redox-directed cancer therapeutics: molecular mechanisms and opportunities. , 2009, Antioxidants & redox signaling.

[542]  G. Mufti,et al.  Impact of pre-transplant serum ferritin on outcomes of patients with myelodysplastic syndromes or secondary acute myeloid leukaemia receiving reduced intensity conditioning allogeneic haematopoietic stem cell transplantation. , 2010, Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis.

[543]  A. Sadovnick,et al.  Mutations in the hemochromatosis gene and the clinical outcome of multiple sclerosis , 2008, Journal of Neuroimmunology.

[544]  S. Mandel,et al.  Multifunctional neuroprotective derivatives of rasagiline as anti-alzheimer’s disease drugs , 2011, Neurotherapeutics.

[545]  L. Petrucelli,et al.  The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity. , 2000, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[546]  E. Høiby,et al.  Citrinin, ochratoxin A and iron. Possible implications for their biological function and induction of nephropathy , 2004, Mycopathologia.

[547]  T. Varzakas,et al.  In Vitro Activity of Vitamins, Flavonoids, and Natural Phenolic Antioxidants Against the Oxidative Deterioration of Oil-Based Systems , 2008, Critical reviews in food science and nutrition.

[548]  A. Ledbetter,et al.  Pulmonary Oxidative Stress, Inflammation, and Dysregulated Iron Homeostasis in Rat Models of Cardiovascular Disease , 2010, Journal of toxicology and environmental health. Part A.

[549]  James R. Johnson,et al.  Oscillations in NF-κB Signaling Control the Dynamics of Gene Expression , 2004, Science.

[550]  R. Mitchell,et al.  Protecting the pump: controlling myocardial inflammatory responses. , 2006, Annual review of physiology.

[551]  G. Helal SYSTEMIC ADMINISTRATION OF Zn2+ DURING THE REPERFUSION PHASE OF TRANSIENT CEREBRAL ISCHAEMIA PROTECTS RAT HIPPOCAMPUS AGAINST IRON‐CATALYSED POSTISCHAEMIC INJURY , 2008, Clinical and experimental pharmacology & physiology.

[552]  E. Schleicher,et al.  Oxidative stress, AGE, and atherosclerosis. , 2007, Kidney international. Supplement.

[553]  Hui-yi Chen,et al.  Dysfunction of the retinal pigment epithelium with age: increased iron decreases phagocytosis and lysosomal activity. , 2009, Investigative ophthalmology & visual science.

[554]  N. Fujii,et al.  Cloning and characterization of mouse 5'-AMP-activated protein kinase γ3 subunit , 2004 .

[555]  W. Green,et al.  IRON TOXICITY AS A POTENTIAL FACTOR IN AMD , 2007, Retina.

[556]  N. Tanaka,et al.  Efficacy and safety of 6-month iron reduction therapy in patients with hepatitis C virus-related cirrhosis: a pilot study , 2007, Journal of Gastroenterology.

[557]  E. Hirsch,et al.  Neuromelanin associated redox‐active iron is increased in the substantia nigra of patients with Parkinson's disease , 2003, Journal of neurochemistry.

[558]  S. Aust,et al.  Transition metals as catalysts of "autoxidation" reactions. , 1990, Free radical biology & medicine.

[559]  R. Richards,et al.  Selective neuronal requirement for huntingtin in the developing zebrafish , 2009, Human molecular genetics.

[560]  T. Oury,et al.  Iron accumulation and expression of iron-related proteins following murine exposure to crocidolite. , 2009, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

[561]  Bor-Sen Chen,et al.  Integrated cellular network of transcription regulations and protein-protein interactions , 2010, BMC Systems Biology.

[562]  M. Evans,et al.  Oxidative DNA damage: mechanisms, mutation, and disease , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[563]  G. Ansari,et al.  Activation of oxidative stress-responsive signaling pathways in early splenotoxic response of aniline. , 2008, Toxicology and applied pharmacology.

[564]  V. Chandrasekaran,et al.  THE PROTECTIVE EFFECT OF SESAMOL AGAINST MITOCHONDRIAL OXIDATIVE STRESS AND HEPATIC INJURY IN ACETAMINOPHEN-OVERDOSED RATS , 2009, Shock.

[565]  M. Levy,et al.  Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 , 2007, Intensive Care Medicine.

[566]  S. Kitagawa,et al.  Enhanced skin delivery of quercetin by microemulsion. , 2009, The Journal of pharmacy and pharmacology.

[567]  U. Schaible,et al.  Targeting the lysosome: fluorescent iron(III) chelators to selectively monitor endosomal/lysosomal labile iron pools. , 2008, Journal of medicinal chemistry.

[568]  D. Winge,et al.  Metal acquisition and availability in the mitochondria. , 2009, Chemical reviews.

[569]  David E. Goldberg,et al.  The Design of Innovation: Lessons from and for Competent Genetic Algorithms , 2002 .

[570]  J. Laissue,et al.  Hepatocyte apoptosis in hepatic iron overload diseases. , 1997, Histology and histopathology.

[571]  J. Choi,et al.  The effect of Fenton reaction on protease-resistant prion protein (PrPSc) degradation and scrapie infectivity , 2008, Brain Research.

[572]  A. Wagner Robustness, evolvability, and neutrality , 2005, FEBS letters.

[573]  J. Postgate Viability Measurements and the Survival of Microbes Under Minimum Stress , 1967 .

[574]  A. Harken,et al.  Iron depletion or chelation reduces ischemia/reperfusion-induced edema in gerbil brains. , 1990, Journal of pediatric surgery.

[575]  A. Warren,et al.  Are hereditary hemochromatosis mutations involved in Alzheimer disease? , 2000, American journal of medical genetics.

[576]  E. Deitch,et al.  Scientific and clinical challenges in sepsis. , 2009, Current pharmaceutical design.

[577]  A. Minagar,et al.  Evidence for gray matter pathology in multiple sclerosis: A neuroimaging approach , 2009, Journal of the Neurological Sciences.

[578]  Ronald N Kostoff,et al.  The Unknown Impacts of Combinations of Large Numbers of Drugs , 2006, Drug safety.

[579]  M. Keel,et al.  Pathophysiology of polytrauma. , 2005, Injury.

[580]  James F. Gusella,et al.  Molecular genetics: Unmasking polyglutamine triggers in neurodegenerative disease , 2000, Nature Reviews Neuroscience.

[581]  B. Rigas,et al.  NF-κB, inflammation and pancreatic carcinogenesis: NF-κB as a chemoprevention target (Review) , 2006 .

[582]  Paul M. Ridker,et al.  Inflammation as a Cardiovascular Risk Factor , 2004, Circulation.

[583]  C. Orvig,et al.  Medicinal inorganic chemistry approaches to passivation and removal of aberrant metal ions in disease. , 2009, Chemical reviews.

[584]  Fumio Nomura,et al.  YKL-40 IDENTIFIED BY PROTEOMIC ANALYSIS AS A BIOMARKER OF SEPSIS , 2009, Shock.

[585]  J. Keaney,et al.  Role of oxidative modifications in atherosclerosis. , 2004, Physiological reviews.

[586]  I. Zararsız,et al.  Effects of melatonin on carbon tetrachloride-induced changes in rat serum , 2004, Journal of Physiology and Biochemistry.

[587]  M. Aschner,et al.  The methylmercury‐l‐cysteine conjugate is a substrate for the L‐type large neutral amino acid transporter , 2008, Journal of neurochemistry.

[588]  S. Sriskandan,et al.  The immunology of sepsis , 2008, The Journal of pathology.

[589]  Z. Rybak,et al.  Hypothetical molecular mechanisms by which local iron overload facilitates the development of venous leg ulcers and multiple sclerosis lesions. , 2008, Medical hypotheses.

[590]  B. Lucchini,et al.  Evaluation of Anti-Prionic Activity of Clioquinol in an in vivo Model (Mesocricetus auratus) , 2005, Veterinary Research Communications.

[591]  T. Aw,et al.  Neuronal apoptosis in neurodegeneration. , 2007, Antioxidants & redox signaling.

[592]  N. Hunter,et al.  Partial dissociation of PrP(Sc) deposition and vacuolation in the brains of scrapie and BSE experimentally affected goats. , 2001, The Journal of general virology.

[593]  Y. Christen,et al.  Oxidative stress and Alzheimer disease. , 2000, The American journal of clinical nutrition.

[594]  K. Jokivarsi,et al.  Subacute hemorrhage and resolution of edema in Rose Bengal stroke model in rats coincides with improved sensorimotor functions , 2007, Neuroscience Letters.

[595]  Michalis D. Mantzaris,et al.  Oxidative stress and aging: the potential role of iron , 2008, Hormones.

[596]  E. Middleton,et al.  Free radical scavenging and antioxidant activity of plant flavonoids. , 1994, Advances in experimental medicine and biology.

[597]  S. Okada,et al.  Curcumin attenuates oxidative damage in animals treated with a renal carcinogen, ferric nitrilotriacetate (Fe-NTA): implications for cancer prevention , 2009, Molecular and Cellular Biochemistry.

[598]  D. Richardson,et al.  Iron Chelation by Clinically Relevant Anthracyclines: Alteration in Expression of Iron-Regulated Genes and Atypical Changes in Intracellular Iron Distribution and Trafficking , 2008, Molecular Pharmacology.

[599]  F. Cerra,et al.  Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction. , 1994, JAMA.

[600]  M. Massari,et al.  Iron reduction and sustained response to interferon-α therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study , 2002, American Journal of Gastroenterology.

[601]  S. Mandel,et al.  Low Dosage of Rasagiline and Epigallocatechin Gallate Synergistically Restored the Nigrostriatal Axis in MPTP-Induced Parkinsonism , 2010, Neurodegenerative Diseases.

[602]  R. Elton,et al.  Relationship between chemical structure and the occupational asthma hazard of low molecular weight organic compounds , 2005, Occupational and Environmental Medicine.

[603]  G. Sebastiani,et al.  HFE gene in primary and secondary hepatic iron overload. , 2007, World journal of gastroenterology.

[604]  M. Filippi,et al.  Closing the Clinical‐Imaging Gap in Multiple Sclerosis? Imaging Iron Deposition in Deep Gray Matter , 2009, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[605]  J. Carter,et al.  Iron and iron-related proteins in the lower respiratory tract of patients with acute respiratory distress syndrome , 2003, Critical care medicine.

[606]  T. Montine,et al.  Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. , 1999, The American journal of pathology.

[607]  J. Sullivan IRON AND THE SEX DIFFERENCE IN HEART DISEASE RISK , 1981, The Lancet.

[608]  E. Calabrese,et al.  The occurrence of hormetic dose responses in the toxicological literature, the hormesis database: an overview. , 2005, Toxicology and applied pharmacology.

[609]  Josephine A. Wright,et al.  Copper binding regulates intracellular alpha‐synuclein localisation, aggregation and toxicity , 2010, Journal of neurochemistry.

[610]  M. Millan Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application. , 2006, Pharmacology & therapeutics.

[611]  T. Stemmler,et al.  The Structure and Function of Frataxin , 2006, Critical reviews in biochemistry and molecular biology.

[612]  D. Butterfield,et al.  Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment , 2007 .

[613]  Xiao-Bo Sun,et al.  Overexpression of F(0)F(1)-ATP synthase alpha suppresses mutant huntingtin aggregation and toxicity in vitro. , 2009, Biochemical and biophysical research communications.

[614]  John Hardy,et al.  The A53T α-Synuclein Mutation Increases Iron-Dependent Aggregation and Toxicity , 2000, The Journal of Neuroscience.

[615]  W. A. Bradley,et al.  Superoxide and peroxynitrite in atherosclerosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[616]  F. W. Outten,et al.  Fe-S Cluster Assembly Pathways in Bacteria , 2008, Microbiology and Molecular Biology Reviews.

[617]  H. Lee,et al.  Iron chelator-induced growth arrest and cytochrome c-dependent apoptosis in immortalized and malignant oral keratinocytes. , 2006, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[618]  C. Gross,et al.  Diminished adult neurogenesis in the marmoset brain precedes old age , 2007, Proceedings of the National Academy of Sciences.

[619]  S. Heckl Future contrast agents for molecular imaging in stroke. , 2007, Current medicinal chemistry.

[620]  G. Cortopassi,et al.  Frataxin knockdown causes loss of cytoplasmic iron-sulfur cluster functions, redox alterations and induction of heme transcripts. , 2007, Archives of biochemistry and biophysics.

[621]  A. Walters,et al.  Review of the relationship of restless legs syndrome and periodic limb movements in sleep to hypertension, heart disease, and stroke. , 2009, Sleep.

[622]  N. Chandel,et al.  Reactive oxygen species-dependent signaling regulates cancer , 2009, Cellular and Molecular Life Sciences.

[623]  D. Jacobs,et al.  Comparison of the serum ferritin and percentage of transferrin saturation as exposure markers of iron-driven oxidative stress-related disease outcomes. , 2006, American heart journal.

[624]  S. Bondy,et al.  Deferoxamine inhibits methyl mercury-induced increases in reactive oxygen species formation in rat brain. , 1992, Toxicology and applied pharmacology.

[625]  Xudong Huang,et al.  Metal Chelation as a Potential Therapy for Alzheimer's Disease , 2000, Annals of the New York Academy of Sciences.

[626]  L. Claro,et al.  Effect of vitamin C, deferoxamine, quercetin and rutin against tert-butyl hydroperoxide oxidative damage in human erythrocytes , 2009, Hematology.

[627]  K. Albermann,et al.  Nuclear Factor Kb: An Oxidative Stress-Responsive Transcription Factor of Eukaryotic Cells (A Review) , 1992 .

[628]  A. Sun,et al.  Oxidative and Inflammatory Pathways in Parkinson’s Disease , 2008, Neurochemical Research.

[629]  Neha Singh,et al.  Advances in the treatment of Parkinson's disease , 2007, Progress in Neurobiology.

[630]  R. Adams,et al.  Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury. , 2009, Blood.

[631]  Andreas Bender,et al.  "Bayes Affinity Fingerprints" Improve Retrieval Rates in Virtual Screening and Define Orthogonal Bioactivity Space: When Are Multitarget Drugs a Feasible Concept? , 2006, J. Chem. Inf. Model..

[632]  P. Riederer,et al.  Iron-binding characteristics of neuromelanin of the human substantia nigra. , 2003, Biochemical pharmacology.

[633]  J S Beckman,et al.  Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. , 1996, The American journal of physiology.

[634]  Fen Wang,et al.  Induction of apoptosis by iron depletion in the human breast cancer MCF-7 cell line and the 13762NF rat mammary adenocarcinoma in vivo. , 2002, Anticancer research.

[635]  E. Arriaga,et al.  Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial-lysosomal axis theory of aging. , 2010, Antioxidants & redox signaling.

[636]  G. Hoffmann A Perspective on the Scientific, Philosophical, and Policy Dimensions of Hormesis , 2009, Dose-response : a publication of International Hormesis Society.

[637]  J. Stelling,et al.  Robustness of Cellular Functions , 2004, Cell.

[638]  J. Olynyk,et al.  HCV, iron, and oxidative stress: the new choreography of hepcidin. , 2008, Gastroenterology.

[639]  Strong labeling for iron and the iron-handling proteins ferritin and ferroportin in the photoreceptor layer in age-related macular degeneration. , 2005, Archives of ophthalmology.

[640]  K. Saxena,et al.  Fatal Stroke in a Child with Severe Iron Deficiency Anemia and Multiple Hereditary Risk Factors for Thrombosis , 2005, Clinical pediatrics.

[641]  H. Kitano,et al.  A comprehensive map of the toll-like receptor signaling network , 2006, Molecular systems biology.

[642]  E. Calabrese Critical Review HORMESIS : WHY IT IS IMPORTANT TO TOXICOLOGY AND TOXICOLOGISTS , 2008 .

[643]  T. Kazi,et al.  Distribution of zinc, copper and iron in biological samples of Pakistani myocardial infarction (1st, 2nd and 3rd heart attack) patients and controls. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[644]  RONALD N. KOSTOFF Overcoming Specialization , 2002 .

[645]  H. Nishio,et al.  Different cytoprotective effect of antioxidants and change in the iron regulatory system in rodent cells exposed to paraquat or formaldehyde. , 2005, Toxicology.

[646]  Elizabeth C. Theil,et al.  Comparison of organ dysfunction in transfused patients with SCD or β thalassemia , 2005, American Journal of Hematology.

[647]  M. Youdim,et al.  Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson’s disease and other neurodegenerative diseases , 2004, Journal of Neural Transmission.

[648]  Edda Klipp,et al.  SBMLmerge, a system for combining biochemical network models. , 2006, Genome informatics. International Conference on Genome Informatics.

[649]  D. Featherstone,et al.  Wrestling with pleiotropy: genomic and topological analysis of the yeast gene expression network. , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.

[650]  E. Calabrese,et al.  Hormesis and plant biology. , 2009, Environmental pollution.

[651]  B. Halliwell,et al.  A nuclear microscopy study of trace elements Ca, Fe, Zn and Cu in atherosclerosis , 2006 .

[652]  P. Doraiswamy,et al.  Current Status of Metals as Therapeutic Targets in Alzheimer's Disease , 2003, Journal of the American Geriatrics Society.

[653]  V. Kaushal,et al.  Mechanisms of Microglia-Mediated Neurotoxicity in a New Model of the Stroke Penumbra , 2008, The Journal of Neuroscience.

[654]  P Riederer,et al.  Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains , 1991, Journal of neurochemistry.

[655]  Michael Karin,et al.  NF-kappaB: linking inflammation and immunity to cancer development and progression. , 2005, Nature reviews. Immunology.

[656]  C. Lundby,et al.  Erythropoietin depletes iron stores: antioxidant neuroprotection for ischemic stroke? , 2006, Stroke.

[657]  Lester Packer,et al.  Flavonoids in health and disease , 2003 .

[658]  A. Smith,et al.  Synergy between the C2 allele of transferrin and the C282Y allele of the haemochromatosis gene (HFE) as risk factors for developing Alzheimer’s disease , 2004, Journal of Medical Genetics.

[659]  B. Van Houten,et al.  Asbestos induces mitochondrial DNA damage and dysfunction linked to the development of apoptosis. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[660]  D. Berg,et al.  Brain iron pathways and their relevance to Parkinson's disease. , 2001, Journal of neurochemistry.

[661]  R. Sun,et al.  Closed-loop control of cellular functions using combinatory drugs guided by a stochastic search algorithm , 2008, Proceedings of the National Academy of Sciences.

[662]  J. Keaney,et al.  New insights on oxidative stress in the artery wall , 2005, Journal of thrombosis and haemostasis : JTH.

[663]  G. Falkenberg,et al.  Distribution of selected elements in atherosclerotic plaques of apoE/LDLR-double knockout mice assessed by synchrotron radiation-induced micro-XRF spectrometry , 2008 .

[664]  G. Gerhard,et al.  Atherosclerosis: a manifestation of chronic iron toxicity? , 2003, Vascular medicine.

[665]  G. Johnson,et al.  Role of mitochondrial dysfunction in the pathogenesis of Huntington's disease , 2009, Brain Research Bulletin.

[666]  M. Pandolfo,et al.  Friedreich ataxia: The clinical picture , 2009, Journal of Neurology.

[667]  S. Andrews,et al.  Bacterial iron homeostasis. , 2003, FEMS microbiology reviews.

[668]  H. Atamna,et al.  Human and rodent amyloid-beta peptides differentially bind heme: relevance to the human susceptibility to Alzheimer's disease. , 2009, Archives of biochemistry and biophysics.

[669]  Roel P F Schins,et al.  Inhaled particles and lung cancer. Part A: Mechanisms , 2004, International journal of cancer.

[670]  E. Zandi,et al.  Signaling Role of Intracellular Iron in NF-κB Activation* , 2003, The Journal of Biological Chemistry.

[671]  A. Ludolph,et al.  Amyotrophic lateral sclerosis. , 2012, Current opinion in neurology.

[672]  S. Alavian,et al.  Therapy of hepatitis C in thalassemia: the influence of iron on achieving sustained viral response , 2010, Annals of Hematology.

[673]  A. Dávalos,et al.  A review of the state of research into the role of iron in stroke. , 2002, The journal of nutrition, health & aging.

[674]  L. Zon,et al.  Transferrin-a modulates hepcidin expression in zebrafish embryos. , 2009, Blood.

[675]  K. Klouche,et al.  SUPEROXIDE ANION OVERPRODUCTION IN SEPSIS: EFFECTS OF VITAMIN E AND SIMVASTATIN , 2004, Shock.

[676]  C. Weber,et al.  Pyridoxal isonicotinoyl hydrazone analogs induce apoptosis in hematopoietic cells due to their iron-chelating properties. , 2003, Biochemical pharmacology.

[677]  N. E. Babady,et al.  Advancements in the pathophysiology of Friedreich's Ataxia and new prospects for treatments. , 2007, Molecular genetics and metabolism.

[678]  P. Barnes,et al.  Raised levels of exhaled carbon monoxide are associated with an increased expression of heme oxygenase-1 in airway macrophages in asthma: a new marker of oxidative stress , 1998, Thorax.

[679]  Y. Shoenfeld,et al.  Hyperferritinemia in autoimmunity. , 2008, The Israel Medical Association journal : IMAJ.

[680]  Laura P James,et al.  Acetaminophen-induced hepatotoxicity. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[681]  François Mach,et al.  Inflammation and Atherosclerosis , 2004, Herz.

[682]  A. Valavanidis,et al.  8-hydroxy-2′ -deoxyguanosine (8-OHdG): A Critical Biomarker of Oxidative Stress and Carcinogenesis , 2009, Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews.

[683]  D. Souza,et al.  Methylmercury induces oxidative injury, alterations in permeability and glutamine transport in cultured astrocytes , 2007, Brain Research.

[684]  J. Pokorný 3 – Natural antioxidants , 2003 .

[685]  A. Kastrati,et al.  Value of serum ferritin and soluble transferrin receptor for prediction of coronary artery disease and its clinical presentations. , 2004, Atherosclerosis.

[686]  F. Dreyfus The deleterious effects of iron overload in patients with myelodysplastic syndromes. , 2008, Blood reviews.

[687]  C. Quintana Contribution of analytical microscopies to human neurodegenerative diseases research (PSP and AD). , 2007, Mini reviews in medicinal chemistry.

[688]  D B Kell,et al.  Genomic computing. Explanatory analysis of plant expression profiling data using machine learning. , 2001, Plant physiology.

[689]  R. Ratan,et al.  The role of iron neurotoxicity in ischemic stroke , 2004, Ageing Research Reviews.

[690]  F. Hu,et al.  The role of iron in type 2 diabetes in humans. , 2009, Biochimica et biophysica acta.

[691]  Christoph Palm,et al.  Cerebral bioimaging of Cu, Fe, Zn, and Mn in the MPTP mouse model of Parkinson’s disease using laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) , 2010, Journal of the American Society for Mass Spectrometry.

[692]  G. Neupane,et al.  In vitro time-kill activities of ciprofloxacin alone and in combination with the iron chelator deferasirox against Vibrio vulnificus , 2010, European Journal of Clinical Microbiology & Infectious Diseases.

[693]  O. Aruoma,et al.  Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. , 1992, The Biochemical journal.

[694]  S. Okada,et al.  Iron-induced apoptosis in mouse renal proximal tubules after an injection of a renal carcinogen, iron-nitrilotriacetate. , 1997, Carcinogenesis.

[695]  J. Eaton,et al.  Antioxidant functions of phytic acid. , 1990, Free radical biology & medicine.

[696]  A. Minihane,et al.  Effect of Dietary Phytate and Microbial Phytase on Mineral and Trace Element Bioavailability - a Literature Review , 2008 .

[697]  V. O’Donnell,et al.  Interactions Between Nitric Oxide and Lipid Oxidation Pathways: Implications for Vascular Disease , 2001, Circulation research.

[698]  Henry S Rzepa,et al.  Enhancement of the chemical semantic web through the use of InChI identifiers. , 2005, Organic & biomolecular chemistry.

[699]  G. Mingrone,et al.  Bloodletting Ameliorates Insulin Sensitivity and Secretion in Parallel to Reducing Liver Iron in Carriers of HFE Gene Mutations , 2008, Diabetes Care.

[700]  Lennart Ljung,et al.  System Identification: Theory for the User , 1987 .

[701]  P. Baeuerle,et al.  Assessing oxygen radicals as mediators in activation of inducible eukaryotic transcription factor NF-kappa B. , 1994, Methods in enzymology.

[702]  P. Lavori,et al.  The iron (Fe) and atherosclerosis study (FeAST): a pilot study of reduction of body iron stores in atherosclerotic peripheral vascular disease. , 2000, American heart journal.

[703]  H. Jaeschke,et al.  Mitochondrial permeability transition in acetaminophen‐induced necrosis and apoptosis of cultured mouse hepatocytes , 2004, Hepatology.

[704]  G. Cortopassi,et al.  Frataxin, iron-sulfur clusters, heme, ROS, and aging. , 2006, Antioxidants & redox signaling.

[705]  J. Hardy,et al.  Iron in Asbestos Chemistry and Carcinogenicity , 1995 .

[706]  J. Salonen,et al.  Association between body iron stores and the risk of acute myocardial infarction in men. , 1998, Circulation.

[707]  B. Halliwell,et al.  Correlation of iron and zinc levels with lesion depth in newly formed atherosclerotic lesions. , 2003, Free radical biology & medicine.

[708]  B. Halliwell,et al.  Free radicals in biology and medicine , 1985 .

[709]  R. Gillum,et al.  Serum transferrin saturation, stroke incidence, and mortality in women and men. The NHANES I Epidemiologic Followup Study. National Health and Nutrition Examination Survey. , 1996, American journal of epidemiology.

[710]  P. Nguyen,et al.  Myelodysplastic syndromes , 2009, Nature Reviews Disease Primers.

[711]  P. Nogueira,et al.  Serum ferritin and obstructive coronary artery disease: angiographic correlation. , 2007, Arquivos brasileiros de cardiologia.

[712]  S. Weitzman,et al.  The molecular basis of asbestos induced lung injury , 1999, Thorax.

[713]  C. Quintana,et al.  Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level. , 2006, Journal of structural biology.

[714]  G. Perry,et al.  Getting the iron out: phlebotomy for Alzheimer's disease? , 2009, Medical hypotheses.

[715]  I. Dalle-Donne Familial amyotrophic lateral sclerosis (FALS): Emerging hints from redox proteomics. Highlight commentary on: "Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis". , 2007, Free radical biology & medicine.

[716]  Xiaohong Wu,et al.  Iron Release and Oxidative DNA Damage in Splenic Toxicity of Aniline , 2005, Journal of toxicology and environmental health. Part A.

[717]  Y. Surh,et al.  NF-κB and Nrf2 as prime molecular targets for chemoprevention and cytoprotection with anti-inflammatory and antioxidant phytochemicals , 2008, Genes & Nutrition.

[718]  Boris Hayete,et al.  Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli , 2007 .

[719]  H. Chung,et al.  Molecular activation of NF-κB, pro-inflammatory mediators, and signal pathways in γ-irradiated mice , 2010, Biotechnology Letters.

[720]  Roy Kishony,et al.  Drug interactions and the evolution of antibiotic resistance , 2009, Nature Reviews Microbiology.

[721]  Qin Chen,et al.  Dihydroartemisinin induces apoptosis in HL-60 leukemia cells dependent of iron and p38 mitogen-activated protein kinase activation but independent of reactive oxygen species , 2008, Cancer biology & therapy.

[722]  M. Lim,et al.  Effects of clioquinol on metal-triggered amyloid-beta aggregation revisited. , 2009, Inorganic chemistry.

[723]  R. Fontana,et al.  Prevalence of hepatic iron overload and association with hepatocellular cancer in end‐stage liver disease: results from the National Hemochromatosis Transplant Registry , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[724]  Young Seol Kim,et al.  Prooxidative effects of green tea polyphenol (−)-epigallocatethin-3-gallate on the HIT-T15 pancreatic beta cell line , 2010, Cell Biology and Toxicology.

[725]  Arthur S Slutsky,et al.  The role of oxidative stress in adult critical care , 2006, Free Radical Biology and Medicine.

[726]  E. Marbán,et al.  Physiological Levels of Reactive Oxygen Species Are Required to Maintain Genomic Stability in Stem Cells , 2010, Stem cells.

[727]  Edward J Calabrese,et al.  Hormesis: the dose-response revolution. , 2003, Annual review of pharmacology and toxicology.

[728]  C. Venugopal,et al.  Challenges associated with metal chelation therapy in Alzheimer's disease. , 2009, Journal of Alzheimer's disease : JAD.

[729]  J. Lehár,et al.  Multi-target therapeutics: when the whole is greater than the sum of the parts. , 2007, Drug discovery today.

[730]  E. Zandi,et al.  Iron activates NF-κB in Kupffer cells , 2002 .

[731]  A. Scalbert,et al.  Polyphenols and prevention of cardiovascular diseases , 2005, Current opinion in lipidology.

[732]  N. Inestrosa,et al.  The role of oxidative stress in the toxicity induced by amyloid β-peptide in Alzheimer’s disease , 2000, Progress in Neurobiology.

[733]  T. Butz,et al.  Trace element mapping in Parkinsonian brain by quantitative ion beam microscopy , 2010 .

[734]  Wei-Ping Zhang,et al.  Dihydroartemisinin Potentiates the Cytotoxic Effect of Temozolomide in Rat C6 Glioma Cells , 2008, Pharmacology.

[735]  E. Weinberg,et al.  Altered iron metabolism in HIV infection: mechanisms, possible consequences, and proposals for management. , 1996, Infectious agents and disease.

[736]  H. Redl,et al.  A novel endotoxin-induced pathway: upregulation of heme oxygenase 1, accumulation of free iron, and free iron-mediated mitochondrial dysfunction , 2008, Laboratory Investigation.

[737]  E. Schwedhelm,et al.  Urinary excretion of biomarkers of oxidatively damaged DNA and RNA in hereditary hemochromatosis. , 2009, Free radical biology & medicine.

[738]  C A Ross,et al.  When more is less: Pathogenesis of glutamine repeat neurodegenerative diseases , 1995, Neuron.

[739]  T. Komatsu,et al.  Direct Assessments of the Antioxidant Effects of Propofol Medium Chain Triglyceride/Long Chain Triglyceride on the Brain of Stroke-prone Spontaneously Hypertensive Rats Using Electron Spin Resonance Spectroscopy , 2008, Anesthesiology.

[740]  Elizabeth C. Theil,et al.  Cellular regulation and molecular interactions of the ferritins , 2006, Cellular and Molecular Life Sciences.

[741]  A. Geronikaki,et al.  Antioxidants and inflammatory disease: synthetic and natural antioxidants with anti-inflammatory activity. , 2006, Combinatorial chemistry & high throughput screening.

[742]  R. Bowler Oxidative stress in the pathogenesis of asthma , 2004, Current allergy and asthma reports.

[743]  Joshua D. Knowles,et al.  Closed-loop, multiobjective optimization of analytical instrumentation: gas chromatography/time-of-flight mass spectrometry of the metabolomes of human serum and of yeast fermentations. , 2005, Analytical chemistry.

[744]  Torben Hansen,et al.  Development of a Type 2 Diabetes Risk Model From a Panel of Serum Biomarkers From the Inter99 Cohort , 2009, Diabetes Care.

[745]  J. Jabłecki,et al.  Kaposi's sarcoma revisited. , 2007, AIDS reviews.

[746]  Saltelli Andrea,et al.  Global Sensitivity Analysis: The Primer , 2008 .

[747]  P. Reddy,et al.  Mitochondrial Medicine for Aging and Neurodegenerative Diseases , 2008, NeuroMolecular Medicine.

[748]  B. Stockwell,et al.  Multicomponent therapeutics for networked systems , 2005, Nature Reviews Drug Discovery.

[749]  Roberto Cappai,et al.  The redox chemistry of the Alzheimer's disease amyloid β peptide , 2007 .

[750]  O. Rosso,et al.  Uncovering Molecular Biomarkers That Correlate Cognitive Decline with the Changes of Hippocampus' Gene Expression Profiles in Alzheimer's Disease , 2010, PloS one.

[751]  C. Mclean The neuropathology of kuru and variant Creutzfeldt–Jakob disease , 2008, Philosophical Transactions of the Royal Society B: Biological Sciences.

[752]  P. Riederer,et al.  Neuromelanin induces oxidative stress in mitochondria through release of iron: mechanism behind the inhibition of 26S proteasome , 2006, Journal of Neural Transmission.

[753]  Aaron Y. Lee,et al.  Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC) , 2010, Proceedings of the National Academy of Sciences.

[754]  D. Grainger TGF-beta and atherosclerosis in man. , 2007, Cardiovascular research.

[755]  Robert B. Wilson Iron dysregulation in Friedreich ataxia. , 2006, Seminars in pediatric neurology.

[756]  J. D. del Río,et al.  Increased oxidation, glycoxidation, and lipoxidation of brain proteins in prion disease. , 2008, Free radical biology & medicine.

[757]  Eun-Young Kim,et al.  Bioactive dietary polyphenolic compounds reduce nonheme iron transport across human intestinal cell monolayers. , 2008, The Journal of nutrition.

[758]  R. Cappai,et al.  The redox chemistry of the Alzheimer's disease amyloid beta peptide. , 2007, Biochimica et biophysica acta.

[759]  M. S. Butt,et al.  Green Tea: Nature's Defense against Malignancies , 2009, Critical reviews in food science and nutrition.

[760]  H. Bessler,et al.  Phagocytic capacity and apoptosis of peripheral blood cells from patients with iron deficiency anemia. , 2005, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[761]  R. Reiter,et al.  Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin , 2009, Critical reviews in biochemistry and molecular biology.

[762]  Ralf Deichmann,et al.  Quantitative mapping of T1 and T2* discloses nigral and brainstem pathology in early Parkinson's disease , 2010, NeuroImage.

[763]  L. Fleisher,et al.  Iron metabolism in the eye: a review. , 2009, Experimental eye research.

[764]  R. Carp,et al.  Increased ferric iron content and iron-induced oxidative stress in the brains of scrapie-infected mice , 2000, Brain Research.

[765]  D. McLachlan,et al.  Intramuscular desferrioxamine in patients with Alzheimer's disease , 1991, The Lancet.

[766]  J. Doyle,et al.  Bow Ties, Metabolism and Disease , 2022 .

[767]  J. Connor,et al.  Increased incidence of the Hfe mutation in amyotrophic lateral sclerosis and related cellular consequences , 2004, Journal of the Neurological Sciences.

[768]  M. Cabezas,et al.  Lipaemia, Inflammation and Atherosclerosis: Novel Opportunities in the Understanding and Treatment of Atherosclerosis , 2012, Drugs.

[769]  A. Munnich,et al.  Redistribution of accumulated cell iron: a modality of chelation with therapeutic implications. , 2008, Blood.

[770]  D. Butterfield,et al.  Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment. , 2007, Free radical biology & medicine.

[771]  L. Hallberg,et al.  Iron absorption in man: ascorbic acid and dose-dependent inhibition by phytate. , 1989, The American journal of clinical nutrition.

[772]  P. Zamboni The Big Idea: Iron-Dependent Inflammation in Venous Disease and Proposed Parallels in Multiple Sclerosis , 2006, Journal of the Royal Society of Medicine.

[773]  J. Weber,et al.  Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging. , 2008, Current medicinal chemistry.

[774]  Y. Chan,et al.  Oxidative damage in Parkinson disease: Measurement using accurate biomarkers. , 2010, Free radical biology & medicine.

[775]  B. S. van Asbeck,et al.  Combining iron chelators with the nucleoside analog didanosine in anti-HIV therapy. , 2000, Transfusion science.

[776]  G. Miele,et al.  A novel erythroid-specific marker of transmissible spongiform encephalopathies , 2001, Nature Medicine.

[777]  Andrew G Smith,et al.  Complex gene-chemical interactions: hepatic uroporphyria as a paradigm. , 2010, Chemical research in toxicology.

[778]  David Blum,et al.  Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease , 2001, Progress in Neurobiology.

[779]  J. March,et al.  Dietary phytate and mineral bioavailability. , 2001, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[780]  Masao Omata,et al.  Inflammation and cancer: Role of nuclear factor‐kappaB activation , 2008, Cancer science.

[781]  Hirokazu Takahashi,et al.  Serum Ferritin Is a Clinical Biomarker in Japanese Patients with Nonalcoholic Steatohepatitis (NASH) Independent of HFE Gene Mutation , 2010, Digestive Diseases and Sciences.

[782]  S. Bansal,et al.  Prion metal interaction: is prion pathogenesis a cause or a consequence of metal imbalance? , 2009, Chemico-biological interactions.

[783]  D. Bhatnagar,et al.  Free radical scavenging activity, metal chelation and antioxidant power of some of the Indian spices , 2007, BioFactors.

[784]  R. Ness,et al.  Nonglycosylated ferritin predominates in the circulation of women with preeclampsia but not intrauterine growth restriction. , 2004, Clinical chemistry.

[785]  C. Rice-Evans,et al.  Antioxidant properties of phenolic compounds , 1997 .

[786]  C. Northrop-Clewes Interpreting indicators of iron status during an acute phase response – lessons from malaria and human immunodeficiency virus , 2008, Annals of clinical biochemistry.

[787]  K. Jellinger Recent advances in our understanding of neurodegeneration , 2009, Journal of Neural Transmission.

[788]  P. Ridker,et al.  Novel clinical markers of vascular wall inflammation. , 2001, Circulation research.

[789]  P. Patel,et al.  Human frataxin maintains mitochondrial iron homeostasis in Saccharomyces cerevisiae. , 2000, Human molecular genetics.

[790]  R. Rosenfeld Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[791]  A. Casini,et al.  Clioquinol decreases amyloid-beta burden and reduces working memory impairment in a transgenic mouse model of Alzheimer's disease. , 2009, Journal of Alzheimer's disease : JAD.

[792]  C. Sawyers,et al.  Cancer: Mixing cocktails , 2007, Nature.

[793]  S Bornholdt,et al.  Robustness as an evolutionary principle , 2000, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[794]  M. Sehested,et al.  Neutrophil Gelatinase-Associated Lipocalin Is Up-Regulated in Human Epithelial Cells by IL-1β, but Not by TNF-α 1 , 2003, The Journal of Immunology.

[795]  S. Weitzman,et al.  Asbestos-induced alveolar epithelial cell apoptosis: Role of mitochondrial dysfunction caused by iron-derived free radicals , 2004, Molecular and Cellular Biochemistry.

[796]  D. Noble The music of life : biology beyond genes , 2008 .

[797]  M. Selim Deferoxamine mesylate: a new hope for intracerebral hemorrhage: from bench to clinical trials. , 2009, Stroke.

[798]  A. Aguzzi,et al.  Insights into prion strains and neurotoxicity , 2007, Nature Reviews Molecular Cell Biology.

[799]  Shweta Trivedi,et al.  Oxidants and the pathogenesis of lung diseases. , 2008, The Journal of allergy and clinical immunology.

[800]  A. Pastore,et al.  Dynamics, stability and iron‐binding activity of frataxin clinical mutants , 2008, The FEBS journal.

[801]  Eva Balsa-Canto,et al.  Parameter estimation and optimal experimental design. , 2008, Essays in biochemistry.

[802]  Colin L. Masters,et al.  Neurodegenerative diseases and oxidative stress , 2004, Nature Reviews Drug Discovery.

[803]  T. Stemmler,et al.  Drosophila frataxin: an iron chaperone during cellular Fe-S cluster bioassembly. , 2008, Biochemistry.

[804]  P. Messa,et al.  HFE Gene Mutations and Oxidative Stress Influence Serum Ferritin, Associated with Vascular Damage, in Hemodialysis Patients , 2007, American Journal of Nephrology.

[805]  B. Maher Personal genomes: The case of the missing heritability , 2008, Nature.

[806]  C. Rigamonti,et al.  Gender and liver fibrosis in chronic hepatitis: the role of iron status , 2005, Alimentary pharmacology & therapeutics.

[807]  S. Tuntipopipat,et al.  Inhibitory effects of spices and herbs on iron availability , 2009, International journal of food sciences and nutrition.

[808]  Sudhir V. Shah,et al.  Role of iron in atherosclerosis. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[809]  D. Berg,et al.  Disturbance of iron metabolism in Parkinson’s disease — ultrasonography as a biomarker , 2009, Neurotoxicity Research.

[810]  J. Terao,et al.  Dietary flavonoids as antioxidants. , 2009, Forum of nutrition.

[811]  G. Sirugo,et al.  Mortality in HIV infection is independently predicted by host iron status and SLC11A1 and HP genotypes, with new evidence of a gene-nutrient interaction. , 2009, The American journal of clinical nutrition.

[812]  Qingbo Xu,et al.  Lipoprotein-associated phospholipase A2 activity, ferritin levels, metabolic syndrome, and 10-year cardiovascular and non-cardiovascular mortality: results from the Bruneck study. , 2008, European heart journal.

[813]  Denise Drago,et al.  Chelation therapy for neurodegenerative diseases , 2009, Medicinal research reviews.

[814]  Y. Takei,et al.  Iron Overload Is Associated with Hepatic Oxidative Damage to DNA in Nonalcoholic Steatohepatitis , 2009, Cancer Epidemiology Biomarkers & Prevention.

[815]  D. Meyer,et al.  Necrosis of host cells and survival of pathogens following iron overload in an in vitro model of co-infection with human immunodeficiency virus (HIV) and Mycobacterium tuberculosis. , 2007, International journal of antimicrobial agents.

[816]  A. Rossi,et al.  Combined use of X-ray photoelectron and Mössbauer spectroscopic techniques in the analytical characterization of iron oxidation state in amphibole asbestos , 2010, Analytical and bioanalytical chemistry.

[817]  Pritha Bagchi,et al.  In situ Imaging of Metals in Cells and Tissues , 2010 .

[818]  J. Andersen,et al.  Does cellular iron dysregulation play a causative role in Parkinson’s disease? , 2004, Ageing Research Reviews.

[819]  Mark A. Smith,et al.  Metal chelators coupled with nanoparticles as potential therapeutic agents for Alzheimer's disease. , 2009, Journal of nanoneuroscience.

[820]  I. Kola,et al.  Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.

[821]  G. Lescoat,et al.  Role of flavonoids and iron chelation in antioxidant action. , 1994, Methods in enzymology.

[822]  Olanow Cw,et al.  Metals and free radicals in neurodegeneration. , 1994 .

[823]  S. Weitzman,et al.  Asbestos causes DNA strand breaks in cultured pulmonary epithelial cells: role of iron-catalyzed free radicals. , 1995, The American journal of physiology.

[824]  D. Westaway,et al.  The cellular prion protein binds copper in vivo , 1997, Nature.

[825]  F. Cuccurullo,et al.  Association of body iron stores with low molecular weight iron and oxidant damage of human atherosclerotic plaques. , 2007, Free radical biology & medicine.

[826]  J. Schenck,et al.  Iron accumulation in the substantia nigra of patients with Alzheimer disease and parkinsonism. , 2009, Archives of neurology.

[827]  P. Valent,et al.  Deferasirox induces regression of iron overload in patients with myelodysplastic syndromes , 2009, European journal of clinical investigation.

[828]  R. Reiter,et al.  Pharmacological utility of melatonin in the treatment of septic shock: experimental and clinical evidence , 2006, The Journal of pharmacy and pharmacology.

[829]  M. Lodovici,et al.  Release of free, redox-active iron in the liver and DNA oxidative damage following phenylhydrazine intoxication. , 1997, Biochemical pharmacology.

[830]  T. Ohtsuka,et al.  Continuous neurogenesis in the adult brain , 2009, Development, growth & differentiation.

[831]  S. Stohs,et al.  The role of iron in 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced lipid peroxidation by rat liver microsomes. , 1987, Toxicology letters.

[832]  Ivana Vucenik,et al.  Protection Against Cancer by Dietary IP6 and Inositol , 2006, Nutrition and cancer.

[833]  H. Puccio Multicellular models of Friedreich ataxia , 2009, Journal of Neurology.

[834]  M. Guérin,et al.  Neurodegenerative disorders: the role of peroxynitrite , 1999, Brain Research Reviews.

[835]  D. Mannino,et al.  The epidemiology of sepsis in the United States from 1979 through 2000. , 2003, The New England journal of medicine.

[836]  B. Winblad,et al.  Uncontrolled diabetes increases the risk of Alzheimer’s disease: a population-based cohort study , 2009, Diabetologia.

[837]  D. Richardson,et al.  Iron trafficking in the mitochondrion: novel pathways revealed by disease. , 2005, Blood.

[838]  Michael Catt,et al.  Ten commandments for the future of ageing research in the UK: a vision for action , 2007, BMC geriatrics.

[839]  C. W. Adams,et al.  Perivascular iron deposition and other vascular damage in multiple sclerosis. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[840]  S Ropele,et al.  Quantitative assessment of brain iron by R2* relaxometry in patients with clinically isolated syndrome and relapsing–remitting multiple sclerosis , 2009, Multiple sclerosis.

[841]  R. Fontana,et al.  Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C. , 2006, Gastroenterology.

[842]  Nathan R. Perron,et al.  A Review of the Antioxidant Mechanisms of Polyphenol Compounds Related to Iron Binding , 2009, Cell Biochemistry and Biophysics.

[843]  A. Ghio,et al.  Dopaminergic neurotoxicity following pulmonary exposure to manganese-containing welding fumes , 2010, Archives of Toxicology.

[844]  T. Lieu,et al.  Preventing Stroke Among Children With Sickle Cell Anemia: An Analysis of Strategies That Involve Transcranial Doppler Testing and Chronic Transfusion , 2007, Pediatrics.

[845]  R. Kurten,et al.  Mechanisms of Acetaminophen-Induced Hepatotoxicity: Role of Oxidative Stress and Mitochondrial Permeability Transition in Freshly Isolated Mouse Hepatocytes , 2005, Journal of Pharmacology and Experimental Therapeutics.

[846]  Istvan Pirko,et al.  Deep gray matter T2 hypointensity correlates with disability in a murine model of MS , 2009, Journal of the Neurological Sciences.

[847]  J. C. Smith,et al.  Inositol phosphates inhibit uptake and transport of iron and zinc by a human intestinal cell line. , 1994, The Journal of nutrition.

[848]  M. Smith,et al.  Oxidative stress in Alzheimer's disease. , 2000, Biochimica et biophysica acta.

[849]  J. Sullivan Is stored iron safe? , 2004, The Journal of laboratory and clinical medicine.

[850]  D. Phillips,et al.  Comparison of the formation of 8-hydroxy-2'-deoxyguanosine and single- and double-strand breaks in DNA mediated by fenton reactions. , 1998, Chemical research in toxicology.

[851]  M. Schrag,et al.  Deposition of iron and β‐amyloid plaques is associated with cortical cellular damage in rabbits fed with long‐term cholesterol‐enriched diets , 2006, Journal of neurochemistry.

[852]  David H. Miller,et al.  What you see depends on how you look , 2009, Neurology.

[853]  Pam Susi,et al.  Manganese, Iron, and Total Particulate Exposures to Welders , 2009, Journal of occupational and environmental hygiene.

[854]  N. Sugihara,et al.  Anti- and pro-oxidative effects of flavonoids on metal-induced lipid hydroperoxide-dependent lipid peroxidation in cultured hepatocytes loaded with alpha-linolenic acid. , 1999, Free radical biology & medicine.

[855]  D. Geschwind,et al.  Small Molecule Activation of Adaptive Gene Expression , 2008, Annals of the New York Academy of Sciences.

[856]  E. Gabazza,et al.  Iron reduction therapy by phlebotomy reduces lipid peroxidation and oxidative stress in patients with chronic hepatitis C , 2006, Journal of Gastroenterology.

[857]  F. Taroni,et al.  Mitochondrial ferritin limits oxidative damage regulating mitochondrial iron availability: hypothesis for a protective role in Friedreich ataxia. , 2008, Human molecular genetics.

[858]  N. Vermeulen,et al.  Evaluation of a Multi-parameter Biomarker Set for Oxidative Damage in Man: Increased Urinary Excretion of Lipid, Protein and DNA Oxidation Products after One Hour of Exercise , 2004, Free radical research.

[859]  Alberto Ferri,et al.  Amyotrophic lateral sclerosis: from current developments in the laboratory to clinical implications. , 2008, Antioxidants & redox signaling.

[860]  Heikki Korpela,et al.  High Stored Iron Levels Are Associated With Excess Risk of Myocardial Infarction in Eastern Finnish Men , 1992, Circulation.

[861]  W. Luck,et al.  Serum ferritin concentration in Gaucher's disease. , 1983, British medical journal.

[862]  R. Carp,et al.  Oxidative Stress and Neurodegeneration in Prion Diseases , 2001, Annals of the New York Academy of Sciences.

[863]  M Purdey,et al.  Ecosystems supporting clusters of sporadic TSEs demonstrate excesses of the radical-generating divalent cation manganese and deficiencies of antioxidant co factors Cu, Se, Fe, Zn. Does a foreign cation substitution at prion protein's Cu domain initiate TSE? , 2000, Medical hypotheses.

[864]  M. N. Álvarez,et al.  Unraveling peroxynitrite formation in biological systems. , 2001, Free radical biology & medicine.

[865]  Attila Csikász-Nagy,et al.  Computational systems biology of the cell cycle , 2009, Briefings Bioinform..

[866]  L. Cooper,et al.  Iron and peripheral arterial disease: revisiting the iron hypothesis in a different light , 2003, Vascular medicine.

[867]  F. Dal-Pizzol,et al.  Efficacy of the combination of N-acetylcysteine and desferrioxamine in the prevention and treatment of gentamicin-induced acute renal failure in male Wistar rats. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[868]  Aldons J. Lusis,et al.  Atherosclerosis : Vascular biology , 2000 .

[869]  Rui Hai Liu,et al.  Apple phytochemicals and their health benefits , 2004, Nutrition journal.

[870]  J. Dobson,et al.  Mapping and characterization of iron compounds in Alzheimer's tissue. , 2006, Journal of Alzheimer's disease : JAD.

[871]  Sukru Oter,et al.  Melatonin: An Established Antioxidant Worthy of Use in Clinical Trials , 2009, Molecular medicine.

[872]  Elisabetta Foresti,et al.  Iron-loaded synthetic chrysotile: a new model solid for studying the role of iron in asbestos toxicity. , 2007, Chemical research in toxicology.

[873]  Y. Tse‐Dinh,et al.  Hydroxyl Radicals Are Involved in Cell Killing by the Bacterial Topoisomerase I Cleavage Complex , 2009, Journal of bacteriology.

[874]  C. Guttmann,et al.  Deep Gray Matter Involvement on Brain MRI Scans Is Associated with Clinical Progression in Multiple Sclerosis , 2009, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[875]  B. Hasinoff,et al.  The iron chelating cardioprotective prodrug dexrazoxane does not affect the cell growth inhibitory effects of bleomycin. , 2004, Journal of inorganic biochemistry.

[876]  P. Riederer,et al.  Iron‐Melanin Interaction and Lipid Peroxidation: Implications for Parkinson's Disease , 1991, Journal of neurochemistry.

[877]  I. Ferrer,et al.  Oxidation, glycoxidation, lipoxidation, nitration, and responses to oxidative stress in the cerebral cortex in Creutzfeldt–Jakob disease , 2006, Neurobiology of Aging.

[878]  S. Gieseg,et al.  Macrophage antioxidant protection within atherosclerotic plaques. , 2009, Frontiers in bioscience.

[879]  J. Connor,et al.  HFE mutations and Alzheimer's disease. , 2006, Journal of Alzheimer's disease : JAD.

[880]  Julie S. Jurenka Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. , 2009, Alternative medicine review : a journal of clinical therapeutic.

[881]  H. F. Goode,et al.  Free radicals and antioxidants in sepsis , 1993, Critical care medicine.

[882]  A. Othman,et al.  Melatonin controls oxidative stress and modulates iron, ferritin, and transferrin levels in adriamycin treated rats. , 2008, Life sciences.

[883]  R. Allen,et al.  Systems genetic analysis of peripheral iron parameters in the mouse. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

[884]  S. Al-Karadaghi,et al.  Structural basis of the iron storage function of frataxin from single-particle reconstruction of the iron-loaded oligomer. , 2008, Biochemistry.

[885]  T. Meinertz,et al.  Zytokine in der Pathogenese der Atherosklerose , 2002, Deutsche medizinische Wochenschrift.

[886]  L. Fleisher,et al.  Distribution of ferritin chains in canine lenses with and without age-related nuclear cataracts , 2009, Molecular vision.

[887]  J. Imlay Cellular defenses against superoxide and hydrogen peroxide. , 2008, Annual review of biochemistry.

[888]  M. Smith,et al.  Causes of oxidative stress in Alzheimer disease , 2007, Cellular and Molecular Life Sciences.

[889]  S. Lydersen,et al.  Prevalence of haemochromatosis gene mutations in Parkinson’s disease , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[890]  D. Kamp,et al.  Asbestos-Induced Pulmonary Toxicity: Role of DNA Damage and Apoptosis , 2003, Experimental biology and medicine.

[891]  R. Reiter,et al.  Melatonin reduces phenylhydrazine-induced oxidative damage to cellular membranes: evidence for the involvement of iron. , 2000, The international journal of biochemistry & cell biology.

[892]  S. García-Castiñeiras Iron, the retina and the lens: a focused review. , 2010, Experimental eye research.

[893]  Rohit Bakshi,et al.  Role of MRI in multiple sclerosis II: brain and spinal cord atrophy. , 2004, Frontiers in bioscience : a journal and virtual library.

[894]  Dean P. Jones,et al.  Oxidative damage and protection of the RPE , 2000, Progress in Retinal and Eye Research.

[895]  S. Mandel,et al.  Neurorescue activity, APP regulation and amyloid-beta peptide reduction by novel multi-functional brain permeable iron- chelating- antioxidants, M-30 and green tea polyphenol, EGCG. , 2007, Current Alzheimer research.

[896]  A. Pastore,et al.  The pathogenesis of Friedreich ataxia and the structure and function of frataxin , 2009, Journal of Neurology.

[897]  A. Dancis,et al.  Evidence that yeast frataxin is not an iron storage protein in vivo. , 2010, Biochimica et biophysica acta.

[898]  Johannes Stegmann,et al.  Hypothesis generation guided by co-word clustering , 2004, Scientometrics.

[899]  Jason W. Chin,et al.  Encoding multiple unnatural amino acids via evolution of a quadruplet-decoding ribosome , 2010, Nature.

[900]  Zhaohui Zhang,et al.  Iron-induced oxidative damage and apoptosis in cerebellar granule cells: attenuation by tetramethylpyrazine and ferulic acid. , 2003, European journal of pharmacology.

[901]  Nicki Panoskaltsis,et al.  Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. , 2006, The New England journal of medicine.

[902]  Janet M. Thornton,et al.  Metal ions in biological catalysis: from enzyme databases to general principles , 2008, JBIC Journal of Biological Inorganic Chemistry.

[903]  V. Adhami,et al.  Effective Prostate Cancer Chemopreventive Intervention with Green Tea Polyphenols in the TRAMP Model Depends on the Stage of the Disease , 2009, Clinical Cancer Research.

[904]  D. Meyer Iron chelation as therapy for HIV and Mycobacterium tuberculosis co-infection under conditions of iron overload. , 2006, Current pharmaceutical design.

[905]  Takeo Kato,et al.  Mutations of optineurin in amyotrophic lateral sclerosis , 2010, Nature.

[906]  J. Stockman Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease , 2011 .

[907]  L. Liaudet,et al.  Nitric oxide and peroxynitrite in health and disease. , 2007, Physiological reviews.

[908]  S. Saab,et al.  Serum ferritin concentration predicts mortality in patients awaiting liver transplantation , 2010, Hepatology.

[909]  M. Daemen,et al.  Accumulation of Zinc in Human Atherosclerotic Lesions Correlates With Calcium Levels But Does Not Protect Against Protein Oxidation , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[910]  Gary Williamson,et al.  Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. , 2005, The American journal of clinical nutrition.

[911]  Richard C. Moore,et al.  Genes contributing to prion pathogenesis. , 2008, The Journal of general virology.

[912]  D. Weatherall,et al.  Iron-chelating therapy. , 1988, Critical reviews in clinical laboratory sciences.

[913]  M Gulumian,et al.  Hydroxyl radical production in the presence of fibres by a Fenton-type reaction. , 1987, Chemico-biological interactions.

[914]  S. Cadenas,et al.  Fighting the stranger-antioxidant protection against endotoxin toxicity. , 2002, Toxicology.

[915]  D. Kamp,et al.  Asbestos-induced lung diseases: an update. , 2009, Translational research : the journal of laboratory and clinical medicine.

[916]  A. Hilliker,et al.  Hydrogen peroxide scavenging rescues frataxin deficiency in a Drosophila model of Friedreich's ataxia , 2008, Proceedings of the National Academy of Sciences.

[917]  A. Minihane,et al.  Biomarkers of the intake of dietary polyphenols: strengths, limitations and application in nutrition research , 2007, British Journal of Nutrition.

[918]  H. Drakesmith,et al.  Viral infection and iron metabolism , 2008, Nature Reviews Microbiology.

[919]  Neena Singh,et al.  Abnormal Brain Iron Homeostasis in Human and Animal Prion Disorders , 2009, PLoS pathogens.

[920]  P. Riederer,et al.  Neuromelanin-bound ferric iron as an experimental model of dopaminergic neurodegeneration in Parkinson's disease. , 2008, Parkinsonism & related disorders.

[921]  K. Bedecs,et al.  Changed iron regulation in scrapie-infected neuroblastoma cells. , 2005, Brain research. Molecular brain research.

[922]  Peng Huang,et al.  Redox regulation of cell survival. , 2008, Antioxidants & redox signaling.

[923]  N. Franks,et al.  Molecular targets underlying general anaesthesia , 2006, British journal of pharmacology.

[924]  H. L. Persson Iron-dependent lysosomal destabilization initiates silica-induced apoptosis in murine macrophages. , 2005, Toxicology letters.

[925]  K. Kowdley,et al.  The role of iron in the pathophysiology and treatment of chronic hepatitis C. , 2009, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[926]  David Weininger,et al.  SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules , 1988, J. Chem. Inf. Comput. Sci..

[927]  Douglas B. Kell,et al.  The role of modeling in systems biology , 2005 .

[928]  J. Eaton,et al.  Intralysosomal iron: a major determinant of oxidant-induced cell death. , 2003, Free radical biology & medicine.

[929]  D. Bredesen,et al.  bcl-2 expression decreases methyl mercury-induced free-radical generation and cell killing in a neural cell line. , 1994, Toxicology letters.

[930]  W. Rayens,et al.  Iron accumulation in the striatum predicts aging-related decline in motor function in rhesus monkeys , 2007, Neurobiology of Aging.

[931]  Rohit Bakshi,et al.  Deep gray matter T2 hypointensity is present in patients with clinically isolated syndromes suggestive of multiple sclerosis , 2010, Multiple sclerosis.

[932]  P. Delepelaire,et al.  Bacterial iron sources: from siderophores to hemophores. , 2004, Annual review of microbiology.

[933]  M. Olaleye,et al.  Acetaminophen-induced liver damage in mice: effects of some medicinal plants on the oxidative defense system. , 2008, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[934]  D. Richardson,et al.  Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents. , 2009, Biochimica et biophysica acta.

[935]  S. Nariman,et al.  Early markers of renal dysfunction in patients with beta-thalassemia major , 2008, Pediatric Nephrology.

[936]  Stephen L. Hauser,et al.  Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis , 2010, Nature.

[937]  Matthew S. Grubb,et al.  Adult neurogenesis and functional plasticity in neuronal circuits , 2006, Nature Reviews Neuroscience.

[938]  S. Dooley,et al.  Current experimental perspectives on the clinical progression of alcoholic liver disease. , 2009, Alcoholism, clinical and experimental research.

[939]  Andrew G Smith,et al.  Chapter 6 Disruption of Heme Synthesis by Polyhalogenated Aromatics , 2009 .

[940]  C. Arean,et al.  Chemical aspects of the toxicity of inhaled mineral dusts , 2000 .

[941]  J S Beckman,et al.  Kinetics of superoxide dismutase- and iron-catalyzed nitration of phenolics by peroxynitrite. , 1992, Archives of biochemistry and biophysics.

[942]  Pha Peter Mutsaers,et al.  Spatial correlation of trace elements with morphological features of atherosclerotic plaques , 2005 .

[943]  D. Bhatnagar,et al.  Modulatory effect of spice extracts on iron‐induced lipid peroxidation in rat liver , 2007, BioFactors.

[944]  D. Richardson,et al.  Elucidation of the mechanism of mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant , 2009, Proceedings of the National Academy of Sciences.

[945]  W. Tolman,et al.  Biologically inspired oxidation catalysis , 2008, Nature.

[946]  P. Riederer,et al.  Neuromelanin in human dopamine neurons: Comparison with peripheral melanins and relevance to Parkinson's disease , 2005, Progress in Neurobiology.

[947]  F. Visseren,et al.  Intracellular labile iron promotes firm adhesion of human monocytes to endothelium under flow and transendothelial migration: Iron and monocyte-endothelial cell interactions. , 2009, Atherosclerosis.

[948]  J. Vaupel Biodemography of human ageing , 2010, Nature.

[949]  Margaret A. Pericak-Vance,et al.  Genetic variants near TIMP3 and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration , 2010, Proceedings of the National Academy of Sciences.

[950]  E. Mark Haacke,et al.  Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study , 2010, Acta Neuropathologica.

[951]  J. Collins,et al.  Mistranslation of Membrane Proteins and Two-Component System Activation Trigger Antibiotic-Mediated Cell Death , 2008, Cell.

[952]  Laszlo Magos,et al.  The toxicology of mercury--current exposures and clinical manifestations. , 2003, The New England journal of medicine.

[953]  P. Leeson,et al.  The influence of drug-like concepts on decision-making in medicinal chemistry , 2007, Nature Reviews Drug Discovery.

[954]  E J Calabrese,et al.  Hormesis: U-shaped dose responses and their centrality in toxicology. , 2001, Trends in pharmacological sciences.

[955]  T. Rouault,et al.  Hereditary hemochromatosis. , 1993, JAMA.

[956]  P. Taupin Protocols for studying adult neurogenesis: insights and recent developments. , 2007, Regenerative medicine.

[957]  T. Evans,et al.  Iron and the redox status of the lungs. , 2002, Free radical biology & medicine.

[958]  R. Brudevold,et al.  Hyperferritinemia Is Associated with Insulin Resistance and Fatty Liver in Patients without Iron Overload , 2008, PloS one.

[959]  Yong Chul Lee,et al.  Heme oxygenase-1 and carbon monoxide: emerging therapeutic targets in inflammation and allergy. , 2008, Recent patents on inflammation & allergy drug discovery.

[960]  N. Patel,et al.  INHIBITORS OF NADPH OXIDASE REDUCE THE ORGAN INJURY IN HEMORRHAGIC SHOCK , 2005, Shock.

[961]  K. Kataoka,et al.  Spatial Redox Regulation of a Critical Cysteine Residue of NF-κB in Vivo * , 2002, The Journal of Biological Chemistry.

[962]  K. Franz,et al.  A Prochelator Activated by Hydrogen Peroxide Prevents Metal‐Induced Amyloid β Aggregation , 2009, Chembiochem : a European journal of chemical biology.

[963]  Nicholas J Turner,et al.  Directed evolution drives the next generation of biocatalysts. , 2009, Nature chemical biology.

[964]  W. Pryor,et al.  The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. , 1995, The American journal of physiology.

[965]  M. Gladwin,et al.  Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[966]  S. Colonna,et al.  Polyamino acids as synthetic enzymes: mechanism, applications and relevance to prebiotic catalysis. , 2005, Trends in biotechnology.

[967]  Donald J Brambilla,et al.  Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results. , 2006, Blood.

[968]  C. Palm,et al.  Bioimaging of metals in brain tissue by laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) and metallomics. , 2010, Metallomics : integrated biometal science.

[969]  S. Shah,et al.  Safety issues of iron chelation therapy in patients with normal range iron stores including thalassaemia, neurodegenerative, renal and infectious diseases , 2010, Expert opinion on drug safety.

[970]  P. Muriel,et al.  Pharmacological actions of curcumin in liver diseases or damage , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[971]  D B Kell,et al.  Dormancy in non-sporulating bacteria. , 1993, FEMS microbiology reviews.

[972]  B. Lindholm,et al.  Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2'-deoxyguanosine levels. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[973]  M. Murphy,et al.  Peroxynitrite: a biologically significant oxidant. , 1998, General pharmacology.

[974]  P. Baeuerle,et al.  Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.

[975]  Hod Lipson,et al.  Nonlinear system identification using coevolution of models and tests , 2005, IEEE Transactions on Evolutionary Computation.

[976]  A. Naganuma,et al.  Characterization of antioxidant protection of cultured neural progenitor cells (NPC) against methylmercury (MeHg) toxicity. , 2009, The Journal of toxicological sciences.

[977]  R. Lill,et al.  Maturation of iron-sulfur proteins in eukaryotes: mechanisms, connected processes, and diseases. , 2008, Annual review of biochemistry.

[978]  Guangjun Nie,et al.  Neuroprotective mechanism of mitochondrial ferritin on 6-hydroxydopamine-induced dopaminergic cell damage: implication for neuroprotection in Parkinson's disease. , 2010, Antioxidants & redox signaling.

[979]  Michael Peyton,et al.  Synthetic lethal screen identification of chemosensitizer loci in cancer cells , 2007, Nature.

[980]  D. Meyer,et al.  The effect of iron overload on in vitro HIV-1 infection. , 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[981]  K. Bidle,et al.  Iron Starvation and Culture Age Activate Metacaspases and Programmed Cell Death in the Marine Diatom Thalassiosira pseudonana , 2007, Eukaryotic Cell.

[982]  Andrea Califano,et al.  Reverse engineering biological networks. Opportunities and challenges in computational methods for pathway inference. Proceedings of the workshop entitled Dialogue on Reverse Engineering Assessment and Methods (DREAM). September 7-8, 2006. Bronx, New York, USA. , 2007, Annals of the New York Academy of Sciences.

[983]  U. John,et al.  Association Between High Serum Ferritin Levels and Carotid Atherosclerosis in the Study of Health in Pomerania (SHIP) , 2004, Stroke.

[984]  M. Youdim,et al.  Ironing Iron Out in Parkinson's Disease and Other Neurodegenerative Diseases with Iron Chelators: A Lesson from 6‐Hydroxydopamine and Iron Chelators, Desferal and VK‐28 , 2004, Annals of the New York Academy of Sciences.

[985]  Griffin M. Weber,et al.  BioNumbers—the database of key numbers in molecular and cell biology , 2009, Nucleic Acids Res..

[986]  I. Poser,et al.  Modulation of genotoxic effects in asbestos-exposed primary human mesothelial cells by radical scavengers, metal chelators and a glutathione precursor. , 2004, Mutation research.

[987]  S. LeVine,et al.  The Role of Iron in the Pathogenesis of Experimental Allergic Encephalomyelitis and Multiple Sclerosis , 2004, Annals of the New York Academy of Sciences.

[988]  M. Jimenez-Del-Rio,et al.  The Effects of Polyphenols on Survival and Locomotor Activity in Drosophila melanogaster Exposed to Iron and Paraquat , 2010, Neurochemical Research.

[989]  J. Eaton,et al.  Ferritin: a cytoprotective antioxidant strategem of endothelium. , 1992, The Journal of biological chemistry.

[990]  N. Nukina,et al.  The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies , 2009, Journal of neurochemistry.

[991]  B. Halliwell,et al.  Artifacts in cell culture: rapid generation of hydrogen peroxide on addition of (-)-epigallocatechin, (-)-epigallocatechin gallate, (+)-catechin, and quercetin to commonly used cell culture media. , 2000, Biochemical and biophysical research communications.

[992]  You-nian Liu,et al.  Binding of alpha-synuclein with Fe(III) and with Fe(II) and biological implications of the resultant complexes. , 2010, Journal of inorganic biochemistry.

[993]  A. Abbruzzese,et al.  Desferioxamine increases iron depletion and apoptosis induced by ara‐C of human myeloid leukaemic cells , 1998, British journal of haematology.

[994]  R. Grossman,et al.  Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging , 2009, Journal of magnetic resonance imaging : JMRI.

[995]  Edda Klipp,et al.  Bringing metabolic networks to life: integration of kinetic, metabolic, and proteomic data , 2006, Theoretical Biology and Medical Modelling.

[996]  Michael E. Andrades,et al.  Treatment with N-acetylcysteine plus deferoxamine protects rats against oxidative stress and improves survival in sepsis* , 2004, Critical care medicine.

[997]  J. Joseph,et al.  Nitric oxide mitigates peroxide-induced iron-signaling, oxidative damage, and apoptosis in endothelial cells: role of proteasomal function? , 2004, Archives of biochemistry and biophysics.

[998]  S. Nekhai,et al.  Iron chelators ICL670 and 311 inhibit HIV-1 transcription. , 2007, Virology.

[999]  Masaru Tomita,et al.  GEM System: automatic prototyping of cell-wide metabolic pathway models from genomes , 2006, BMC Bioinformatics.

[1000]  L. Mascitelli,et al.  High iron stores and risk of ischemic stroke in persons with metabolic syndrome. , 2006, Internal medicine.

[1001]  Daniel J. Rader,et al.  Translating molecular discoveries into new therapies for atherosclerosis , 2008, Nature.

[1002]  R. Vijayaraghavan,et al.  Oxidative stress associated hepatic and renal toxicity induced by ricin in mice. , 2003, Toxicon : official journal of the International Society on Toxinology.

[1003]  R. Adams Big strokes in small persons. , 2007, Archives of neurology.

[1004]  Charles B. Hall,et al.  Transferrin therapy ameliorates disease in β-thalassemic mice , 2010, Nature Medicine.

[1005]  S. Legrand-Poels,et al.  NF-κB activation by reactive oxygen species: Fifteen years later , 2006 .

[1006]  V. Castranova,et al.  Oxidative stress and inflammatory response in dermal toxicity of single-walled carbon nanotubes. , 2009, Toxicology.

[1007]  C. Wermuth Selective optimization of side activities: another way for drug discovery. , 2004, Journal of medicinal chemistry.

[1008]  D. Giachetti,et al.  Protection against oxidative damage of erythrocyte membrane by the flavonoid quercetin and its relation to iron chelating activity , 1997, FEBS letters.

[1009]  Andrew C. Oates,et al.  Quantitative approaches in developmental biology , 2009, Nature Reviews Genetics.

[1010]  F. Foury,et al.  Deletion of the yeast homologue of the human gene associated with Friedreich's ataxia elicits iron accumulation in mitochondria , 1997, FEBS letters.

[1011]  J. R. Lancaster Protein cysteine thiol nitrosation: maker or marker of reactive nitrogen species-induced nonerythroid cellular signaling? , 2008, Nitric oxide : biology and chemistry.

[1012]  Christian Hölscher,et al.  Common pathological processes in Alzheimer disease and type 2 diabetes: A review , 2007, Brain Research Reviews.

[1013]  M. Garey Johnson: computers and intractability: a guide to the theory of np- completeness (freeman , 1979 .

[1014]  A. Nel,et al.  Importance of oxidative stress in the pathogenesis and treatment of asthma , 2008, Current opinion in allergy and clinical immunology.

[1015]  L. Chau Iron and atherosclerosis. , 2000, Proceedings of the National Science Council, Republic of China. Part B, Life sciences.

[1016]  M. Youdim,et al.  Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer's, Parkinson's, and other neurodegenerative diseases. , 2005, Bioorganic & medicinal chemistry.

[1017]  M. Runge,et al.  Oxidative Stress and Vascular Disease , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[1018]  M. Mohan,et al.  Modulation of proteinase K-resistant prion protein in cells and infectious brain homogenate by redox iron: implications for prion replication and disease pathogenesis. , 2007, Molecular biology of the cell.

[1019]  Irfan Rahman,et al.  Environmental toxicity, redox signaling and lung inflammation: the role of glutathione. , 2009, Molecular aspects of medicine.

[1020]  G. Vercellotti,et al.  Iron and atherosclerosis: inhibition by the iron chelator deferiprone (L1). , 1997, The Journal of surgical research.

[1021]  Ashutosh Kumar Singh,et al.  The Elements of Statistical Learning: Data Mining, Inference, and Prediction , 2010 .

[1022]  P. Brown Spongiform encephalopathies: B lymphocytes and neuroinvasion , 1997, Nature.

[1023]  Chao Zhang,et al.  Combinatorial efficacy achieved through two-point blockade within a signaling pathway-a chemical genetic approach. , 2003, Cancer research.

[1024]  C. Burrows,et al.  Oxidative Nucleobase Modifications Leading to Strand Scission. , 1998, Chemical reviews.

[1025]  N. Nighoghossian,et al.  Novel Applications of Magnetic Resonance Imaging to Image Tissue Inflammation after Stroke , 2008, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[1026]  Y. Fernandez,et al.  Paraquat and iron-dependent lipid peroxidation , 2000, Biological Trace Element Research.

[1027]  R. M. Adibhatla,et al.  Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities. , 2010, Antioxidants & redox signaling.

[1028]  I. Moseley,et al.  Signal intensity on MRI of basal ganglia in multiple sclerosis. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[1029]  Xiongwei Zhu,et al.  Involvement of Oxidative Stress in Alzheimer Disease , 2006, Journal of neuropathology and experimental neurology.

[1030]  J. Lehár,et al.  Systematic discovery of multicomponent therapeutics , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[1031]  D. Kell,et al.  Here is the evidence, now what is the hypothesis? The complementary roles of inductive and hypothesis-driven science in the post-genomic era. , 2004, BioEssays : news and reviews in molecular, cellular and developmental biology.

[1032]  C. Pierpont,et al.  Dopamine complexes of iron in the etiology and pathogenesis of Parkinson's disease. , 2009, Journal of inorganic biochemistry.

[1033]  Ilja C W Arts,et al.  Polyphenols and disease risk in epidemiologic studies. , 2005, The American journal of clinical nutrition.

[1034]  U. Brunk,et al.  The lysosomal-mitochondrial axis theory of postmitotic aging and cell death. , 2006, Chemico-biological interactions.

[1035]  Douglas B Kell,et al.  The virtual human: Towards a global systems biology of multiscale, distributed biochemical network models , 2007, IUBMB life.

[1036]  J. Stamler,et al.  Redox-based regulation of signal transduction: principles, pitfalls, and promises. , 2008, Free radical biology & medicine.

[1037]  D. Perl,et al.  Protein Nitration in Parkinson's Disease , 1998, Journal of neuropathology and experimental neurology.

[1038]  S. Dimauro,et al.  Mitochondrial disorders in the nervous system. , 2008, Annual review of neuroscience.

[1039]  K. Takeuchi,et al.  A toxicogenomic approach revealed hepatic gene expression changes mechanistically linked to drug-induced hemolytic anemia. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[1040]  R. Bowler,et al.  Oxidative stress in allergic respiratory diseases. , 2002, The Journal of allergy and clinical immunology.

[1041]  B. Palsson,et al.  A protocol for generating a high-quality genome-scale metabolic reconstruction , 2010 .

[1042]  A. Bush Drug development based on the metals hypothesis of Alzheimer's disease. , 2008, Journal of Alzheimer's disease : JAD.

[1043]  G. Williamson,et al.  Dietary intake and bioavailability of polyphenols. , 2000, The Journal of nutrition.

[1044]  Manabu Okada,et al.  Toxicogenomics of drug-induced hemolytic anemia by analyzing gene expression profiles in the spleen. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[1045]  A. Chowdhury,et al.  Stroke in the young: relationship with iron deficiency anemia and thrombocytosis. , 2008, Mymensingh medical journal : MMJ.

[1046]  K. Bedecs,et al.  Increased susceptibility to oxidative stress in scrapie-infected neuroblastoma cells is associated with intracellular iron status , 2005, Neuroscience Letters.

[1047]  K. Batts Iron overload syndromes and the liver , 2007, Modern Pathology.

[1048]  P. Mitchell,et al.  Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. , 2008, Ophthalmology.

[1049]  L. Johnson Iron and siderophores in fungal-host interactions. , 2008, Mycological research.

[1050]  C. Bolton,et al.  Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. , 1996, Critical care medicine.

[1051]  S. Jovanovic,et al.  Antioxidants in Nutrition , 2000, Annals of the New York Academy of Sciences.

[1052]  S. Lee,et al.  Metabolic engineering of Escherichia coli for the production of l-valine based on transcriptome analysis and in silico gene knockout simulation , 2007, Proceedings of the National Academy of Sciences.

[1053]  J. D. Barker,et al.  Chronic excessive acetaminophen use and liver damage. , 1977, Annals of internal medicine.

[1054]  David R. Brown,et al.  Oxidative impairment in scrapie‐infected mice is associated with brain metals perturbations and altered antioxidant activities , 2001, Journal of neurochemistry.

[1055]  H. Silver,et al.  Multifunctional pharmacotherapy: What can we learn from study of selective serotonin reuptake inhibitor augmentation of antipsychotics in negative-symptom schizophrenia? , 2011, Neurotherapeutics.

[1056]  W. Harris,et al.  Neurogenesis and the Cell Cycle , 2003, Neuron.

[1057]  U. Brunk,et al.  Lysosomes in iron metabolism, ageing and apoptosis , 2008, Histochemistry and Cell Biology.

[1058]  K. Jellinger,et al.  Recent developments in the pathology of Parkinson's disease. , 2002, Journal of neural transmission. Supplementum.

[1059]  J. Rifkind,et al.  Assessment of antioxidant activity of eugenol in vitro and in vivo. , 2010, Methods in molecular biology.

[1060]  J. Moriguti,et al.  (Pre)diabetes, brain aging, and cognition. , 2009, Biochimica et biophysica acta.

[1061]  U. Brunk,et al.  Oxidative stress, accumulation of biological 'garbage', and aging. , 2006, Antioxidants & redox signaling.

[1062]  D. Karcher,et al.  Bone marrow macrophage iron grade and survival of HIV-seropositive patients. , 1999, AIDS.

[1063]  George Perry,et al.  Oxidative stress in diabetes and Alzheimer's disease. , 2009, Journal of Alzheimer's disease : JAD.

[1064]  Stephen J. Galli,et al.  The development of allergic inflammation , 2008, Nature.

[1065]  H. Atamna Amino acids variations in Amyloid-β peptides, mitochondrial dysfunction, and new therapies for Alzheimer’s disease , 2009, Journal of bioenergetics and biomembranes.

[1066]  R. Petersen,et al.  Prion Protein (PrP) Knock-Out Mice Show Altered Iron Metabolism: A Functional Role for PrP in Iron Uptake and Transport , 2009, PloS one.

[1067]  Hartmut Jaeschke,et al.  Intracellular signaling mechanisms of acetaminophen-induced liver cell death. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[1068]  R. Reiter,et al.  The use of melatonin to combat mustard toxicity. REVIEW. , 2008, Neuro endocrinology letters.

[1069]  Peter Stenvinkel,et al.  The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. , 2002, Kidney international.

[1070]  Douglas B. Kell,et al.  In silico modelling of directed evolution: Implications for experimental design and stepwise evolution. , 2009, Journal of theoretical biology.

[1071]  J. Ironside,et al.  Review: pathology of variant Creutzfeldt-Jakob disease. , 2004, Folia neuropathologica.

[1072]  Inyoul Y. Lee,et al.  A systems approach to prion disease , 2009, Molecular systems biology.

[1073]  H. Nichol,et al.  The chemical form of mitochondrial iron in Friedreich's ataxia. , 2007, Journal of inorganic biochemistry.

[1074]  Jan-Yow Chen,et al.  Green tea extract protects rats against myocardial infarction associated with left anterior descending coronary artery ligation , 2009, Pflügers Archiv - European Journal of Physiology.

[1075]  S. Prusiner,et al.  Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins , 1994, Cell.

[1076]  D. Grainger TGF-β and atherosclerosis in man , 2007 .

[1077]  S. Weitzman,et al.  The role of free radicals in asbestos-induced diseases. , 1992, Free radical biology & medicine.

[1078]  Philip S. Yu,et al.  Top 10 algorithms in data mining , 2007, Knowledge and Information Systems.

[1079]  Paolo Zamboni,et al.  Anomalous Venous Blood Flow and Iron Deposition in Multiple Sclerosis , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[1080]  F. Zamani,et al.  Relationship between elevated liver enzyme with iron overload and viral hepatitis in thalassemia major patients in Northern Iran. , 2008, Saudi medical journal.

[1081]  J. Eberle,et al.  New caspase-independent but ROS-dependent apoptosis pathways are targeted in melanoma cells by an iron-containing cytosine analogue. , 2010, Biochemical pharmacology.

[1082]  G. Andrei,et al.  Iron chelators inhibit the growth and induce the apoptosis of Kaposi's sarcoma cells and of their putative endothelial precursors. , 2000, The Journal of investigative dermatology.

[1083]  B. Nordestgaard,et al.  Hemochromatosis genotypes and risk of 31 disease endpoints: Meta‐analyses including 66,000 cases and 226,000 controls , 2007, Hepatology.

[1084]  Xilin Zhao,et al.  Contribution of Oxidative Damage to Antimicrobial Lethality , 2009, Antimicrobial Agents and Chemotherapy.

[1085]  D. Berg,et al.  Contribution of disturbed iron metabolism to the pathogenesis of Parkinson's disease , 2008 .

[1086]  R. Kishony,et al.  Functional classification of drugs by properties of their pairwise interactions , 2006, Nature Genetics.

[1087]  R. Strong,et al.  Siderocalins: siderophore-binding proteins of the innate immune system , 2009, BioMetals.

[1088]  K. Blennow,et al.  PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses. , 2010, Journal of Alzheimer's disease : JAD.

[1089]  I. Rahman,et al.  Biomarkers in risk assessment of asbestos exposure. , 2005, Mutation research.

[1090]  L. S. Greene Asthma and oxidant stress: nutritional, environmental, and genetic risk factors. , 1995, Journal of the American College of Nutrition.

[1091]  D. Perl,et al.  Evidence of neuronal oxidative damage in Alzheimer's disease. , 1996, The American journal of pathology.

[1092]  A. Proos,et al.  Hereditary Haemochromatosis , 1997 .

[1093]  A. Inati,et al.  Iron overload indices rise linearly with transfusion rate in patients with sickle cell disease. , 2010, Blood.

[1094]  D. Butterfield,et al.  Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis. , 2005, Free radical biology & medicine.

[1095]  M. Groppo,et al.  Iron chelating-mediated antioxidant activity of Plectranthus barbatus extract on mitochondria , 2010 .

[1096]  B. Foxwell,et al.  Signalling, inflammation and arthritis: NF-kappaB and its relevance to arthritis and inflammation. , 2008, Rheumatology.

[1097]  J. Lovato,et al.  The transplant iron score as a predictor of stem cell transplant survival , 2009, Journal of Hematology & Oncology.

[1098]  Sven Sahle,et al.  A new strategy for assessing sensitivities in biochemical models , 2008, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

[1099]  A. Lusis,et al.  Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. , 2004, The New England journal of medicine.

[1100]  M. Youdim,et al.  Therapeutic targets and potential of the novel brain‐ permeable multifunctional iron chelator–monoamine oxidase inhibitor drug, M‐30, for the treatment of Alzheimer's disease 1 , 2007, Journal of neurochemistry.

[1101]  A. Young,et al.  A potent small molecule inhibits polyglutamine aggregation in Huntington's disease neurons and suppresses neurodegeneration in vivo. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[1102]  R. Keep,et al.  Deferoxamine therapy for intracerebral hemorrhage. , 2008, Acta neurochirurgica. Supplement.

[1103]  Randolph A. Coleman,et al.  In silico evidence for glutathione- and iron-related pathogeneses in Parkinson's disease , 2010, Journal of Neuroscience Methods.

[1104]  C. Atwood,et al.  Metals and Alzheimer's Disease , 2011, International journal of Alzheimer's disease.

[1105]  U. Dirnagl,et al.  Desferrioxamine Induces Delayed Tolerance against Cerebral Ischemia in Vivo and in Vitro , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[1106]  Douglas B. Kell,et al.  Statistical strategies for avoiding false discoveries in metabolomics and related experiments , 2007, Metabolomics.

[1107]  J L Haines,et al.  Supporting Online Material Materials and Methods Figs. S1 to S7 Tables S1 to S4 References Mutations in the Fus/tls Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis , 2022 .

[1108]  E. Bomhard,et al.  Genotoxic Activities of Aniline and its Metabolites and Their Relationship to the Carcinogenicity of Aniline in the Spleen of Rats , 2005, Critical reviews in toxicology.

[1109]  Y. Kanai,et al.  Functional properties of multispecific amino acid transporters and their implications to transporter-mediated toxicity. , 2003, The Journal of toxicological sciences.

[1110]  T. Hei,et al.  Serial Review : Role of Reactive Oxygen and Nitrogen Species ( ROS / RNS ) in Lung Injury and Diseases , 2003 .

[1111]  V. Basile,et al.  Curcumin derivatives: molecular basis of their anti-cancer activity. , 2009, Biochemical pharmacology.

[1112]  A. Dorrance,et al.  Neuroprotection by tempol in a model of iron-induced oxidative stress in acute ischemic stroke. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[1113]  Steffen Loft,et al.  Measurement and Meaning of Oxidatively Modified DNA Lesions in Urine , 2008, Cancer Epidemiology Biomarkers & Prevention.

[1114]  J. Andersen,et al.  Iron-enhanced paraquat-mediated dopaminergic cell death due to increased oxidative stress as a consequence of microglial activation. , 2009, Free radical biology & medicine.

[1115]  G. Kempermann,et al.  Neurogenesis in the adult hippocampus , 2007, Cell and Tissue Research.

[1116]  V. Gordeuk,et al.  Iron status and the outcome of HIV infection: an overview. , 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[1117]  W. Pryor,et al.  Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. , 1992, Chemical research in toxicology.

[1118]  Rob Phillips,et al.  A feeling for the numbers in biology , 2009, Proceedings of the National Academy of Sciences.

[1119]  S. Weitzman,et al.  Phytic Acid, an Iron Chelator, Attenuates Pulmonary Inflammation and Fibrosis in Rats after Intratracheal Instillation of Asbestos , 1995, Toxicologic pathology.

[1120]  S. Sheth,et al.  Genetic disorders affecting proteins of iron metabolism: clinical implications. , 2000, Annual review of medicine.

[1121]  P. Riederer,et al.  The dopamine receptor agonist lisuride attenuates iron-mediated dopaminergic neurodegeneration , 2003, Experimental Neurology.

[1122]  R. Richards,et al.  Huntingtin-deficient zebrafish exhibit defects in iron utilization and development. , 2007, Human molecular genetics.

[1123]  B. Aggarwal,et al.  Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. , 2009, Trends in pharmacological sciences.

[1124]  K. Zarember,et al.  Antifungal Activities of Natural and Synthetic Iron Chelators Alone and in Combination with Azole and Polyene Antibiotics against Aspergillus fumigatus , 2009, Antimicrobial Agents and Chemotherapy.

[1125]  P. Riederer,et al.  Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases? , 1994, Journal of neurochemistry.

[1126]  An-Ping Zeng,et al.  The Connectivity Structure, Giant Strong Component and Centrality of Metabolic Networks , 2003, Bioinform..

[1127]  M. Youdim,et al.  M30, a novel multifunctional neuroprotective drug with potent iron chelating and brain selective monoamine oxidase-ab inhibitory activity for Parkinson's disease. , 2006, Journal of neural transmission. Supplementum.

[1128]  Asamoah Bosomtwi,et al.  Quantitative Evaluation of Microvascular Density after Stroke in Rats using MRI , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[1129]  R. Simpson,et al.  Biochemical and Molecular Actions of Nutrients Duodenal Ascorbate Levels Are Changed in Mice with Altered Iron Metabolism , 2004 .

[1130]  J. Kemp,et al.  Direct evidence that iron deprivation induces apoptosis in murine lymphoma 38C13. , 1997, Pathobiology : journal of immunopathology, molecular and cellular biology.

[1131]  O. Fardel,et al.  A new lactoferrin- and iron-dependent lysosomal death pathway is induced by benzo[a]pyrene in hepatic epithelial cells. , 2008, Toxicology and applied pharmacology.

[1132]  C. Olanow,et al.  Metals and free radicals in neurodegeneration. , 1994, Current opinion in neurology.

[1133]  C. Scully,et al.  Polyphenols, oral health and disease: A review. , 2009, Journal of dentistry.

[1134]  Tianhong Pan,et al.  Neuroprotection by iron chelator against proteasome inhibitor-induced nigral degeneration. , 2005, Biochemical and biophysical research communications.

[1135]  O. Augusto,et al.  Inhibition of myeloperoxidase-mediated protein nitration by tempol: Kinetics, mechanism, and implications , 2008, Proceedings of the National Academy of Sciences.

[1136]  D. Leibfritz,et al.  Free radicals and antioxidants in normal physiological functions and human disease. , 2007, The international journal of biochemistry & cell biology.

[1137]  B. Kennedy,et al.  Shortest-Path Network Analysis Is a Useful Approach toward Identifying Genetic Determinants of Longevity , 2008, PloS one.

[1138]  M. Mohan,et al.  Prion protein and metal interaction: physiological and pathological implications. , 2010, Current issues in molecular biology.

[1139]  M. Mohsenzadegan,et al.  Antioxidant therapy in multiple sclerosis , 2009, Immunopharmacology and immunotoxicology.

[1140]  E. Sidransky,et al.  Glucocerebrosidase mutations in subjects with parkinsonism. , 2004, Molecular genetics and metabolism.

[1141]  R. Altman,et al.  Risk factors in coronary atherosclerosis athero-inflammation: the meeting point , 2003, Thrombosis journal.

[1142]  J. Collins,et al.  A network biology approach to aging in yeast , 2009, Proceedings of the National Academy of Sciences.

[1143]  William D. Atchison,et al.  Mechanisms of methylmercury‐induced neurotoxicity , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[1144]  P. Hof,et al.  Distribution of the Iron-Binding Protein Lactoferrin in the Pathological Lesions of Neurodegenerative Diseases , 1997 .

[1145]  S. Robinson,et al.  Hemin toxicity: a preventable source of brain damage following hemorrhagic stroke , 2009, Redox report : communications in free radical research.

[1146]  M. Yano,et al.  Iron Cytotoxicity in Chronic Hepatitis C , 2002 .

[1147]  E. Ford,et al.  Diabetes and serum ferritin concentration among U.S. adults. , 1999, Diabetes care.

[1148]  I. Izquierdo,et al.  Physiology of the prion protein. , 2008, Physiological reviews.

[1149]  E. Nudler,et al.  Endogenous Nitric Oxide Protects Bacteria Against a Wide Spectrum of Antibiotics , 2009, Science.

[1150]  Peter Riederer,et al.  The relevance of iron in the pathogenesis of Parkinson’s disease , 2011, Journal of neurochemistry.

[1151]  M. Selim,et al.  The Relationship between Hematoma Iron Content and Perihematoma Edema: An MRI Study , 2009, Cerebrovascular Diseases.

[1152]  T. D. Pugh,et al.  Mitochondrial DNA Mutations, Oxidative Stress, and Apoptosis in Mammalian Aging , 2005, Science.

[1153]  S. Toyokuni Iron and carcinogenesis: from Fenton reaction to target genes , 2002, Redox report : communications in free radical research.

[1154]  Monica L. Mo,et al.  Global reconstruction of the human metabolic network based on genomic and bibliomic data , 2007, Proceedings of the National Academy of Sciences.

[1155]  仁科 惣治 Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription , 2008 .

[1156]  J. Andersen,et al.  Chronic expression of H-ferritin in dopaminergic midbrain neurons results in an age-related expansion of the labile iron pool and subsequent neurodegeneration: implications for Parkinson's disease , 2009, Brain Research.

[1157]  B. Hasinoff,et al.  NADPH-cytochrome-P-450 reductase promoted hydroxyl radical production by the iron(III)-ochratoxin A complex. , 1990, Biochimica et biophysica acta.

[1158]  F. Foury,et al.  Human genetic diseases: a cross-talk between man and yeast. , 1997, Gene.

[1159]  K. Jellinger,et al.  The Role of Iron in Neurodegeneration , 1999, Drugs & aging.

[1160]  M. Youdim,et al.  Restoration of Nigrostriatal Dopamine Neurons in Post-MPTP Treatment by the Novel Multifunctional Brain-Permeable Iron Chelator-Monoamine Oxidase Inhibitor Drug, M30 , 2009, Neurotoxicity Research.

[1161]  B. Ermiş,et al.  Alterations in plasma essential trace elements selenium, manganese, zinc, copper, and iron concentrations and the possible role of these elements on oxidative status in patients with childhood asthma , 2007, Biological Trace Element Research.

[1162]  W. Dröge Free radicals in the physiological control of cell function. , 2002, Physiological reviews.

[1163]  T. Rouault The role of iron regulatory proteins in mammalian iron homeostasis and disease , 2006, Nature chemical biology.

[1164]  J. Hodgson,et al.  A metabolite profiling approach to identify biomarkers of flavonoid intake in humans. , 2009, The Journal of nutrition.

[1165]  L. Kenar,et al.  Effects of N-Acetylcysteine, Deferoxamine and Selenium on Doxorubicin-Induced Hepatotoxicity , 2009, Biological Trace Element Research.

[1166]  P. Ghazal,et al.  Logic models of pathway biology. , 2008, Drug discovery today.

[1167]  Laura Herrero,et al.  Obesity, inflammation, and insulin resistance. , 2007, Gastroenterology.

[1168]  C. Keith,et al.  The novel combination of chlorpromazine and pentamidine exerts synergistic antiproliferative effects through dual mitotic action. , 2007, Cancer research.

[1169]  J. D. Robertson,et al.  Copper, iron and zinc in Alzheimer's disease senile plaques , 1998, Journal of the Neurological Sciences.

[1170]  Paolo Arosio,et al.  Ferritins: a family of molecules for iron storage, antioxidation and more. , 2009, Biochimica et biophysica acta.

[1171]  M. F. Perutz,et al.  Cause of neural death in neurodegenerative diseases attributable to expansion of glutamine repeats , 2001, Nature.

[1172]  F. Gomez-Pinilla The influences of diet and exercise on mental health through hormesis , 2008, Ageing Research Reviews.

[1173]  U. Brunk,et al.  Lysosomal labilization , 2006, IUBMB life.

[1174]  J. Connor,et al.  Alteration of iron regulatory proteins (IRP1 and IRP2) and ferritin in the brains of scrapie-infected mice , 2007, Neuroscience Letters.

[1175]  H. Verschueren,et al.  Dopamine and iron induce apoptosis in PC12 cells. , 1997, Pharmacology & toxicology.

[1176]  J. Lehár,et al.  High-order combination effects and biological robustness , 2008, Molecular systems biology.

[1177]  Ken E. Whelan,et al.  The Automation of Science , 2009, Science.

[1178]  C. Exley Aluminium and iron, but neither copper nor zinc, are key to the precipitation of beta-sheets of Abeta_{42} in senile plaque cores in Alzheimer's disease. , 2006, Journal of Alzheimer's disease : JAD.

[1179]  D. Gems,et al.  Antioxidant defense and aging in C. elegans: Is the oxidative damage theory of aging wrong? , 2009, Cell cycle.

[1180]  Chester Hartman,et al.  Rejoinder by the Author , 1965 .

[1181]  M. Puricelli,et al.  Effects of clioquinol on memory impairment and the neurochemical modifications induced by scrapie infection in golden hamsters , 2009, Brain Research.

[1182]  P. Patel,et al.  Friedreich ataxia: from GAA triplet-repeat expansion to frataxin deficiency. , 2001, American journal of human genetics.

[1183]  C. W. Tjoa,et al.  MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis , 2005, Journal of the Neurological Sciences.

[1184]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[1185]  J. Skidmore,et al.  Polyamino acids as catalysts in asymmetric synthesis. , 1999, Bioorganic & medicinal chemistry.

[1186]  Zbigniew Michalewicz,et al.  Handbook of Evolutionary Computation , 1997 .

[1187]  Mark A. Girolami,et al.  Bayesian ranking of biochemical system models , 2008, Bioinform..

[1188]  T. Prolla,et al.  The emerging role of iron dyshomeostasis in the mitochondrial decay of aging , 2010, Mechanisms of Ageing and Development.

[1189]  Joshua D. Knowles,et al.  Closed-loop, multiobjective optimization of two-dimensional gas chromatography/mass spectrometry for serum metabolomics. , 2007, Analytical chemistry.

[1190]  G. Lenoir,et al.  Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease , 2010, European journal of haematology.

[1191]  W. Gorczyca,et al.  Cytochemical diagnosis of Gaucher's disease by iron stain , 2004, British journal of haematology.

[1192]  Christine Van Broeckhoven,et al.  Pathogenesis of polyglutamine disorders: aggregation revisited. , 2003, Human molecular genetics.

[1193]  Edward J. Calabrese,et al.  Converging concepts: Adaptive response, preconditioning, and the Yerkes–Dodson Law are manifestations of hormesis , 2008, Ageing Research Reviews.

[1194]  S. Lee,et al.  Application of systems biology for bioprocess development. , 2008, Trends in biotechnology.

[1195]  Leo Breiman,et al.  Statistical Modeling: The Two Cultures (with comments and a rejoinder by the author) , 2001, Statistical Science.

[1196]  N. Heintz,et al.  Asbestos, lung cancers, and mesotheliomas: from molecular approaches to targeting tumor survival pathways. , 2010, American journal of respiratory cell and molecular biology.

[1197]  P. Moreira,et al.  An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer's disease. , 2009, Journal of Alzheimer's disease : JAD.

[1198]  Sang -Geon Kim,et al.  Inhibition of Arachidonic Acid and Iron-Induced Mitochondrial Dysfunction and Apoptosis by Oltipraz and Novel 1,2-Dithiole-3-thione Congeners , 2009, Molecular Pharmacology.

[1199]  R. Depalma,et al.  Ferritin levels, inflammatory biomarkers, and mortality in peripheral arterial disease: a substudy of the Iron (Fe) and Atherosclerosis Study (FeAST) Trial. , 2010, Journal of vascular surgery.

[1200]  Darren J. Wilkinson,et al.  Bayesian methods in bioinformatics and computational systems biology , 2006, Briefings Bioinform..

[1201]  Joseph Jankovic,et al.  Neurodegenerative disease and iron storage in the brain , 2004, Current opinion in neurology.

[1202]  Stefano Tarantola,et al.  Sensitivity Analysis in Practice: A Guide to Assessing Scientific Models , 2004 .

[1203]  A. Scalbert,et al.  Catechin reduces atherosclerotic lesion development in apo E-deficient mice: a transcriptomic study. , 2009, Atherosclerosis.

[1204]  B. Aggarwal,et al.  Curcumin and Cancer Cells: How Many Ways Can Curry Kill Tumor Cells Selectively? , 2009, The AAPS Journal.

[1205]  P. Dietz,et al.  The pineal gland hormone melatonin improves survival in a rat model of sepsis/shock induced by zymosan A. , 2003, Surgery.

[1206]  R. Simó,et al.  Glucose abnormalities in non‐alcoholic fatty liver disease and chronic hepatitis C virus infection: the role of iron overload , 2009, Diabetes/metabolism research and reviews.

[1207]  B. Maher,et al.  The case of the missing heritability , 2008 .

[1208]  Douglas B Kell,et al.  Implications of the dominant role of transporters in drug uptake by cells. , 2009, Current topics in medicinal chemistry.

[1209]  J. Cowan,et al.  Mapping iron binding sites on human frataxin: implications for cluster assembly on the ISU Fe–S cluster scaffold protein , 2008, JBIC Journal of Biological Inorganic Chemistry.

[1210]  J. Collins,et al.  A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics , 2007, Cell.

[1211]  G Bekyarova,et al.  Protective effect of melatonin against oxidative hepatic injury after experimental thermal trauma. , 2009, Methods and findings in experimental and clinical pharmacology.

[1212]  David R. Brown Role of Microglia in Age-Related Changes to the Nervous System , 2009, TheScientificWorldJournal.

[1213]  O. Dangles,et al.  Chemical modeling of heme-induced lipid oxidation in gastric conditions and inhibition by dietary polyphenols. , 2010, Journal of agricultural and food chemistry.

[1214]  H. Bonkovsky,et al.  Phlebotomy Improves Therapeutic Response to Interferon in Patients with Chronic Hepatitis C: A Meta-Analysis of Six Prospective Randomized Controlled Trials , 2008, Digestive Diseases and Sciences.

[1215]  L. Silver Multi-targeting by monotherapeutic antibacterials , 2007, Nature Reviews Drug Discovery.

[1216]  M. Andrades,et al.  Oxidative parameters differences during non-lethal and lethal sepsis development. , 2005, The Journal of surgical research.

[1217]  A. Churg,et al.  Mechanisms in the pathogenesis of asbestosis and silicosis. , 1998, American journal of respiratory and critical care medicine.

[1218]  D. Abrous,et al.  Adult Neurogenesis : From Precursors to Network and Physiology , 2005 .

[1219]  D. Kell,et al.  Calling International Rescue: knowledge lost in literature and data landslide! , 2009, The Biochemical journal.

[1220]  Markus J. Herrgård,et al.  A consensus yeast metabolic network reconstruction obtained from a community approach to systems biology , 2008, Nature Biotechnology.

[1221]  A. Goldfine,et al.  Getting away from glucose: fanning the flames of obesity-induced inflammation , 2009, Nature Medicine.

[1222]  Sanjay Gupta,et al.  Green tea and prostate cancer: from bench to clinic. , 2009, Frontiers in bioscience.

[1223]  George Perry,et al.  Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence. , 2003, Biochemistry.

[1224]  Guibin Jiang,et al.  Effects of waterborne nano-iron on medaka (Oryzias latipes): antioxidant enzymatic activity, lipid peroxidation and histopathology. , 2009, Ecotoxicology and environmental safety.

[1225]  S. Rattan,et al.  Hormesis can and Does Work in Humans , 2010, Dose-response : a publication of International Hormesis Society.

[1226]  A. Prigent-Tessier,et al.  Cytoprotective Efficacy and Mechanisms of the Liposoluble Iron Chelator 2,2′-Dipyridyl in the Rat Photothrombotic Ischemic Stroke Model , 2004, Journal of Pharmacology and Experimental Therapeutics.

[1227]  S. Sensi,et al.  Alzheimer's disease, metal ions and metal homeostatic therapy. , 2009, TIPS - Trends in Pharmacological Sciences.

[1228]  C. Exley Aluminium and iron, but neither copper nor zinc, are key to the precipitation of beta-sheets of Abeta_{42} in senile plaque cores in Alzheimer's disease. , 2006, Journal of Alzheimer's disease : JAD.

[1229]  Rohit Bakshi,et al.  MRI in multiple sclerosis: What’s inside the toolbox? , 2007, Neurotherapeutics.

[1230]  E. Topol,et al.  Proteomic approach to coronary atherosclerosis shows ferritin light chain as a significant marker: evidence consistent with iron hypothesis in atherosclerosis. , 2003, Physiological genomics.

[1231]  D. Richardson,et al.  Frataxin: its role in iron metabolism and the pathogenesis of Friedreich's ataxia. , 2001, The international journal of biochemistry & cell biology.

[1232]  Nathalie Boddaert,et al.  Selective iron chelation in Friedreich ataxia: biologic and clinical implications. , 2007, Blood.

[1233]  David S. Johnson,et al.  Computers and Intractability: A Guide to the Theory of NP-Completeness , 1978 .

[1234]  Elizabeth C. Theil Coordinating responses to iron and oxygen stress with DNA and mRNA promoters: The ferritin story , 2007, BioMetals.

[1235]  U. Lindh,et al.  Trace element distribution in heart tissue sections studied by nuclear microscopy is changed in coxsackie virus B3 myocarditis in methyl mercury-exposed mice , 2007, Biological Trace Element Research.

[1236]  Douglas B. Kell,et al.  Towards a rational approach to the optimization of flux in microbial biotransformations , 1986 .

[1237]  P. Lamey,et al.  Relationship between iron status and recrudescent herpes labialis , 1995, European Journal of Clinical Microbiology and Infectious Diseases.

[1238]  G. Gerhard,et al.  Perspective: Atherosclerosis: a manifestation of chronic iron toxicity? , 2003 .

[1239]  Douglas B. Kell,et al.  Metabolic control theory: its role in microbiology and biotechnology , 1986 .

[1240]  G. Schlaug,et al.  Association Between Serum Ferritin Level and Perihematoma Edema Volume in Patients With Spontaneous Intracerebral Hemorrhage , 2008, Stroke.

[1241]  S. Weitzman,et al.  Asbestosis: Clinical Spectrum and Pathogenic Mechanisms , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[1242]  David E. Goldberg,et al.  Genetic Algorithms in Search Optimization and Machine Learning , 1988 .

[1243]  B. Babior Phagocytes and oxidative stress. , 2000, The American journal of medicine.

[1244]  D. Koziorowski,et al.  Iron as a cause of Parkinson disease - a myth or a well established hypothesis? , 2009, Parkinsonism & related disorders.

[1245]  J. Forrester Common ancestors: Chronic progressive diseases have the same pathogenesis , 2004, Clinical cardiology.

[1246]  L. Messori,et al.  Metal Ion Physiopathology in Neurodegenerative Disorders , 2009, NeuroMolecular Medicine.

[1247]  S. Chakrabarti,et al.  The molecular genetic basis of age-related macular degeneration: an overview , 2009, Journal of Genetics.

[1248]  M. Aschner,et al.  Methylmercury-induced reactive oxygen species formation in neonatal cerebral astrocytic cultures is attenuated by antioxidants. , 2003, Brain research. Molecular brain research.

[1249]  G. Kitas,et al.  Aberrant reactive oxygen and nitrogen species generation in rheumatoid arthritis (RA): causes and consequences for immune function, cell survival, and therapeutic intervention. , 2010, Antioxidants & redox signaling.

[1250]  S. Prusiner,et al.  Shattuck lecture--neurodegenerative diseases and prions. , 2001, The New England journal of medicine.

[1251]  J. Gillard,et al.  Iron oxide particles for atheroma imaging. , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[1252]  F. Dong,et al.  Genetic variants in three genes and smoking show strong associations with susceptibility to exudative age-related macular degeneration in a Chinese population. , 2008, Chinese medical journal.

[1253]  K. Raymond,et al.  Enterobactin: An archetype for microbial iron transport , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[1254]  J. Connor,et al.  A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains , 1992, Journal of neuroscience research.

[1255]  D. Richardson,et al.  The novel iron chelator, 2-pyridylcarboxaldehyde 2-thiophenecarboxyl hydrazone, reduces catecholamine-mediated myocardial toxicity. , 2009, Chemical research in toxicology.

[1256]  R. de Silva,et al.  Oxidative stress: apoptosis in neuronal injury. , 2006, Current Alzheimer research.

[1257]  G. Wortley,et al.  Inhibition of iron uptake by phytic acid, tannic acid, and ZnCl2: studies using an in vitro digestion/Caco-2 cell model. , 2002, Journal of agricultural and food chemistry.

[1258]  S. Pongor,et al.  Multiple weak hits confuse complex systems: a transcriptional regulatory network as an example. , 2004, Physical review. E, Statistical, nonlinear, and soft matter physics.

[1259]  H. Schulman,et al.  Polyphenol tannic acid inhibits hydroxyl radical formation from Fenton reaction by complexing ferrous ions. , 1999, Biochimica et biophysica acta.

[1260]  Peter Libby,et al.  Inflammation in Atherosclerosis : From Vascular Biology to Biomarker Discovery and Risk Prediction , 2007 .

[1261]  S. Mandel,et al.  Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives , 2005, Brain Research Reviews.

[1262]  V. Raghavan Insulin resistance and atherosclerosis. , 2012, Heart failure clinics.

[1263]  J. Connor,et al.  Iron, brain ageing and neurodegenerative disorders , 2004, Nature Reviews Neuroscience.

[1264]  Arthur S Slutsky,et al.  Role of oxidative stress in experimental sepsis and multisystem organ dysfunction , 2006, Free radical research.

[1265]  J. Eaton,et al.  Prevention of oxidant-induced cell death by lysosomotropic iron chelators. , 2003, Free radical biology & medicine.

[1266]  T. Okanoue,et al.  Role of hepatic iron in non‐alcoholic steatohepatitis , 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

[1267]  L. Malcovati Red blood cell transfusion therapy and iron chelation in patients with myelodysplastic syndromes. , 2009, Clinical lymphoma & myeloma.

[1268]  Linda Partridge,et al.  Minireview Stress-response Hormesis and Aging: ''that Which Does Not Kill Us Makes Us Stronger'' Figure 1. Dose-response Curve of a Treatment with a Hormetic Effect Minireview Cell Metabolism , 2022 .

[1269]  Penny Nymark,et al.  Molecular and genetic changes in asbestos-related lung cancer. , 2008, Cancer letters.

[1270]  Iron reduction and sustained response to interferon-α therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study , 2002 .

[1271]  D. Barbosa,et al.  Increased Oxidative Stress, Decreased Total Antioxidant Capacity, and Iron Overload in Untreated Patients with Chronic Hepatitis C , 2010, Digestive Diseases and Sciences.

[1272]  B. Polla,,et al.  Iron as the malignant spirit in successful ageing , 2003, Ageing Research Reviews.

[1273]  S. Balcerzak,et al.  Gaucher's disease: A morphologic study and measurements of iron metabolism , 1967 .

[1274]  J. Preiser,et al.  Biomarkers of oxidative stress in critically ill patients: what should be measured, when and how? , 2006, Current opinion in clinical nutrition and metabolic care.

[1275]  E. Folch-Puy,et al.  Oxygen Free Radicals and the Systemic Inflammatory Response , 2004, IUBMB life.

[1276]  S. Toyokuni,et al.  Role of iron in carcinogenesis: Cancer as a ferrotoxic disease , 2009, Cancer science.

[1277]  Rohit Bakshi,et al.  MRI in multiple sclerosis: current status and future prospects , 2008, The Lancet Neurology.

[1278]  Victor S. Van Laar,et al.  Mitochondrial dynamics in Parkinson's disease , 2009, Experimental Neurology.

[1279]  Maria Rodriguez-Fernandez,et al.  A hybrid approach for efficient and robust parameter estimation in biochemical pathways. , 2006, Bio Systems.

[1280]  S. Mandel,et al.  Reduction of iron‐regulated amyloid precursor protein and β‐amyloid peptide by (–)‐epigallocatechin‐3‐gallate in cell cultures: implications for iron chelation in Alzheimer's disease , 2006, Journal of neurochemistry.

[1281]  T. Takayama,et al.  Long-term phlebotomy with low-iron diet therapy lowers risk of development of hepatocellular carcinoma from chronic hepatitis C , 2007, Journal of Gastroenterology.

[1282]  P. Toynbee THE PATIENT AND THE NHS , 1984, The Lancet.

[1283]  S. Srichairatanakool,et al.  Efficacy of curcuminoids in alleviation of iron overload and lipid peroxidation in thalassemic mice. , 2009, Medicinal chemistry (Shariqah (United Arab Emirates)).

[1284]  L. Mascitelli,et al.  Iron, type 2 diabetes mellitus, and Alzheimer’s disease , 2009, Cellular and Molecular Life Sciences.

[1285]  D. Harris,et al.  The cellular prion protein (PrP(C)): its physiological function and role in disease. , 2007, Biochimica et biophysica acta.

[1286]  S. Shore,et al.  Obesity and asthma: possible mechanisms. , 2008, The Journal of allergy and clinical immunology.

[1287]  J. Marx,et al.  Iron, atherosclerosis, and ischemic heart disease. , 1999, Archives of internal medicine.

[1288]  K. Sumikawa,et al.  Glutathione Downregulates the Phosphorylation of IκB: Autoloop Regulation of the NF-κB-Mediated Expression of NF-κB Subunits by TNF-α in Mouse Vascular Endothelial Cells , 1998 .

[1289]  K. Pantopoulos,et al.  Iron metabolism and toxicity. , 2005, Toxicology and applied pharmacology.

[1290]  M. Cudkowicz,et al.  Serum Ferritin and Metal Levels as Risk Factors for Amyotrophic Lateral Sclerosis , 2008, The open neurology journal.

[1291]  M. Mansour Protective effects of thymoquinone and desferrioxamine against hepatotoxicity of carbon tetrachloride in mice. , 2000, Life sciences.

[1292]  Hyoung-Gon Lee,et al.  Redox metals and oxidative abnormalities in human prion diseases , 2005, Acta Neuropathologica.

[1293]  M. Fenech,et al.  Grape seed polyphenols and curcumin reduce genomic instability events in a transgenic mouse model for Alzheimer's disease. , 2009, Mutation research.

[1294]  Xiongwei Zhu,et al.  Alzheimer disease: evidence for a central pathogenic role of iron-mediated reactive oxygen species. , 2004, Journal of Alzheimer's disease : JAD.

[1295]  Jimmy D Bell,et al.  Conflicting MRI signals from gliosis and neuronal vacuolation in prion diseases. , 1999, Neuroreport.

[1296]  F. Galateau,et al.  Bronchial necrosis induced by inhalation of an iron tablet. , 1996, Journal of Thoracic and Cardiovascular Surgery.

[1297]  M. Jaurand Mechanisms of fiber-induced genotoxicity. , 1997, Environmental health perspectives.

[1298]  J. Cowland,et al.  Induction of Neutrophil Gelatinase-associated Lipocalin Expression by Co-stimulation with Interleukin-17 and Tumor Necrosis Factor-α Is Controlled by IκB-ζ but neither by C/EBP-β nor C/EBP-δ* , 2010, The Journal of Biological Chemistry.

[1299]  I. Drenjančević-Perić,et al.  The role of transferrin in atherosclerosis. , 2008, Medical hypotheses.

[1300]  J. Cowland,et al.  IL-1β-Specific Up-Regulation of Neutrophil Gelatinase-Associated Lipocalin Is Controlled by IκB-ζ1 , 2006, The Journal of Immunology.

[1301]  P. Wardman,et al.  Fenton chemistry: an introduction. , 1996, Radiation research.

[1302]  Andrew F Hill,et al.  Delineating common molecular mechanisms in Alzheimer's and prion diseases. , 2006, Trends in biochemical sciences.

[1303]  I. Verma,et al.  Inflammation-associated cancer: NF-κB is the lynchpin , 2005 .

[1304]  Fei He,et al.  Sensitivity analysis and robust experimental design of a signal transduction pathway system , 2008 .

[1305]  D. Girelli,et al.  Reduced serum hepcidin levels in patients with chronic hepatitis C. , 2009, Journal of hepatology.

[1306]  Stanley B. Prusiner,et al.  Nobel Lecture: Prions , 1998 .

[1307]  D. Birchall,et al.  T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation , 2008, Neurology.

[1308]  C. Anuradha,et al.  Mitochondrial damage, cytotoxicity and apoptosis in iron-potentiated alcoholic liver fibrosis: amelioration by taurine , 2010, Amino Acids.

[1309]  T. Kondo,et al.  Glutathione downregulates the phosphorylation of I kappa B: autoloop regulation of the NF-kappa B-mediated expression of NF-kappa B subunits by TNF-alpha in mouse vascular endothelial cells. , 1998, Biochemical and biophysical research communications.

[1310]  Mark A. Smith,et al.  Nanoparticle–chelator conjugates as inhibitors of amyloid-β aggregation and neurotoxicity: A novel therapeutic approach for Alzheimer disease , 2009, Neuroscience Letters.

[1311]  Egil Lien,et al.  NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals , 2010, Nature.

[1312]  Denis Noble,et al.  Biophysics and systems biology , 2010, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

[1313]  R. Bakshi,et al.  Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis , 2006, Multiple sclerosis.

[1314]  G. C. Ferreira,et al.  Mitochondrial iron detoxification is a primary function of frataxin that limits oxidative damage and preserves cell longevity. , 2006, Human molecular genetics.

[1315]  J. Collins,et al.  Hydroxyurea induces hydroxyl radical-mediated cell death in Escherichia coli. , 2009, Molecular cell.

[1316]  P. Lucassen,et al.  PrP Deposition, Microglial Activation, and Neuronal Apoptosis in Murine Scrapie , 1997, Experimental Neurology.

[1317]  B. van Ravenzwaay,et al.  Aniline: early indicators of toxicity in male rats and their relevance to spleen carcinogenicity , 2004, Human & experimental toxicology.

[1318]  C. Coopersmith,et al.  The systemic inflammatory response syndrome. , 2006, Microbes and infection.

[1319]  A. Bokov,et al.  Is the oxidative stress theory of aging dead? , 2009, Biochimica et biophysica acta.

[1320]  R. Haq,et al.  Induction of apoptosis by iron deprivation in human leukemic CCRF-CEM cells. , 1995, Experimental hematology.

[1321]  J. Postgate,et al.  The Survival of Vegetative Microbes. , 1977 .

[1322]  Marcela Colombres,et al.  Structure and function of amyloid in Alzheimer's disease , 2004, Progress in Neurobiology.

[1323]  S. Haggarty,et al.  Revealing complex traits with small molecules and naturally recombinant yeast strains. , 2006, Chemistry & biology.

[1324]  G. Ferns,et al.  Relationship between indices of iron status and coronary risk factors including diabetes and the metabolic syndrome in Saudi subjects without overt coronary disease. , 2007, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[1325]  M. DePristo,et al.  Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis. , 2010, Molecular cell.

[1326]  M. Kantorow,et al.  Mitochondrial function and redox control in the aging eye: role of MsrA and other repair systems in cataract and macular degenerations. , 2009, Experimental eye research.

[1327]  D. Kell Metabolomics, modelling and machine learning in systems biology – towards an understanding of the languages of cells , 2006, The FEBS journal.

[1328]  N. V. Chong,et al.  Age-related macular degeneration: a perspective on genetic studies , 2008, Eye.

[1329]  Feng-Sheng Wang,et al.  Inverse problems of biological systems using multi-objective optimization , 2008 .

[1330]  V. Roggli,et al.  Review: Ferruginous Bodies: Implications in the Mechanism of Fiber and Particle Toxicity , 2004, Toxicologic pathology.

[1331]  J. Connor,et al.  The case for iron chelation and/or antioxidant therapy in Alzheimer's disease , 2002 .

[1332]  Steven M LeVine,et al.  Iron deposits in multiple sclerosis and Alzheimer's disease brains , 1997, Brain Research.

[1333]  I. Mayers,et al.  Multiple organ dysfunction syndrome: a narrative review , 2001, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[1334]  E. Hirsch Iron transport in Parkinson's disease. , 2009, Parkinsonism & related disorders.

[1335]  S. Weitzman,et al.  Asbestos catalyzes hydroxyl and superoxide radical generation from hydrogen peroxide. , 1984, Archives of biochemistry and biophysics.

[1336]  L. Silvestri,et al.  A potential pathogenetic role of iron in Alzheimer's disease , 2008, Journal of cellular and molecular medicine.

[1337]  Torsten Rohlfing,et al.  MRI estimates of brain iron concentration in normal aging: Comparison of field-dependent (FDRI) and phase (SWI) methods , 2009, NeuroImage.

[1338]  Vanessa Neveu,et al.  Systematic analysis of the content of 502 polyphenols in 452 foods and beverages: an application of the phenol-explorer database. , 2010, Journal of agricultural and food chemistry.

[1339]  A. Leonardi,et al.  The neutrophil gelatinase-associated lipocalin (NGAL), a NF-κB-regulated gene, is a survival factor for thyroid neoplastic cells , 2008, Proceedings of the National Academy of Sciences.

[1340]  Toshiharu Horie,et al.  Involvement of mitochondrial permeability transition in acetaminophen-induced liver injury in mice. , 2005, Journal of hepatology.

[1341]  Hong-yu Zhang Same causes, same cures. , 2006, Biochemical and biophysical research communications.

[1342]  Wei Li,et al.  Iron involvement in multiple signaling pathways of atherosclerosis: a revisited hypothesis. , 2008, Current medicinal chemistry.

[1343]  R. Bhidayasiri,et al.  Chorea and related disorders , 2004, Postgraduate Medical Journal.

[1344]  Christopher H. Bryant,et al.  Functional genomic hypothesis generation and experimentation by a robot scientist , 2004, Nature.

[1345]  M. Soares,et al.  Mechanisms of cell protection by heme oxygenase-1. , 2010, Annual review of pharmacology and toxicology.

[1346]  Keith L. Ligon,et al.  Coactivation of Receptor Tyrosine Kinases Affects the Response of Tumor Cells to Targeted Therapies , 2007, Science.

[1347]  C. Babbs,et al.  Effect of deferoxamine on late deaths following CPR in rats. , 1985, Annals of emergency medicine.

[1348]  F. Palau,et al.  Friedreich's ataxia and frataxin: molecular genetics, evolution and pathogenesis (Review). , 2001, International journal of molecular medicine.

[1349]  Joshua D. Knowles,et al.  Multiobjective Optimization in Bioinformatics and Computational Biology , 2007, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[1350]  J. Sabine Becker,et al.  Bioimaging of metals in brain tissue from micrometre to nanometre scale by laser ablation inductively coupled plasma mass spectrometry: State of the art and perspectives , 2010 .

[1351]  A. Munnich,et al.  Molecular insights into Friedreich's ataxia and antioxidant-based therapies. , 2002, Trends in molecular medicine.

[1352]  G. Merényi,et al.  The chemistry of peroxynitrite: implications for biological activity. , 2008, Methods in enzymology.

[1353]  Jim Mintz,et al.  Brain ferritin iron may influence age- and gender-related risks of neurodegeneration , 2007, Neurobiology of Aging.

[1354]  A. Cnaan,et al.  Survival and Complications in Thalassemia , 2005, Annals of the New York Academy of Sciences.

[1355]  M. Agarwal Deferasirox: Oral, once daily iron chelator — an expert opinion , 2010, Indian journal of pediatrics.

[1356]  Xiaobo Ji,et al.  Super-washing does not leave single walled carbon nanotubes iron-free. , 2007, The Analyst.

[1357]  A. Hamby,et al.  Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[1358]  M. Kew,et al.  Dietary iron overload in the African and hepatocellular carcinoma , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[1359]  Xiaohua Ma,et al.  Mechanisms of drug combinations: interaction and network perspectives , 2009, Nature Reviews Drug Discovery.

[1360]  M. Davies,et al.  Ascorbyl radical formation in patients with sepsis: effect of ascorbate loading. , 1996, Free radical biology & medicine.

[1361]  H. R. Massie,et al.  Iron accumulation and lipid peroxidation in aging C57BL/6J mice , 1983, Experimental Gerontology.

[1362]  H. Hartung,et al.  Iron Oxide Particle-Enhanced MRI Suggests Variability of Brain Inflammation at Early Stages After Ischemic Stroke , 2007, Stroke.

[1363]  J. Connor,et al.  Iron and neurodegenerative disorders , 2001, Brain Research Bulletin.

[1364]  Gary C. Brown,et al.  Analysis of six genetic risk factors highly associated with AMD in the region surrounding ARMS2 and HTRA1 on chromosome 10, region q26. , 2010, Investigative ophthalmology & visual science.

[1365]  M. Cazzola,et al.  Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study , 2007, European journal of haematology.

[1366]  D. Kell Systems biology, metabolic modelling and metabolomics in drug discovery and development. , 2006, Drug discovery today.

[1367]  B. Ames,et al.  N‐tert‐butyl hydroxylamine, a mitochondrial antioxidant, protects human retinal pigment epithelial cells from iron overload: relevance to macular degeneration , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[1368]  M. Falagas,et al.  Statins for sepsis: a critical and updated review. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[1369]  R. Hider,et al.  Iron chelation as a potential therapy for neurodegenerative disease. , 2008, Biochemical Society transactions.

[1370]  Avi Ma’ayan Insights into the Organization of Biochemical Regulatory Networks Using Graph Theory Analyses* , 2009, Journal of Biological Chemistry.

[1371]  M. Muscaritoli,et al.  Amyotrophic lateral sclerosis, enteral nutrition and the risk of iron overload , 2009, Journal of Neurology.

[1372]  Grzegorz Chodaczek,et al.  Iron-Mediated Dismutation of Superoxide Anion Augments Antigen-Induced Allergic Infl ammation: Effect of Lactoferrin Dysmutacja anionorodnika ponadtlenkowego katalizowana jonami żelaza nasila zapalenie alergiczne wywołane swoistym antygenem - ochronne działanie laktoferryny , 2007 .

[1373]  J. J. Lucas,et al.  Induction of human host cell apoptosis by Trichomonas vaginalis cysteine proteases is modulated by parasite exposure to iron. , 2008, Microbial pathogenesis.

[1374]  B. H. Choi,et al.  Methylmercury poisoning induces oxidative stress in the mouse brain. , 1994, Experimental and molecular pathology.

[1375]  METAL ION CATALYZED AUTOXIDATION REACTIONS: KINETICS AND MECHANISMS , 2003 .

[1376]  K. Kowdley,et al.  Hereditary hemochromatosis and diabetes mellitus: implications for clinical practice , 2010, Nature Reviews Endocrinology.

[1377]  Joseph S. Beckman,et al.  Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease , 1997, The Journal of Neuroscience.

[1378]  L G Korkina,et al.  Antioxidant and chelating properties of flavonoids. , 1997, Advances in pharmacology.

[1379]  E. M. Reyes-Reyes,et al.  Environmental toxicity, oxidative stress and apoptosis: ménage à trois. , 2009, Mutation research.

[1380]  G. Réus,et al.  Antioxidant treatment prevented late memory impairment in an animal model of sepsis* , 2007, Critical care medicine.

[1381]  S. Lehmann Metal ions and prion diseases. , 2002, Current opinion in chemical biology.

[1382]  G. Weiss,et al.  New pharmacological concepts for the treatment of iron overload disorders. , 2009, Current medicinal chemistry.

[1383]  Julia L. Brumaghim,et al.  Predicting how polyphenol antioxidants prevent DNA damage by binding to iron. , 2008, Inorganic chemistry.

[1384]  B. Bergamasco,et al.  Modifications of the iron–neuromelanin system in Parkinson's disease , 2006, Journal of neurochemistry.

[1385]  S. Stohs,et al.  Desferrioxamine‐induced alterations in hepatic iron distribution, DNA damage and lipid peroxidation in control and 2, 3, 7,8‐tetrachlorodibenzo‐p‐dioxin‐treated rats , 1990, Journal of applied toxicology : JAT.

[1386]  G. Hutter,et al.  Transcriptional stability of cultured cells upon prion infection. , 2008, Journal of molecular biology.

[1387]  Marc Dhenain,et al.  Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease , 2006, Neurobiology of Disease.

[1388]  J. Salonen,et al.  Body iron is a contributor to oxidative damage of DNA , 2007, Free radical research.

[1389]  M. Filippi,et al.  T2 hypointensity in the deep gray matter of patients with benign multiple sclerosis , 2009, Multiple sclerosis.

[1390]  E. Heathcote,et al.  Prevention of hepatitis C virus-related hepatocellular carcinoma. , 2004, Gastroenterology.

[1391]  Axel Kowald,et al.  Systems biology standards—the community speaks , 2007, Nature Biotechnology.

[1392]  D. Männel,et al.  Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells , 1992, The Journal of experimental medicine.

[1393]  O. Cevik,et al.  Oxidized-LDL and Fe3+/ascorbic acid-induced oxidative modifications and phosphatidylserine exposure in human platelets are reduced by melatonin. , 2009, Folia biologica.

[1394]  C. Miaskowski,et al.  ALTERED IRON METABOLISM IN CHILDREN WITH HUMAN IMMUNODEFICIENCY VIRUS DISEASE , 2009, Pediatric hematology and oncology.

[1395]  Carole J Proctor,et al.  GSK3 and p53 - is there a link in Alzheimer's disease? , 2010, Molecular Neurodegeneration.

[1396]  S. Weitzman,et al.  P53 mediates amosite asbestos-induced alveolar epithelial cell mitochondria-regulated apoptosis. , 2006, American Journal of Respiratory Cell and Molecular Biology.

[1397]  F. Visseren,et al.  Iron chelation and hydroxyl radical scavenging reduce the inflammatory response of endothelial cells after infection with Chlamydia pneumoniae or influenza A , 2002, European journal of clinical investigation.

[1398]  J. K. Kundu,et al.  International Conference on Diet , Nutrition , and Cancer Redox-Sensitive Transcription Factors as Prime Targets for Chemoprevention with Anti-Inflammatory and Antioxidative Phytochemicals 1 – 3 , 2005 .

[1399]  X. Muñoz,et al.  Occupational Asthma Caused by Metal Arc Welding of Iron , 2009, Respiration.

[1400]  S. Goldstein,et al.  The Fenton reagents. , 1993, Free radical biology & medicine.

[1401]  S. Rohrmann,et al.  Biomarkers of dietary intake of flavonoids and phenolic acids for studying diet–cancer relationship in humans , 2008, European journal of nutrition.

[1402]  J. Quevedo,et al.  The Septic Brain , 2008, Neurochemical Research.

[1403]  E. Cabiscol,et al.  Major targets of iron-induced protein oxidative damage in frataxin-deficient yeasts are magnesium-binding proteins. , 2008, Free radical biology & medicine.

[1404]  A. Bast,et al.  Flavonoids as protectors against doxorubicin cardiotoxicity: role of iron chelation, antioxidant activity and inhibition of carbonyl reductase. , 2007, Biochimica et biophysica acta.

[1405]  P. Howdle,et al.  The effects of intravenous antioxidants in patients with septic shock. , 1997, Free radical biology & medicine.

[1406]  C. Peng,et al.  Mechanisms of and obstacles to iron cardiomyopathy in thalassemia. , 2008, Frontiers in bioscience : a journal and virtual library.

[1407]  H. Lee,et al.  p38 and ERK MAP kinase mediates iron chelator-induced apoptosis and -suppressed differentiation of immortalized and malignant human oral keratinocytes. , 2006, Life sciences.

[1408]  V. Preedy,et al.  National Health and Nutrition Examination Survey , 2010 .

[1409]  David O Carpenter,et al.  The role of metals in the etiology of Alzheimer's disease. , 2007, Journal of Alzheimer's disease : JAD.

[1410]  Axel Kowald,et al.  Systems Biology in Practice: Concepts, Implementation and Application , 2005 .

[1411]  S. Ceccatelli,et al.  Neurobehavioural and molecular changes induced by methylmercury exposure during development , 2007, Neurotoxicity Research.

[1412]  B. Halliwell The wanderings of a free radical. , 2009, Free radical biology & medicine.

[1413]  Tak Yee Aw,et al.  Reactive oxygen species, cellular redox systems, and apoptosis. , 2010, Free radical biology & medicine.

[1414]  N. Kumar,et al.  Genotype–phenotype correlations between GBA mutations and Parkinson disease risk and onset , 2009 .

[1415]  J. Arenillas,et al.  Biological Signatures of Brain Damage Associated with High Serum Ferritin Levels in Patients with Acute Ischemic Stroke and Thrombolytic Treatment , 2008, Disease markers.

[1416]  J. Stockman Association Between Iron-Deficiency Anemia and Stroke in Young Children , 2009 .

[1417]  A. Munnich,et al.  Iron redistribution as a therapeutic strategy for treating diseases of localized iron accumulation. , 2010, Canadian journal of physiology and pharmacology.

[1418]  George A Kaysen,et al.  Biochemistry and biomarkers of inflamed patients: why look, what to assess. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[1419]  M. Ehrlichová,et al.  Iron deprivation induces apoptosis independently of p53 in human and murine tumour cells , 2003, Cell proliferation.

[1420]  C. Velez-Pardo,et al.  Transition metal-induced apoptosis in lymphocytes via hydroxyl radical generation, mitochondria dysfunction, and caspase-3 activation: an in vitro model for neurodegeneration. , 2004, Archives of medical research.

[1421]  T. Aoyama,et al.  Efficacy and safety of addition of minor bloodletting (petit phlebotomy) in hepatitis C virus-infected patients receiving regular glycyrrhizin injections , 2009, Journal of Gastroenterology.

[1422]  T. Wieder,et al.  Iron-containing nucleoside analogues with pronounced apoptosis-inducing activity. , 2004, Angewandte Chemie.

[1423]  M. Bronner,et al.  Hepatitis C, iron status, and disease severity: relationship with HFE mutations. , 2003, Gastroenterology.

[1424]  Mathias Hoehn,et al.  MRI Detection of Secondary Damage After Stroke: Chronic Iron Accumulation in the Thalamus of the Rat Brain , 2008, Stroke.

[1425]  R. Goodacre,et al.  Metabolic Profiling: Its Role in Biomarker Discovery and Gene Function Analysis , 2003, Springer US.

[1426]  D. Pennell,et al.  One‐stop measurement of iron deposition in the anterior pituitary, liver, and heart in thalassemia patients , 2008, Journal of magnetic resonance imaging : JMRI.

[1427]  G. Hansson,et al.  Immune mechanisms in atherosclerosis. , 1994, Coronary artery disease.

[1428]  J. Piette,et al.  Redox regulation of nuclear post-translational modifications during NF-kappaB activation. , 2009, Antioxidants & redox signaling.

[1429]  A. Friedman,et al.  Iron as a trigger of neurodegeneration in Parkinson's disease. , 2007, Handbook of clinical neurology.

[1430]  David P. Cox,et al.  Hydroxyl radical is produced via the Fenton reaction in submitochondrial particles under oxidative stress: implications for diseases associated with iron accumulation , 2009, Redox report : communications in free radical research.

[1431]  Hsing-Yi Chang,et al.  Is Ischemic Stroke Risk Related to Folate Status or Other Nutrients Correlated With Folate Intake? , 2008, Stroke.

[1432]  Lindy Grant Amiens Cathedral west front , 2004 .

[1433]  M. Mattson,et al.  Evidence that 4-Hydroxynonenal Mediates Oxidative Stress-Induced Neuronal Apoptosis , 1997, The Journal of Neuroscience.

[1434]  Raffaella Origa,et al.  BETA THALASSEMIA , 2018, The Professional Medical Journal.

[1435]  Jim Mintz,et al.  Prevalent iron metabolism gene variants associated with increased brain ferritin iron in healthy older men. , 2010, Journal of Alzheimer's disease : JAD.

[1436]  S. LeVine,et al.  Desferrioxamine suppresses experimental allergic encephalomyelitis induced by MBP in SJL mice , 1998, Journal of Neuroimmunology.

[1437]  J. Collinge,et al.  Targeting Cellular Prion Protein Reverses Early Cognitive Deficits and Neurophysiological Dysfunction in Prion-Infected Mice , 2007, Neuron.

[1438]  M. De la Fuente,et al.  Immune cells: free radicals and antioxidants in sepsis. , 2004, International immunopharmacology.

[1439]  A. Minihane,et al.  Iron absorption and the iron-binding and anti-oxidant properties of phytic acid , 2002 .

[1440]  Y. Béjot,et al.  Temporal changes in free iron levels after brain ischemia Relevance to the timing of iron chelation therapy in stroke , 2008, Neurochemistry International.

[1441]  Jing Zhao,et al.  Reconstruction and analysis of human liver-specific metabolic network based on CNHLPP data. , 2010, Journal of proteome research.

[1442]  O. Dereure,et al.  Measurement of liver iron content by magnetic resonance imaging in 20 patients with overt porphyria cutanea tarda before phlebotomy therapy: a prospective study. , 2008, Acta dermato-venereologica.

[1443]  K. Erikson,et al.  Iron overload alters iron-regulatory genes and proteins, down-regulates osteoblastic phenotype, and is associated with apoptosis in fetal rat calvaria cultures. , 2009, Bone.

[1444]  A. Lonardo,et al.  Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver , 2004, Hepatology.

[1445]  D. Kell,et al.  'Metabolite-likeness' as a criterion in the design and selection of pharmaceutical drug libraries. , 2009, Drug discovery today.

[1446]  B. Patil,et al.  Bioactive compounds: historical perspectives, opportunities, and challenges. , 2009, Journal of agricultural and food chemistry.

[1447]  C. Datz,et al.  Pathways underlying iron accumulation in human nonalcoholic fatty liver disease. , 2008, The American journal of clinical nutrition.

[1448]  L. Ferguson,et al.  Evaluation of the cytoprotective effects of bovine lactoferrin against intestinal toxins using cellular model systems , 2010, BioMetals.

[1449]  Liliana Jiménez,et al.  Polyphenols: food sources and bioavailability. , 2004, The American journal of clinical nutrition.

[1450]  N. Ballatori,et al.  Transport of a neurotoxicant by molecular mimicry: the methylmercury-L-cysteine complex is a substrate for human L-type large neutral amino acid transporter (LAT) 1 and LAT2. , 2002, The Biochemical journal.

[1451]  C. Palm,et al.  Bioimaging of metals by laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS). , 2010, Mass spectrometry reviews.

[1452]  E. Cabiscol,et al.  Manganese Is the Link between Frataxin and Iron-Sulfur Deficiency in the Yeast Model of Friedreich Ataxia* , 2006, Journal of Biological Chemistry.

[1453]  P. Ridker,et al.  Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. , 2004, Circulation.

[1454]  P. Sharma,et al.  Release of iron from ferritin by metabolites of benzene and superoxide radical generating agents. , 2001, Toxicology.

[1455]  Y. Rojanasakul,et al.  Inflammation and Lung Cancer: Roles of Reactive Oxygen/Nitrogen Species , 2008, Journal of toxicology and environmental health. Part B, Critical reviews.

[1456]  D. Westaway,et al.  The prion protein family: diversity, rivalry, and dysfunction. , 2007, Biochimica et biophysica acta.

[1457]  A. Auriat,et al.  Failure of deferoxamine, an iron chelator, to improve outcome after collagenase-induced intracerebral hemorrhage in rats , 2010, Brain Research.

[1458]  M. Sporn,et al.  Platforms and networks in triterpenoid pharmacology , 2007 .

[1459]  M. Strnad,et al.  Antioxidant and antimicrobial properties of Moltkia petraea (Tratt.) Griseb. flower, leaf and stem infusions. , 2010, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[1460]  A. OHagan,et al.  Bayesian analysis of computer code outputs: A tutorial , 2006, Reliab. Eng. Syst. Saf..

[1461]  Paul A Clemons,et al.  Chemical genomic profiling of biological networks using graph theory and combinations of small molecule perturbations. , 2003, Journal of the American Chemical Society.

[1462]  B. Yoo,et al.  Serum ferritin as a serologic marker of activity in systemic lupus erythematosus , 2001, Rheumatology International.

[1463]  J. Kwiatkowski Oral iron chelators. , 2010, Hematology/oncology clinics of North America.

[1464]  P. Ponka,et al.  Dysregulation of Iron Homeostasis in the CNS Contributes to Disease Progression in a Mouse Model of Amyotrophic Lateral Sclerosis , 2009, The Journal of Neuroscience.

[1465]  J. Schenck,et al.  High‐field magnetic resonance imaging of brain iron: birth of a biomarker? , 2004, NMR in biomedicine.

[1466]  F. Foury,et al.  Mitochondrial Control of Iron Homeostasis , 2001, The Journal of Biological Chemistry.

[1467]  P. Arosio,et al.  Role of iron and ferritin in TNFalpha-induced apoptosis in HeLa cells. , 2003, FEBS letters.

[1468]  T. Mizoue,et al.  Body iron store as a predictor of oxidative DNA damage in healthy men and women , 2010, Cancer science.

[1469]  M. Sandhu,et al.  Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study , 2007, Diabetologia.

[1470]  D. Bhatnagar,et al.  Inhibition of Iron Induced Lipid Peroxidation and Antioxidant Activity of Indian Spices and Acacia In Vitro , 2010, Plant foods for human nutrition.

[1471]  R. Pavlovic,et al.  Peroxynitrite and nitrosoperoxycarbonate, a tightly connected oxidizing‐nitrating couple in the reactive nitrogen‐oxygen species family: new perspectives for protection from radical‐promoted injury by flavonoids , 2007, The Journal of pharmacy and pharmacology.

[1472]  H. Okada,et al.  Lactoferrin induces cell surface retention of prion protein and inhibits prion accumulation , 2008, Journal of neurochemistry.

[1473]  C. Epstein,et al.  The overexpression of major antioxidant enzymes does not extend the lifespan of mice , 2008, Aging cell.

[1474]  M. Kruszewski,et al.  Labile iron pool: the main determinant of cellular response to oxidative stress. , 2003, Mutation research.

[1475]  A. Cherubini,et al.  Risk Factors for Short-Term Mortality in Older Subjects with Acute Ischemic Stroke , 2006, Gerontology.

[1476]  E. Levin,et al.  Metallothionein in the central nervous system: Roles in protection, regeneration and cognition. , 2008, Neurotoxicology.

[1477]  B. Hyman,et al.  Converse modulation of toxic alpha-synuclein oligomers in living cells by N'-benzylidene-benzohydrazide derivates and ferric iron. , 2010, Biochemical and biophysical research communications.

[1478]  J. Altschmied,et al.  Nuclear redox signaling. , 2010, Antioxidants & redox signaling.

[1479]  Vidya Subramanian,et al.  Obesity, inflammation, and macrophages. , 2009, Nestle Nutrition workshop series. Paediatric programme.

[1480]  E. Weinberg IRON, ASBESTOS, AND CARCINOGENICITY , 1989, The Lancet.

[1481]  S. Terai,et al.  The iron chelator deferoxamine causes activated hepatic stellate cells to become quiescent and to undergo apoptosis , 2007, Journal of Gastroenterology.

[1482]  D. Jiang,et al.  Ternary complexes of iron, amyloid-beta, and nitrilotriacetic acid: binding affinities, redox properties, and relevance to iron-induced oxidative stress in Alzheimer's disease. , 2009, Biochemistry.

[1483]  T. Gunatilaka,et al.  The iron carrier transferrin is upregulated in retinas from patients with age-related macular degeneration. , 2006, Investigative ophthalmology & visual science.

[1484]  A. Sommer,et al.  The prevalence of blindness and visual impairment among nursing home residents in Baltimore. , 1995, The New England journal of medicine.

[1485]  Xiaohui Xie,et al.  Parameter inference for discretely observed stochastic kinetic models using stochastic gradient descent , 2010, BMC Systems Biology.

[1486]  P. Borm,et al.  Temporal variation of hydroxyl radical generation and 8-hydroxy-2′-deoxyguanosine formation by coarse and fine particulate matter , 2003, Occupational and environmental medicine.

[1487]  S. Harrison,et al.  Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection , 2010, Hepatology.

[1488]  H. Büeler Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease , 2009, Experimental Neurology.

[1489]  F. Grases,et al.  Phytate in foods and significance for humans: food sources, intake, processing, bioavailability, protective role and analysis. , 2009, Molecular nutrition & food research.

[1490]  Joseph Rafter,et al.  Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: direct or indirect effects? Antioxidant or not? , 2005, The American journal of clinical nutrition.

[1491]  M. Jädersten,et al.  New clues to the molecular pathogenesis of myelodysplastic syndromes. , 2010, Experimental cell research.

[1492]  Pascal Kahlem,et al.  The challenges of systems biology : community efforts to harness biological complexity , 2009 .

[1493]  J. Eaton,et al.  Iron-catalyzed hydroxyl radical formation. Stringent requirement for free iron coordination site. , 1984, The Journal of biological chemistry.

[1494]  A. Butler,et al.  Microbial Iron Acquisition: Marine and Terrestrial Siderophores , 2010 .

[1495]  B. Doble,et al.  The ground state of embryonic stem cell self-renewal , 2008, Nature.

[1496]  M. Cappellini,et al.  Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias , 2010, Haematologica.

[1497]  Douglas B. Kell,et al.  Non-linear optimization of biochemical pathways: applications to metabolic engineering and parameter estimation , 1998, Bioinform..

[1498]  A. Favier,et al.  Soil fungi reduce the iron content and the DNA damaging effects of asbestos fibers. , 2006, Environmental science & technology.

[1499]  Osamu Hori,et al.  Cellular Stress Responses: Cell Survival and Cell Death , 2010, International journal of cell biology.

[1500]  F. Locatelli,et al.  Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[1501]  S. Mandel,et al.  Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (‐)‐epigallocatechin‐3‐gallate: implications for neurodegenerative diseases , 2004, Journal of neurochemistry.

[1502]  R. D'Agostino,et al.  Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator. , 2009, Blood.

[1503]  P. Arosio,et al.  Role of iron and ferritin in TNFα‐induced apoptosis in HeLa cells , 2003 .

[1504]  Robert Hider,et al.  Fenton chemistry and oxidative stress mediate the toxicity of the β-amyloid peptide in a Drosophila model of Alzheimer’s disease , 2009, The European journal of neuroscience.

[1505]  Zongming Song,et al.  Erythropoietin as a novel therapeutic agent for atrophic age-related macular degeneration. , 2009, Medical hypotheses.

[1506]  M. Bähr,et al.  Neuronal Apoptosis in Neurodegenerative Diseases: From Basic Research to Clinical Application , 2004, Neurodegenerative Diseases.

[1507]  Hiroaki Kitano,et al.  The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models , 2003, Bioinform..

[1508]  C. Chong,et al.  New uses for old drugs , 2007, Nature.

[1509]  G. Krause,et al.  Effect on biochemical markers of brain injury of therapy with deferoxamine or superoxide dismutase following cardiac arrest. , 1988, The American journal of emergency medicine.

[1510]  C. Levenson Trace metal regulation of neuronal apoptosis: From genes to behavior , 2005, Physiology & Behavior.

[1511]  Jihwan Song,et al.  In Vivo Tracking of Human Mesenchymal Stem Cells in Experimental Stroke , 2007, Cell transplantation.

[1512]  H. Bonkovsky,et al.  Iron in nonhemochromatotic liver disorders. , 2005, Seminars in liver disease.

[1513]  A. Boveris,et al.  Systemic Oxidative Stress Associated with the Neurological Diseases of Aging , 2009, Neurochemical Research.

[1514]  Steve Pettifer,et al.  Visualising biological data: a semantic approach to tool and database integration , 2009, BMC Bioinformatics.

[1515]  M. Turkalj,et al.  Iron and Ferritin Concentrations in Exhaled Breath Condensate of Children with Asthma , 2009, The Journal of asthma : official journal of the Association for the Care of Asthma.

[1516]  Joseph F. Clark,et al.  Heme and Iron Metabolism: Role in Cerebral Hemorrhage , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[1517]  R. Klein,et al.  Early age-related macular degeneration, cognitive function, and dementia: the Cardiovascular Health Study. , 2009, Archives of ophthalmology.

[1518]  S. Mandel,et al.  Neuroprotective molecular mechanisms of (−)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties , 2009, Genes & Nutrition.

[1519]  R. Bakshi,et al.  T1‐ and T2‐Based MRI Measures of Diffuse Gray Matter and White Matter Damage in Patients with Multiple Sclerosis , 2007, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[1520]  J. Terao,et al.  Protective effect of phytic acid hydrolysis products on iron-induced lipid peroxidation of liposomal membranes , 2000, Lipids.

[1521]  Dianne Ford,et al.  Metalloproteins and metal sensing , 2009, Nature.

[1522]  J. Schmeidler,et al.  Diabetes mellitus in midlife and the risk of dementia three decades later , 2004, Neurology.

[1523]  R. Nagai,et al.  Iron Chelation Suppresses Ferritin Upregulation and Attenuates Vascular Dysfunction in the Aorta of Angiotensin II–Infused Rats , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[1524]  Janet M Thornton,et al.  Structural analysis of metal sites in proteins: non-heme iron sites as a case study. , 2009, Journal of molecular biology.

[1525]  K. Murakami,et al.  Interaction of iron with polyphenolic compounds: application to antioxidant characterization. , 1998, Analytical biochemistry.

[1526]  Neena Singh,et al.  Redox control of prion and disease pathogenesis. , 2010, Antioxidants & redox signaling.

[1527]  A. Nathens,et al.  Randomized, Prospective Trial of Antioxidant Supplementation in Critically Ill Surgical Patients , 2002, Annals of surgery.

[1528]  F. Klamt,et al.  Antioxidant treatment reverses mitochondrial dysfunction in a sepsis animal model. , 2008, Mitochondrion.

[1529]  G. Lippi,et al.  The effect of iron depletion on chronic hepatitis C virus infection , 2008, Hepatology international.

[1530]  M. Youdim,et al.  A novel approach of proteomics and transcriptomics to study the mechanism of action of the antioxidant-iron chelator green tea polyphenol (-)-epigallocatechin-3-gallate. , 2007, Free radical biology & medicine.

[1531]  Elizabeth Gould,et al.  How widespread is adult neurogenesis in mammals? , 2007, Nature Reviews Neuroscience.

[1532]  Simon J. Walker,et al.  NADPH oxidases in cardiovascular health and disease. , 2006, Antioxidants & redox signaling.

[1533]  J. Andersen,et al.  Iron dysregulation and neurodegeneration: the molecular connection. , 2006, Molecular interventions.

[1534]  R. Roesler,et al.  Effects of N-Acetylcysteine/Deferoxamine, Taurine and RC-3095 on Respiratory Chain Complexes and Creatine Kinase Activities in Rat Brain After Sepsis , 2010, Neurochemical Research.

[1535]  D. Rubinsztein,et al.  Huntington's disease: from pathology and genetics to potential therapies. , 2008, The Biochemical journal.

[1536]  Michael R. Green,et al.  A Cell-Surface Receptor for Lipocalin 24p3 Selectively Mediates Apoptosis and Iron Uptake , 2005, Cell.

[1537]  P. Brissot,et al.  Liver iron is a surrogate marker of severe fibrosis in chronic hepatitis C. , 2007, Journal of hepatology.

[1538]  D. P. Hayes Nutritional Hormesis and Aging , 2010, Dose-response : a publication of International Hormesis Society.

[1539]  T. Aw,et al.  Apoptosis: a key in neurodegenerative disorders. , 2004, Current neurovascular research.

[1540]  R. Benecke,et al.  Transcranial brain sonography findings predict disease progression in multiple sclerosis , 2009, Neurology.

[1541]  B. Halliwell,et al.  Promotion of atherogenesis by copper or iron--which is more likely? , 2007, Biochemical and biophysical research communications.

[1542]  E. van Nood,et al.  Flavonoids: a review of probable mechanisms of action and potential applications. , 2001, The American journal of clinical nutrition.

[1543]  R. Radi,et al.  Peroxynitrite reactions and formation in mitochondria. , 2002, Free radical biology & medicine.

[1544]  P. Woo,et al.  Cytokine Profiles Induced by the Novel Swine-Origin Influenza A/H1N1 Virus: Implications for Treatment Strategies , 2010, The Journal of infectious diseases.

[1545]  D. Berg Disturbance of Iron Metabolism as a Contributing Factor to SN Hyperechogenicity in Parkinson’s Disease: Implications for Idiopathic and Monogenetic Forms , 2007, Neurochemical Research.

[1546]  S. Srichairatanakool,et al.  Improvement in oxidative stress and antioxidant parameters in beta-thalassemia/Hb E patients treated with curcuminoids. , 2010, Clinical biochemistry.

[1547]  E. Cassani,et al.  Phytic acid prevents oxidative stress in seeds: evidence from a maize (Zea mays L.) low phytic acid mutant. , 2009, Journal of experimental botany.

[1548]  M Brune,et al.  Iron absorption and phenolic compounds: importance of different phenolic structures. , 1989, European journal of clinical nutrition.

[1549]  K. Franz,et al.  Minding metals: tailoring multifunctional chelating agents for neurodegenerative disease. , 2010, Dalton transactions.

[1550]  L. Klimaschewski,et al.  From Birth Till Death: Neurogenesis, Cell Cycle, and Neurodegeneration , 2009, Anatomical record.

[1551]  A. Prigent-Tessier,et al.  Beneficial effect of dipyridyl, a liposoluble iron chelator against focal cerebral ischemia: In vivo and in vitro evidence of protection of cerebral endothelial cells , 2008, Brain Research.

[1552]  R. MacLaren,et al.  Lactoferrin protects against acetaminophen‐induced liver injury in mice , 2010, Hepatology.

[1553]  T. Iizuka,et al.  THE RISK FACTORS OF CORONARY ATHEROSCLEROSIS , 1985 .

[1554]  S. Toyokuni,et al.  [Mechanisms of asbestos-induced carcinogenesis]. , 2011, Nihon eiseigaku zasshi. Japanese journal of hygiene.

[1555]  M. Steiner,et al.  Multiple Markers of Inflammation and Weight Status: Cross-sectional Analyses Throughout Childhood , 2010, Pediatrics.

[1556]  Tzong-Shyuan Lee,et al.  Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice. , 1999, Circulation.

[1557]  R. Currie,et al.  Huntingtin inclusion bodies are iron‐dependent centers of oxidative events , 2006, The FEBS journal.

[1558]  E. Beutler Gaucher's disease. , 1980, The New England journal of medicine.

[1559]  B. Caughey,et al.  Prions and their partners in crime , 2006, Nature.

[1560]  Peng Huang,et al.  Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? , 2009, Nature Reviews Drug Discovery.

[1561]  Denis Noble,et al.  The rise of computational biology , 2002, Nature Reviews Molecular Cell Biology.

[1562]  P. Greenberg,et al.  The costs of drugs used to treat myelodysplastic syndromes following National Comprehensive Cancer Network Guidelines. , 2008, Journal of the National Comprehensive Cancer Network : JNCCN.

[1563]  D. Das,et al.  Protection of ischemic heart from reperfusion injury by myo-inositol hexaphosphate, a natural antioxidant. , 1991, The Annals of thoracic surgery.

[1564]  Subramanian Rajagopalan,et al.  Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo A Novel Therapy for Parkinson's Disease , 2003, Neuron.

[1565]  A. Marais,et al.  Effects of iron overload in a rat nutritional model of non‐alcoholic fatty liver disease , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[1566]  D. Tarng,et al.  Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients. , 2008, Journal of the American Society of Nephrology : JASN.

[1567]  J. Ioannidis Why Most Published Research Findings Are False , 2005, PLoS medicine.

[1568]  J. Andersen Paraquat and iron exposure as possible synergistic environmental risk factors in Parkinson’s disease , 2009, Neurotoxicity Research.

[1569]  D. Westaway,et al.  Evolutionary Descent of Prion Genes from the ZIP Family of Metal Ion Transporters , 2009, PloS one.

[1570]  Douglas Bruce Kell,et al.  Progress being made on standards for use in data sharing , 2008, Nature.

[1571]  A. Korkmaz,et al.  Molecular targets against mustard toxicity: implication of cell surface receptors, peroxynitrite production, and PARP activation , 2006, Archives of Toxicology.

[1572]  Sebastian Brandner,et al.  Depleting Neuronal PrP in Prion Infection Prevents Disease and Reverses Spongiosis , 2003, Science.

[1573]  B. Yankner,et al.  Neural mechanisms of ageing and cognitive decline , 2010, Nature.

[1574]  P. Tak,et al.  Systemic inflammation as a risk factor for atherothrombosis. , 2008, Rheumatology.

[1575]  G. Brewer,et al.  Risks of copper and iron toxicity during aging in humans. , 2010, Chemical research in toxicology.

[1576]  A. Aguzzi Prion diseases of humans and farm animals: epidemiology, genetics, and pathogenesis , 2006, Journal of neurochemistry.

[1577]  F. Gage,et al.  Mechanisms and Functional Implications of Adult Neurogenesis , 2008, Cell.

[1578]  Andrew G Smith,et al.  Interaction between iron metabolism and 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice with variants of the Ahr gene: a hepatic oxidative mechanism. , 1998, Molecular pharmacology.

[1579]  Houli Wang,et al.  The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome. , 2008, The American journal of emergency medicine.

[1580]  P. Hayes,et al.  The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure , 2008, Gut.

[1581]  E. Beutler Iron storage disease: facts, fiction and progress. , 2007, Blood cells, molecules & diseases.

[1582]  J. Wilson,et al.  Use of allopurinol and deferoxamine in cellular protection during ischemia. , 1992, Surgical neurology.

[1583]  J. Eaton,et al.  Phytic acid. A natural antioxidant. , 1987, The Journal of biological chemistry.

[1584]  R. Hider,et al.  Metal chelation of polyphenols. , 2001, Methods in enzymology.

[1585]  D. Yablonskiy,et al.  Biophysical mechanisms of phase contrast in gradient echo MRI , 2009, Proceedings of the National Academy of Sciences.

[1586]  Mila Lebedeva,et al.  Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections , 2009, Journal of Virology.

[1587]  Carla C. C. R. de Carvalho,et al.  Production of Metabolites as Bacterial Responses to the Marine Environment , 2010, Marine drugs.

[1588]  P. Libby Inflammation in atherosclerosis , 2002, Nature.

[1589]  K. Iwasaki,et al.  Intracellular iron transport and storage: from molecular mechanisms to health implications. , 2008, Antioxidants & redox signaling.

[1590]  E. Sigurdsson,et al.  Therapeutic approaches for prion and Alzheimer's diseases , 2007, The FEBS journal.

[1591]  Lin Chen,et al.  Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[1592]  Suresh I. S. Rattan,et al.  Aging, anti-aging, and hormesis , 2004, Mechanisms of Ageing and Development.

[1593]  F. Coppedè,et al.  Searching for the role and the most suitable biomarkers of oxidative stress in Alzheimer's disease and in other neurodegenerative diseases , 2005, Neurobiology of Aging.

[1594]  R. Adams,et al.  Pathophysiology and treatment of stroke in sickle-cell disease: present and future , 2006, The Lancet Neurology.

[1595]  K. Fischbeck,et al.  Altered Gene Expression and DNA Damage in Peripheral Blood Cells from Friedreich's Ataxia Patients: Cellular Model of Pathology , 2010, PLoS genetics.

[1596]  S. You,et al.  Ferritin in atherosclerosis. , 2005, Clinica chimica acta; international journal of clinical chemistry.

[1597]  W Craelius,et al.  Iron deposits surrounding multiple sclerosis plaques. , 1982, Archives of pathology & laboratory medicine.

[1598]  Rohit Bakshi,et al.  Iron in chronic brain disorders: Imaging and neurotherapeutic implications , 2007, Neurotherapeutics.

[1599]  M. Andrades,et al.  Effects of N-acetylcysteine plus deferoxamine in lipopolysaccharide-induced acute lung injury in the rat* , 2006, Critical care medicine.

[1600]  D. Pennell,et al.  Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia. , 2010, Blood.

[1601]  Y. Takei,et al.  Impaired regulation of serum hepcidin during phlebotomy in patients with chronic hepatitis C , 2009, Hepatology research : the official journal of the Japan Society of Hepatology.

[1602]  N. Greig,et al.  Metal specificity of an iron-responsive element in Alzheimer's APP mRNA 5'untranslated region, tolerance of SH-SY5Y and H4 neural cells to desferrioxamine, clioquinol, VK-28, and a piperazine chelator. , 2006, Journal of neural transmission. Supplementum.

[1603]  E. Haacke,et al.  Imaging iron stores in the brain using magnetic resonance imaging. , 2005, Magnetic resonance imaging.

[1604]  O. Franco,et al.  Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly chinese. , 2008, The Journal of clinical endocrinology and metabolism.

[1605]  J. Schulz,et al.  Diagnosis and treatment of Friedreich ataxia: a European perspective , 2009, Nature Reviews Neurology.

[1606]  B. Halliwell,et al.  Aromatic hydroxylation as a potential measure of hydroxyl-radical formation in vivo. Identification of hydroxylated derivatives of salicylate in human body fluids. , 1986, The Biochemical journal.

[1607]  M. MacDonald,et al.  Reversal of a full-length mutant huntingtin neuronal cell phenotype by chemical inhibitors of polyglutamine-mediated aggregation , 2005, BMC Neuroscience.

[1608]  P. Pasqualetti,et al.  Ceruloplasmin/Transferrin System Is Related to Clinical Status in Acute Stroke , 2009, Stroke.

[1609]  B. Aggarwal,et al.  Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. , 2010, Biochemical pharmacology.

[1610]  H. Maeda,et al.  Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[1611]  Pedro Mendes,et al.  The markup is the model: reasoning about systems biology models in the Semantic Web era. , 2008, Journal of theoretical biology.

[1612]  A. Gotto,et al.  Inflammation in Atherosclerosis and Implications for Therapy , 2004, Circulation.

[1613]  E. Ramesh,et al.  Green tea catechins, alleviate hepatic lipidemic-oxidative injury in Wistar rats fed an atherogenic diet. , 2009, Chemico-biological interactions.

[1614]  R. Koehler,et al.  Deferoxamine reduces early metabolic failure associated with severe cerebral ischemic acidosis in dogs. , 1995, Stroke.

[1615]  Liliana Jiménez,et al.  Dietary Polyphenols and the Prevention of Diseases , 2005, Critical reviews in food science and nutrition.

[1616]  Y. Park,et al.  Hepatic Iron, Serum Ferritin, HFE Mutation, and Hepatic Fibrosis in Chronic Hepatitis C , 2009, Intervirology.

[1617]  Jide Xu,et al.  Microbial iron transport via a siderophore shuttle: a membrane ion transport paradigm. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[1618]  Carmen G. Moles,et al.  Parameter estimation in biochemical pathways: a comparison of global optimization methods. , 2003, Genome research.

[1619]  G. Rotilio,et al.  Neurodegeneration in amyotrophic lateral sclerosis: the role of oxidative stress and altered homeostasis of metals , 2003, Brain Research Bulletin.

[1620]  S. Stray,et al.  Plasma ferritin determination as a diagnostic tool. , 1986, The Western journal of medicine.

[1621]  Jae-Hyun Park,et al.  Acupuncture inhibits ferric iron deposition and ferritin-heavy chain reduction in an MPTP-induced parkinsonism model , 2009, Neuroscience Letters.

[1622]  J. Sullivan Iron in arterial plaque: modifiable risk factor for atherosclerosis. , 2009, Biochimica et biophysica acta.

[1623]  L. Hanson,et al.  Intranasal Deferoxamine Provides Increased Brain Exposure and Significant Protection in Rat Ischemic Stroke , 2009, Journal of Pharmacology and Experimental Therapeutics.

[1624]  J. Aharon-Peretz,et al.  Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. , 2004, The New England journal of medicine.

[1625]  J. Andersen,et al.  Iron elevations in the aging Parkinsonian brain: a consequence of impaired iron homeostasis? , 2010, Journal of neurochemistry.

[1626]  Douglas B Kell,et al.  Aptamer evolution for array-based diagnostics. , 2009, Analytical biochemistry.

[1627]  Howard E Gendelman,et al.  Oxidative stress and the pathogenesis of neurodegenerative disorders. , 2007, International review of neurobiology.

[1628]  S. Mandel,et al.  Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases. , 2004, Free radical biology & medicine.

[1629]  R Marc Lebel,et al.  Detecting lesions in multiple sclerosis at 4.7 tesla using phase susceptibility‐weighting and T2‐weighting , 2009, Journal of magnetic resonance imaging : JMRI.

[1630]  M. Reith,et al.  Discovery of 4-(4-(2-((5-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)(propyl)amino)ethyl)piperazin-1-yl)quinolin-8-ol and its analogues as highly potent dopamine D2/D3 agonists and as iron chelator: in vivo activity indicates potential application in symptomatic and neuroprotective therapy for Parkins , 2010, Journal of medicinal chemistry.

[1631]  B. Yu,et al.  Iron accumulation in aging: modulation by dietary restriction , 1998, Mechanisms of Ageing and Development.

[1632]  R. Gebhardt,et al.  Protective effects of flavonoids and two metabolites against oxidative stress in neuronal PC12 cells. , 2010, Life sciences.

[1633]  A. Gabrielsen,et al.  Induction of Neutrophil Gelatinase-Associated Lipocalin in Vascular Injury via Activation of Nuclear Factor-κB , 2006 .

[1634]  P. Doherty,et al.  Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent , 1984, The Journal of experimental medicine.

[1635]  G. Winkelmann Microbial siderophore-mediated transport. , 2001, Biochemical Society transactions.

[1636]  H. Rommelspacher,et al.  Degeneration of dopaminergic mesocortical neurons and activation of compensatory processes induced by a long-term paraquat administration in rats: Implications for Parkinson’s disease , 2006, Neuroscience.

[1637]  T. Vanden Berghe,et al.  Molecular mechanisms and pathophysiology of necrotic cell death. , 2008, Current molecular medicine.

[1638]  Jing Zhao,et al.  Hierarchical modularity of nested bow-ties in metabolic networks , 2006, BMC Bioinformatics.

[1639]  B. Fanburg,et al.  Reactive oxygen species in cell signaling. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[1640]  M. Beal,et al.  Oxidative damage in Alzheimer's , 1996, Nature.

[1641]  H. Kantarjian,et al.  Managing iron overload in patients with myelodysplastic syndromes with oral deferasirox therapy. , 2009, The oncologist.

[1642]  J. Marx,et al.  Prevention of organ failure in hereditary haemochromatosis. , 2002, The Netherlands journal of medicine.

[1643]  A. Aust,et al.  Iron-catalyzed reactions may be responsible for the biochemical and biological effects of asbestos. , 1991, BioFactors.

[1644]  D. Berg,et al.  In vivo detection of iron and neuromelanin by transcranial sonography – a new approach for early detection of substantia nigra damage , 2006, Journal of Neural Transmission.

[1645]  S. LeVine,et al.  Deferiprone, an orally deliverable iron chelator, ameliorates experimental autoimmune encephalomyelitis , 2007, Multiple sclerosis.

[1646]  S. Nelson,et al.  Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron , 2008, Annals of neurology.

[1647]  D. Perl,et al.  Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: A laser microprobe (LAMMA) study , 1992, Annals of neurology.

[1648]  B. S. van Asbeck,et al.  Anti-HIV effect of iron chelators: different mechanisms involved. , 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[1649]  A. Lotery,et al.  Progress in defining the molecular biology of age related macular degeneration , 2007, Human Genetics.

[1650]  P. Arosio,et al.  The effects of frataxin silencing in HeLa cells are rescued by the expression of human mitochondrial ferritin. , 2008, Biochimica et biophysica acta.

[1651]  A. Haase,et al.  Scrapie-associated prion protein accumulates in astrocytes during scrapie infection. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[1652]  M. Singer,et al.  Bench-to-bedside review: Potential strategies to protect or reverse mitochondrial dysfunction in sepsis-induced organ failure , 2006, Critical care.

[1653]  W. MacNee,et al.  Free radical activity of industrial fibers: role of iron in oxidative stress and activation of transcription factors. , 1997, Environmental health perspectives.

[1654]  A. Milam,et al.  Maculas affected by age-related macular degeneration contain increased chelatable iron in the retinal pigment epithelium and Bruch's membrane. , 2003, Archives of ophthalmology.

[1655]  A. Narang,et al.  Status of lipid peroxidation and plasma iron level in bronchial asthmatic patients. , 2007, Indian journal of physiology and pharmacology.

[1656]  S. J. Wilkinson,et al.  Properties of the Proximate Parameter Tuning Regularization Algorithm , 2010, Bulletin of mathematical biology.

[1657]  A. Buchan,et al.  The erythropoietin neuroprotective effect: assessment in coronary artery bypass graft surgery (TENPEAKS) – a randomized, double-blind, placebo-controlled, proof-of-concept clinical trial , 2006, Critical Care.

[1658]  K. Marder,et al.  Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease , 2007, Neurology.

[1659]  A. Kanthasamy,et al.  Interaction of metals with prion protein: possible role of divalent cations in the pathogenesis of prion diseases. , 2006, Neurotoxicology.

[1660]  M. Kaito Molecular mechanism of iron metabolism and overload in chronic hepatitis C , 2007, Journal of Gastroenterology.

[1661]  H. Mochizuki,et al.  The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson’s disease , 2010, Apoptosis.

[1662]  J. Meschia,et al.  Genetics of ischemic stroke: Inheritance of a sporadic disorder , 2009, Current neurology and neuroscience reports.

[1663]  E. Elstner,et al.  Transition metal ion‐catalyzed oxygen activation during pathogenic processes , 1999, FEBS letters.

[1664]  V. Haroutunian,et al.  Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology , 2008, Neurology.

[1665]  A Poland,et al.  2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. , 1982, Annual review of pharmacology and toxicology.

[1666]  T. Araki,et al.  Targeting reactive oxygen species, reactive nitrogen species and inflammation in MPTP neurotoxicity and Parkinson’s disease , 2008, Neurological Sciences.

[1667]  T. Stemmler,et al.  Human frataxin: iron and ferrochelatase binding surface. , 2007, Chemical communications.

[1668]  Mario Amendola,et al.  Oxidative stress and cell death in cells expressing L-ferritin variants causing neuroferritinopathy , 2010, Neurobiology of Disease.

[1669]  E. Benarroch Brain iron homeostasis and neurodegenerative disease , 2009, Neurology.

[1670]  F. Luft Doxorubicin toxicity in the Iron Age , 2006, Journal of Molecular Medicine.

[1671]  G. Perry,et al.  Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[1672]  R. Stoohs,et al.  Low iron status and enhanced insulin sensitivity in lacto-ovo vegetarians , 2001, British Journal of Nutrition.

[1673]  H. Sebai,et al.  Protective effect of resveratrol in endotoxemia-induced acute phase response in rats , 2009, Archives of Toxicology.

[1674]  W. Pryor,et al.  Oxidative chemistry of nitric oxide: the roles of superoxide, peroxynitrite, and carbon dioxide. , 1998, Free radical biology & medicine.

[1675]  P. Baeuerle,et al.  Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1. , 1991, The EMBO journal.

[1676]  M. Muckenthaler,et al.  Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis. , 2009, Journal of Alzheimer's disease : JAD.

[1677]  V. Cheynier Polyphenols in foods are more complex than often thought. , 2005, The American journal of clinical nutrition.

[1678]  M. Davies,et al.  The oxidative environment and protein damage. , 2005, Biochimica et biophysica acta.

[1679]  L. Valenti,et al.  Iron genes, dysmetabolism and fibrosis in chronic hepatitis C. , 2008, Journal of hepatology.

[1680]  Michel Theron,et al.  An interferon‐γ‐related cytokine storm in SARS patients† , 2004, Journal of medical virology.

[1681]  M. Reddy,et al.  Neuroprotective effect of the natural iron chelator, phytic acid in a cell culture model of Parkinson's disease. , 2008, Toxicology.

[1682]  J. Ferro,et al.  Other Neuroprotective Therapies on Trial in Acute Stroke , 2006, Cerebrovascular Diseases.

[1683]  C. Franceschi,et al.  Association between the HFE mutations and unsuccessful ageing: a study in Alzheimer's disease patients from Northern Italy , 2003, Mechanisms of Ageing and Development.

[1684]  Mark P Mattson,et al.  Neuronal life-and-death signaling, apoptosis, and neurodegenerative disorders. , 2006, Antioxidants & redox signaling.

[1685]  R. Regan,et al.  Minocycline attenuates iron neurotoxicity in cortical cell cultures. , 2009, Biochemical and biophysical research communications.

[1686]  Kim B Stevens,et al.  Classical sheep scrapie in Great Britain: spatial analysis and identification of environmental and farm-related risk factors , 2009, BMC veterinary research.

[1687]  J. Witztum,et al.  Innate and acquired immunity in atherogenesis , 2002, Nature Medicine.

[1688]  K. Choi,et al.  Association among serum ferritin, alanine aminotransferase levels, and metabolic syndrome in Korean postmenopausal women. , 2005, Metabolism: clinical and experimental.

[1689]  Yiwei Li,et al.  Harnessing the fruits of nature for the development of multi-targeted cancer therapeutics. , 2009, Cancer treatment reviews.

[1690]  F. Dal-Pizzol,et al.  N-acetylcysteine and deferoxamine reduce pulmonary oxidative stress and inflammation in rats after coal dust exposure. , 2005, Environmental research.

[1691]  H. Utsumi,et al.  Noninvasive detection of hydroxyl radical generation in lung by diesel exhaust particles. , 2001, Free radical biology & medicine.

[1692]  D. Cornforth,et al.  Effect of chelating agents and spice-derived antioxidants on myoglobin oxidation in a lipid-free model system. , 2009, Journal of food science.

[1693]  Xun Hu,et al.  Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6 , 2009, Science.

[1694]  T. von Zglinicki,et al.  Relocalized redox-active lysosomal iron is an important mediator of oxidative-stress-induced DNA damage. , 2004, The Biochemical journal.

[1695]  J. Franco,et al.  Methylmercury neurotoxicity is associated with inhibition of the antioxidant enzyme glutathione peroxidase. , 2009, Free radical biology & medicine.

[1696]  Regina M Murphy,et al.  Examining polyglutamine peptide length: a connection between collapsed conformations and increased aggregation. , 2009, Journal of molecular biology.

[1697]  J. Borlak,et al.  Deferoxamine-induced neurite outgrowth and synapse formation in postnatal rat dorsal root ganglion (DRG) cell cultures. , 2009, European journal of cell biology.

[1698]  David R. Jones,et al.  Different roles of radical scavengers – ascorbate and urate in the cerebrospinal fluid of amyotrophic lateral sclerosis patients , 2010, Redox report : communications in free radical research.

[1699]  C. Jacob,et al.  Metal trafficking: from maintaining the metal homeostasis to future drug design. , 2009, Metallomics : integrated biometal science.

[1700]  Paterson Rl,et al.  Sepsis and the systemic inflammatory response syndrome. , 2000, Journal of the Royal College of Surgeons of Edinburgh.

[1701]  B. Halliwell,et al.  Trace elemental distributions in induced atherosclerotic lesions using nuclear microscopy , 2003 .

[1702]  Vipul Periwal,et al.  System Modeling in Cellular Biology: From Concepts to Nuts and Bolts , 2006 .

[1703]  Douglas B. Kell,et al.  The methodologies of systems biology , 2007 .

[1704]  G. Brewer,et al.  Iron and Copper Toxicity in Diseases of Aging, Particularly Atherosclerosis and Alzheimer’s Disease , 2007, Experimental biology and medicine.

[1705]  M. Beal,et al.  Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. , 2008, Trends in molecular medicine.

[1706]  Sophia Ananiadou,et al.  Text mining and its potential applications in systems biology. , 2006, Trends in biotechnology.

[1707]  G. Beckett,et al.  Plasma glutathione S-transferase and F protein are more sensitive than alanine aminotransferase as markers of paracetamol (acetaminophen)-induced liver damage. , 1989, Clinical chemistry.

[1708]  S. Tanabe,et al.  8-Hydroxy-2′-deoxyguanosine (8-OHdG) as a possible marker of arsenic poisoning: a clinical case study on the relationship between concentrations of 8-OHdG and each arsenic compound in urine of an acute promyelocytic leukemia patient being treated with arsenic trioxide , 2009, Forensic Toxicology.

[1709]  W. Markesbery,et al.  Four-Hydroxynonenal, a Product of Lipid Peroxidation, is Increased in the Brain in Alzheimer’s Disease , 1998, Neurobiology of Aging.

[1710]  J. Segura-Aguilar,et al.  Dopamine-dependent iron toxicity in cells derived from rat hypothalamus. , 2005, Chemical Research in Toxicology.

[1711]  Ricardo Aurino Pinho,et al.  Attenuation of bleomycin-induced lung injury and oxidative stress by N-acetylcysteine plus deferoxamine. , 2008, Pulmonary pharmacology & therapeutics.

[1712]  J. Milner,et al.  A review of the interaction among dietary antioxidants and reactive oxygen species. , 2007, The Journal of nutritional biochemistry.

[1713]  D. Richardson,et al.  The ins and outs of mitochondrial iron-loading: the metabolic defect in Friedreich’s ataxia , 2010, Journal of Molecular Medicine.

[1714]  R. Keep,et al.  Iron and Iron-Handling Proteins in the Brain After Intracerebral Hemorrhage , 2003, Stroke.

[1715]  J. Sagripanti,et al.  Association between 8-hydroxy-2'-deoxyguanosine formation and DNA strand breaks mediated by copper and iron. , 1996, Free radical biology & medicine.

[1716]  M. Beal,et al.  Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases , 2006, Nature.

[1717]  C. Coopersmith,et al.  High-dose exogenous iron following cecal ligation and puncture increases mortality rate in mice and is associated with an increase in gut epithelial and splenic apoptosis* , 2004, Critical care medicine.

[1718]  Yau-Huei Wei,et al.  Response to the increase of oxidative stress and mutation of mitochondrial DNA in aging. , 2009, Biochimica et biophysica acta.

[1719]  Carole J. Proctor,et al.  An in silico model of the ubiquitin-proteasome system that incorporates normal homeostasis and age-related decline , 2007, BMC Systems Biology.

[1720]  D. Swinkels,et al.  Recent advances in the understanding of iron overload in sideroblastic myelodysplastic syndrome , 2010, British journal of haematology.

[1721]  Josep M. Guerrero,et al.  Beneficial pleiotropic actions of melatonin in an experimental model of septic shock in mice: regulation of pro‐/anti‐inflammatory cytokine network, protection against oxidative damage and anti‐apoptotic effects , 2005, Journal of pineal research.

[1722]  N. Inestrosa,et al.  The role of oxidative stress in the toxicity induced by amyloid beta-peptide in Alzheimer's disease. , 2000, Progress in neurobiology.

[1723]  D. Kamp,et al.  Molecular mechanisms of asbestos-induced lung epithelial cell apoptosis. , 2010, Chemico-biological interactions.

[1724]  Xiongwei Zhu,et al.  Iron: The Redox-active Center of Oxidative Stress in Alzheimer Disease , 2007, Neurochemical Research.

[1725]  E. Bulger,et al.  Antioxidants in critical illness. , 2001, Archives of surgery.